Spreadsheet: 13dfca20-a060-4c77-80ea-d3a48d00ba05
Sheet: Sheet1

Table S2. [NAME]T Wnt regulated gene list - 1003 transcripts | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5 | Unnamed: 6
FeatureNumber | GeneName | siCTNNB1 | siBRG1 | siP300 | siMLLT10 | Description
16926 | PSCDBP | -3.342806018318672 | -0.008050987060788772 | -0.0005537966395421368 | 0.1827936946237809 | pleckstrin homology, Sec7 and coiled-coil domains, binding protein (PSCDBP), mRNA [NM_004288]
8278 | THC2665398 | -3.212486739957489 | -0.9539452308285701 | -0.5033570945838148 | -0.08700796723671367 | Q5T0S6_HUMAN (Q5T0S6) Palmitoyl-protein thioesterase 1 (Ceroid-lipofuscinosis, neuronal 1, infantile) (Fragment), partial (5%) [THC2665398]
71 | SP5 | -3.148543644660481 | 1.004279151096479 | 1.635993080402939 | 0.3589668091435629 | Sp5 transcription factor (SP5), mRNA [NM_001003845]
16832 | PTPRO | -3.11571481898747 | -0.6046302980489919 | -0.6006174354857938 | -0.5794799472233194 | protein tyrosine phosphatase, receptor type, O (PTPRO), transcript variant 1, mRNA [NM_030667]
37439 | ACSL5 | -2.999854636937934 | 0.1320487555146193 | -1.897144786984871 | 0.06517788653161638 | acyl-CoA synthetase long-chain family member 5 (ACSL5), transcript variant 3, mRNA [NM_203380]
33320 | DEFA6 | -2.930611149244877 | -2.729767880398382 | -3.927679304157365 | 0.8328672677518121 | [NAME], alpha 6, [NAME] cell-specific (DEFA6), mRNA [NM_001926]
17435 | ASCL2 | -2.812536931851354 | 0.03764352444348784 | 0.508084351071532 | -0.2863467968029934 | achaete-scute complex homolog 2 (Drosophila) (ASCL2), mRNA [NM_005170]
31409 | CTNNB1 | -2.803226941018652 | 0.2140461057971234 | 0.2542687589360335 | 0.02787163047155417 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
32329 | CTNNB1 | -2.730136811407251 | 0.206656564116755 | 0.2534344620100872 | 0.007619624731883157 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
14130 | CTNNB1 | -2.72935412379009 | 0.2675687006616714 | 0.2836642541606271 | 0.04237649265437082 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
12154 | CTNNB1 | -2.723794163074852 | 0.2347690367005378 | 0.2617787125372135 | 0.0366693431186228 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
22688 | CTNNB1 | -2.708244286426596 | 0.2382330034647135 | 0.3427084197122885 | 0.006353581462143931 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
3467 | CTNNB1 | -2.706181731169834 | 0.1995204137963797 | 0.2638830280842498 | 0.05847415458108818 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
35727 | CTNNB1 | -2.704438114395557 | 0.2306297820815701 | 0.3159612489453342 | 0.05181635426594267 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
35413 | CTNNB1 | -2.692125498864256 | 0.187855449671278 | 0.2972568700425587 | 0.0234127704930347 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
29757 | CTNNB1 | -2.676111408011392 | 0.2170753198725797 | 0.318536466402618 | 0.02356624689294651 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
7985 | CTNNB1 | -2.673332392923029 | 0.2558221383558107 | 0.2836571106864516 | 0.02544726974168665 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
11447 | AK022843 | -2.655296183979717 | -1.178986254234151 | -0.4365000793697389 | -0.598860520867257 | Homo sapiens cDNA FLJ12781 fis, clone NT2RP2001861. [AK022843]
12967 | KIAA1199 | -2.623386604574474 | 0.2192292836281511 | -0.5171709691474704 | 0.2706239530061141 | [NAME] (KIAA1199), mRNA [NM_018689]
10298 | THC2603717 | -2.591933794932976 | 0.1645962720515979 | 0.05399424912507106 | 0.07335774566681261 | Q8WNW4_PIG (Q8WNW4) Beta-catenin, partial (11%) [THC2603717]
43613 | KIAA1199 | -2.56944753078156 | 0.3388187564997658 | -0.4475097852054974 | 0.3633752731475335 | [NAME] (KIAA1199), mRNA [NM_018689]
8926 | SP5 | -2.545114201693064 | 1.02322940383597 | 1.60224884213328 | 0.2992966956707175 | Sp5 transcription factor (SP5), mRNA [NM_001003845]
19861 | TNFSF12 | -2.502609114378501 | 0.4493662849166552 | 0.4336247237159253 | -0.1850244178396482 | tumor necrosis factor (ligand) superfamily, member 12 (TNFSF12), mRNA [NM_003809]
30265 | CTNNB1 | -2.487200634603026 | -0.04032594085258623 | 0.1147106334830004 | 0.06478907145775059 | catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), mRNA [NM_001904]
6036 | KRTAP9-2 | -2.416767982357744 | -3.912852808910087 | -4.221238151690423 | -0.04723174170281297 | keratin associated protein 9-2 (KRTAP9-2), mRNA [NM_031961]
2860 | RGMB | -2.415978435789549 | -0.813494006335997 | -1.23617259994043 | -0.8728382489607116 | RGM domain family, member B (RGMB), transcript variant 2, mRNA [NM_173670]
26592 | THC2689175 | -2.354977642631058 | -0.4742946557703568 | -0.4052293499886458 | 0.4682011651999106 | AB002334 Start codon is not identified {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (9%) [THC2689175]
37142 | REG1A | -2.346005085115511 | -0.9025073976457136 | -0.678681157834018 | -0.235136561205052 | regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein) (REG1A), mRNA [NM_002909]
29851 | ETS2 | -2.308502578014519 | 0.4371279460365911 | -0.1609834763911486 | -0.2546562186632366 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2), mRNA [NM_005239]
42082 | ASMT | -2.256715544414713 | -0.1424998758192948 | -0.6364314379283744 | 0.0891447875179665 | acetylserotonin O-methyltransferase (ASMT), mRNA [NM_004043]
45165 | ENC1 | -2.25052813160925 | 0.2298756598901945 | 0.03481570159439784 | 0.1641190785357722 | ectodermal-neural cortex (with BTB-like domain) ([NAME]), mRNA [NM_003633]
17665 | ARID5B | -2.243786249639901 | 0.3447826797162548 | -0.4973668224316243 | 0.005572948955799795 | AT rich interactive domain 5B (MRF1-like) (ARID5B), mRNA [NM_032199]
10746 | MEX3A | -2.2406676707158 | -0.07231417404762186 | 0.02860777671342984 | -0.251390026542311 | mex-3 homolog A (C. elegans) (MEX3A), mRNA [NM_001093725]
30076 | EPHA4 | -2.199216044533243 | -0.05693729238574632 | 0.01255301432226038 | -0.1897757285747971 | EPH receptor A4 (EPHA4), mRNA [NM_004438]
12792 | SLC12A2 | -2.173031746743868 | 0.508185341007545 | -0.01202383334596391 | -0.1441667293130573 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 (SLC12A2), mRNA [NM_001046]
23055 | EPHB3 | -2.136321127007703 | -0.3970996834927805 | -0.2053158020471484 | -0.1224573980366657 | EPH receptor B3 (EPHB3), mRNA [NM_004443]
44948 | SLC12A2 | -2.132358098847108 | -0.2241355013515465 | -0.5013504141576086 | -0.1291797679969644 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 (SLC12A2), mRNA [NM_001046]
10561 | ENC1 | -2.048080504868338 | 0.05940388452172973 | -0.2450226278524493 | 0.1847658695184808 | ectodermal-neural cortex (with BTB-like domain) ([NAME]), mRNA [NM_003633]
23962 | ARID5B | -2.0319165578528 | 0.3563180275886181 | -0.442868353387654 | 0.03775152065804532 | AT rich interactive domain 5B (MRF1-like) (ARID5B), mRNA [NM_032199]
11134 | RGMB | -2.028637002777824 | 0.2369561363566635 | 0.2335673122703792 | -0.5387128174463303 | RGM domain family, member B (RGMB), transcript variant 1, mRNA [NM_001012761]
13632 | ETS2 | -2.018084039632098 | 0.006583114070174201 | -0.3213689087249167 | -0.4072052103300319 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2), mRNA [NM_005239]
7654 | ITPR2 | -2.001783557883837 | -0.0081395191020599 | -0.1010443873970379 | -0.1441259114537843 | inositol 1,4,5-triphosphate receptor, type 2 (ITPR2), mRNA [NM_002223]
34975 | AXIN2 | -1.971973746970452 | 0.0121829616743363 | -0.2206098078482825 | 0.1803271723147262 | axin 2 (conductin, axil) (AXIN2), mRNA [NM_004655]
5281 | [NAME] | -1.96539225948237 | 0.08547386323826944 | 0.4930343146457367 | 0.08222121817264966 | [NAME] member 3C ([NAME]), mRNA [NM_002254]
42394 | SMOC2 | -1.935920360243787 | -0.4448938674851952 | -0.2462345615642221 | -0.6254499874164141 | SPARC related modular calcium binding 2 (SMOC2), mRNA [NM_022138]
18345 | SMAD9 | -1.860578959298095 | 0.07300288714261671 | -0.01309752402348963 | -0.1255003014456091 | [NAME] family member 9 (SMAD9), mRNA [NM_005905]
13963 | PMAIP1 | -1.849026753869763 | 0.2702473320658988 | 0.01534844921287293 | -0.09437113945186526 | phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA [NM_021127]
18705 | LOXL3 | -1.812707298641109 | -0.5127680172187883 | -0.3354272443092676 | -0.3259119048372592 | lysyl oxidase-like 3 (LOXL3), mRNA [NM_032603]
24032 | GOLSYN | -1.808502704187961 | 0.3696919051356711 | -0.4711006605411465 | -0.23146664054627 | Golgi-localized protein (GOLSYN), transcript variant 9, mRNA [NM_017786]
12185 | PMAIP1 | -1.801063099888528 | 0.1248198390234235 | -0.01357920027532022 | -0.1411446095472402 | phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA [NM_021127]
1451 | CYP26B1 | -1.797426387880526 | 0.2873614478490674 | 1.202804301615726 | 0.2643218315320881 | cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1), mRNA [NM_019885]
40130 | TMEM80 | -1.774772715827153 | -0.03064221317764071 | 1.585021250947354 | -0.7002374382494856 | [NAME] 80 (TMEM80), transcript variant 2, mRNA [NM_001042463]
8535 | PMAIP1 | -1.773277756997528 | 0.2612040279460039 | 0.01312352674784523 | -0.09671085778606803 | phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA [NM_021127]
45115 | KRTAP3-3 | -1.770184299324162 | -2.467815788129077 | -3.65560834551635 | 0.1791940928711044 | keratin associated protein 3-3 (KRTAP3-3), mRNA [NM_033185]
7642 | ETS2 | -1.765130698945753 | 0.7453600187087501 | 0.0645816894662572 | -0.3450780775878324 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2), mRNA [NM_005239]
40774 | A_24_P565496 | -1.729035607903302 | -0.460403963047936 | 0.06558312555017665 | 0.1367751506263826 | Unknown
8719 | SEMA3A | -1.727729724417728 | 0.4097789109949479 | 0.8226805157863278 | -0.223687532039708 | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A (SEMA3A), mRNA [NM_006080]
5153 | MEX3A | -1.713732644855254 | -0.08642274615397372 | -0.02145526689376598 | -0.1972335908554248 | mex-3 homolog A (C. elegans) (MEX3A), mRNA [NM_001093725]
33659 | LRP4 | -1.712216978786849 | 0.575887623217153 | -0.544245340463934 | -0.3369107791610519 | low density lipoprotein receptor-related protein 4 (LRP4), mRNA [NM_002334]
4591 | BX647543 | -1.658454496366109 | -3.414287518202223 | -2.828866891226856 | -0.1940971359718597 | Homo sapiens mRNA; cDNA [NAME] (from clone DKFZp779F2345). [BX647543]
7384 | PMAIP1 | -1.656052246555738 | 0.1864115786077274 | -0.06571940299956991 | -0.1704167433110658 | phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA [NM_021127]
13511 | PMAIP1 | -1.637113043711766 | 0.2117465960805808 | -0.0179625269172039 | -0.1843771923046308 | phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA [NM_021127]
37294 | ID1 | -1.632852669435206 | 0.7436001411628882 | 0.7671554916134625 | 0.06840541439925318 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1), transcript variant 1, mRNA [NM_002165]
26591 | THC2539634 | -1.62962497978967 | -0.127388994958513 | -0.3686108377846182 | 0.3144675134157293 | [NAME] (Q5T5W6) OTTHUMP00000016820, partial (82%) [THC2539634]
18729 | ENST00000359454 | -1.613047007255763 | -1.231758603265217 | -0.9614947485933589 | -0.3963569767751096 | Similar to CG32662-PA. [Source:Uniprot/SPTREMBL;Acc:Q6NS92] [ENST00000359454]
27893 | BX111592 | -1.60941162717483 | -0.426995094347602 | 0.06184093368814914 | -0.3030872282303818 | BX111592 [NAME] sapiens cDNA clone IMAGp998D162621, mRNA sequence [BX111592]
5817 | RHOBTB3 | -1.590263423065516 | -0.1781689711076769 | -0.5190789806688246 | -0.057582813505897 | Rho-related BTB domain containing 3 (RHOBTB3), mRNA [NM_014899]
37441 | PMAIP1 | -1.576498852226452 | 0.2647019727195056 | -0.02463865763157735 | -0.1534056511482903 | phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA [NM_021127]
2819 | NAV3 | -1.570909082687743 | -0.8954162222454293 | -0.9172949765053593 | -0.4342580453209017 | neuron navigator 3 (NAV3), mRNA [NM_014903]
26269 | CPXM2 | -1.56662365310072 | -0.09058764041055589 | -0.5859935771879199 | -0.4699881508084829 | carboxypeptidase X (M14 family), member 2 (CPXM2), mRNA [NM_198148]
4733 | SLC6A6 | -1.560659284845524 | -0.3284061433211812 | -0.555722801746087 | -0.05077359073898013 | solute carrier family 6 (neurotransmitter transporter, taurine), member 6 (SLC6A6), mRNA [NM_003043]
41982 | PDZD2 | -1.542243561562625 | 0.5620155680062122 | 1.112961842427079 | 0.166232468593785 | PDZ domain containing 2 (PDZD2), mRNA [NM_178140]
27106 | TSPAN5 | -1.539958120045469 | 0.01503406824963616 | -0.1626732976957592 | -0.02749590611973129 | Homo sapiens cDNA [NAME] fis, clone IMR321000210. [AK055659]
43585 | [NAME] | -1.521138130736749 | 0.3229282114746799 | -0.0901061176318036 | -0.2014446530029161 | leucine-rich repeats and immunoglobulin-like domains 1 ([NAME]), mRNA [NM_015541]
17154 | PRTFDC1 | -1.518943382341186 | 0.282038142121791 | 0.4059648704789269 | 0.05056303032668619 | phosphoribosyl transferase domain containing 1 (PRTFDC1), mRNA [NM_020200]
9665 | PHLDA1 | -1.514152311780862 | 0.5093255125018936 | 0.2663955955721898 | -0.242567125375463 | pleckstrin homology-like domain, family A, member 1 (PHLDA1), mRNA [NM_007350]
35637 | MPP5 | -1.514121270355973 | 0.2680688946694743 | -0.1284315760451841 | -0.2560621818433061 | membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) ([NAME]), mRNA [NM_022474]
26437 | [NAME] | -1.510133886482972 | 0.1215665675418227 | 0.5573964000826537 | -0.5351787589959314 | paraneoplastic antigen like 5 ([NAME]), transcript variant 3, mRNA [NM_052926]
2106 | RFC3 | -1.502959692113283 | -0.3892713232830208 | -0.3057686050088644 | -0.04665091685971234 | replication factor C (activator 1) 3, 38kDa (RFC3), transcript variant 1, mRNA [NM_002915]
73 | CN479126 | -1.488397040672749 | 0.2615725839091904 | 0.3038244421399477 | 0.1230272920753704 | CN479126 UI-CF-FN0-afv-i-22-0-UI.s1 UI-CF-FN0 Homo sapiens cDNA clone UI-CF-FN0-afv-i-22-0-UI 3', mRNA sequence [CN479126]
37661 | TSPAN5 | -1.487479788392321 | -0.1249798187619671 | -0.3543394247630551 | -0.102248201984354 | [NAME] (TSPAN5), mRNA [NM_005723]
9944 | SORBS1 | -1.48264339394336 | 0.7181057346899642 | -0.2486588801056031 | -0.2901757866598269 | [NAME] and SH3 domain containing 1 (SORBS1), transcript variant 3, mRNA [NM_001034954]
42524 | AK027667 | -1.473616823205761 | -0.1949189623797371 | 0.3563049606150384 | -0.1416537053257587 | Homo sapiens cDNA FLJ14761 fis, clone NT2RP3003302. [AK027667]
2090 | SLC7A5 | -1.470194115951199 | 0.3844833862642505 | 0.9177373251148602 | -0.318509801950186 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 (SLC7A5), mRNA [NM_003486]
3250 | AW946823 | -1.462733480358901 | 0.7200428208886795 | -0.277981656995428 | -0.1089772955271157 | AW946823 RC2-ET0022-080500-012-b10 ET0022 Homo sapiens cDNA, mRNA sequence [AW946823]
10714 | CYP4X1 | -1.461279244215309 | 0.1402959525905256 | 0.1045682106547847 | 0.1234748182420002 | cytochrome P450, family 4, subfamily X, polypeptide 1 (CYP4X1), mRNA [NM_178033]
33727 | MPP5 | -1.459074017628052 | -0.3982340810774689 | -0.05965145220958035 | -0.2819454882321395 | membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) ([NAME]), mRNA [NM_022474]
31973 | LEF1 | -1.455672325388907 | -0.1122092498639384 | 0.4157787390054963 | 0.5123534937433964 | lymphoid enhancer-binding factor 1 (LEF1), mRNA [NM_016269]
25897 | [NAME] | -1.412243988384934 | 0.03778677461995228 | -0.2615135987573589 | -0.1099301108748594 | growth arrest-specific 5 ([NAME]) on chromosome 1 [NR_002578]
5810 | ZNF473 | -1.400402654128068 | 0.2521765455052396 | 0.129283455670782 | -0.1782543383480525 | zinc finger protein 473 (ZNF473), transcript variant 1, mRNA [NM_015428]
738 | HS3ST1 | -1.396721418816099 | 0.151066719778854 | -0.3271080862981988 | -0.292975621600331 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1), mRNA [NM_005114]
8860 | NELF | -1.385217222058692 | -0.1958346040233274 | -0.09593450624845978 | 0.009351333888806934 | [NAME] LHRH factor (NELF), mRNA [NM_015537]
34534 | C18orf54 | -1.375862274908696 | 0.07216601867891304 | 0.6834046944266539 | 0.01018268662310184 | chromosome 18 open reading frame 54 (C18orf54), mRNA [NM_173529]
39302 | [NAME] | -1.373579841729622 | 0.3577477488662293 | -0.08297748934588564 | -1.012464745042242 | cyclin-dependent kinase 6 ([NAME]), mRNA [NM_001259]
30093 | AP1S2 | -1.364349260757546 | 0.2024266939432153 | -0.03274228330057172 | -0.08481860169343625 | adaptor-related protein complex 1, sigma 2 subunit (AP1S2), mRNA [NM_003916]
20719 | KLHDC4 | -1.356940260218977 | 0.5959604494704707 | 0.9494949654088567 | -0.4325902473033233 | Homo sapiens unknown mRNA. [AY251274]
29151 | LOC91461 | -1.352315265965732 | 1.169224903397606 | -0.2651746538544408 | -0.265322729131463 | hypothetical protein BC007901 (LOC91461), mRNA [NM_138370]
34803 | [NAME] | -1.343900623782276 | 0.1259601772121237 | 0.1535060624044284 | -0.1085154814155573 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
7038 | AK025975 | -1.343175815114891 | -0.4599122578951875 | -0.6408944357005293 | 0.1466777551606064 | Homo sapiens cDNA: [NAME] fis, clone HRC05532. [AK025975]
708 | GEMIN5 | -1.337797937915547 | -0.2906665058643172 | -0.7940848142483031 | 0.1712712192892247 | gem (nuclear organelle) associated protein 5 (GEMIN5), mRNA [NM_015465]
17939 | [NAME] | -1.332571756396559 | -0.003084572346194303 | 0.07046870645966719 | -0.03568463294266122 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
41675 | AL547890 | -1.32970339041165 | 0.09779063224270668 | -0.2100333498678155 | -0.1065145097227815 | AL547890 AL547890 Homo sapiens PLACENTA COT 25-NORMALIZED Homo sapiens cDNA clone CS0DI033YB09 5-PRIME, mRNA sequence [AL547890]
41125 | [NAME] | -1.328866149925219 | -0.7789328777114162 | -0.5810334422461945 | -0.205911450329987 | glutaminase 2 (liver, mitochondrial) (GLS2), nuclear gene encoding mitochondrial protein, mRNA [NM_013267]
19966 | NOTCH1 | -1.327198939490282 | 0.4221000575697895 | 0.2487357079976169 | -0.1828823000796636 | Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA [NM_017617]
21757 | ZAK | -1.323536407630066 | 0.1641378107886413 | 0.4666748816181479 | 0.1174964230457653 | sterile alpha motif and leucine zipper containing kinase AZK (ZAK), transcript variant 2, mRNA [NM_133646]
19775 | ZZZ3 | -1.322682129788309 | 0.1137092718866743 | 0.03657466800182189 | -0.03128281196439846 | zinc finger, ZZ-type containing 3 (ZZZ3), mRNA [NM_015534]
4684 | NOTCH1 | -1.318121093463767 | 0.2753904192077138 | 0.2631773352859911 | -0.272844497169913 | Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA [NM_017617]
12458 | THC2504848 | -1.311905575983946 | -0.3964701844304628 | 0.1168659293317375 | -0.04115815426523106 | Q15142_HUMAN (Q15142) Polycystic kidney disease-associated protein, partial (5%) [THC2504848]
13688 | THC2713242 | -1.311509789179587 | 0.1158307829858964 | -0.09581022727115251 | -0.2155063944937046 | Unknown
10246 | [NAME] | -1.309874891305326 | -0.03080123221457942 | 0.02734633962918709 | -0.1764992747078509 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
25332 | KIAA1549 | -1.300760870810629 | 0.03385323411881952 | 0.3300724723157173 | -0.09360162570460892 | KIAA1549 protein (KIAA1549), mRNA [NM_020910]
6659 | TMEM80 | -1.298424509284766 | -0.3219413427098419 | 0.9329344289446946 | -0.2375945524705658 | [NAME] 80 (TMEM80), transcript variant 2, mRNA [NM_001042463]
4501 | THC2516781 | -1.294188839356965 | 0.2694930012574384 | 0.1718682116241697 | -0.2795331469025051 | Unknown
40703 | STARD13 | -1.293841877753456 | 0.228040458721017 | 0.007101087369333459 | -0.1577141928839377 | StAR-related lipid transfer (START) domain containing 13 (STARD13), transcript variant alpha, mRNA [NM_178006]
8146 | NOTCH1 | -1.288069442530955 | 0.3449909726468703 | 0.1578337929255234 | -0.1121378652833003 | Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA [NM_017617]
28438 | [NAME] | -1.287883586301324 | 0.3199086987580311 | 0.1490117694120781 | -0.7370278972054842 | cyclin-dependent kinase 6 ([NAME]), mRNA [NM_001259]
38667 | [NAME] | -1.279563369425675 | -0.005517877035264407 | 0.2577833804529566 | 0.3339183933424457 | Unknown
32037 | CR609948 | -1.27719659946832 | -0.1199350444143132 | -0.01366886210433704 | 0.01907345574428732 | full-length cDNA clone CS0DH006YD11 of T cells (Jurkat cell line) of Homo sapiens (human). [CR609948]
2626 | KITLG | -1.274503689420563 | 0.176409791266372 | -0.1316251090281004 | 0.2434640858242192 | KIT ligand ([NAME]), transcript variant b, mRNA [NM_000899]
37407 | THC2495068 | -1.254999771589884 | -0.2044545117978894 | -0.02530981533316912 | -0.07450071595201985 | TWST1_GORGO (Q8MI06) Twist-related protein 1, partial (8%) [THC2495068]
23784 | LSM7 | -1.253331102579369 | 0.2098676059196423 | -0.1252035671955787 | -0.1422109118580512 | LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM7), mRNA [NM_016199]
34902 | AW327568 | -1.246885161799547 | 0.08653992085585704 | -0.03289740040077005 | -0.1075968643209713 | AW327568 [NAME] NIH_MGC_2 Homo sapiens cDNA clone IMAGE:2846557 3', mRNA sequence [AW327568]
31060 | TSNARE1 | -1.246767738949634 | -0.008676770546532708 | 0.294786569372488 | -0.41122333084102 | Homo sapiens t-SNARE domain containing 1, mRNA (cDNA clone IMAGE:5768818), partial cds. [BC065226]
13676 | FAM123B | -1.240636242664924 | 0.2063190980786085 | -0.1474000089995325 | -0.04961702925004291 | family with sequence similarity 123B (FAM123B), mRNA [NM_152424]
16238 | RAB15 | -1.23977915581738 | 0.3271314769904935 | -0.2222687316339283 | -0.2102532465590211 | RAB15, member RAS onocogene family (RAB15), mRNA [NM_198686]
33552 | THC2565422 | -1.238361607712053 | 0.004241779285760083 | -0.3764266516034718 | -0.02643250112816631 | ALU1_HUMAN (P39188) Alu subfamily J sequence contamination warning entry, partial (3%) [THC2565422]
26167 | ENST00000341154 | -1.233303368261059 | -0.3039262306342551 | 0.1134805298211266 | 0.1772733062108776 | FUS-interacting serine-arginine-rich protein 1 (TLS-associated protein with Ser-Arg repeats) (TLS-associated protein with SR repeats) (TASR) (TLS-associated serine-arginine protein) (TLS-associated SR protein) (40 kDa SR-repressor protein) (SRrp40) (S
8685 | [NAME] | -1.233192386795819 | 0.2036161166092524 | 0.1118422342123709 | 0.1764138213298794 | retinoblastoma binding protein 6 ([NAME]), transcript variant 3, mRNA [NM_032626]
19860 | NFKBIA | -1.229046198200071 | 0.2908870423588734 | 0.2493596132652158 | 0.08570891230653221 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA), mRNA [NM_020529]
9826 | PLA2G4A | -1.225104450593216 | -0.1194061237011168 | 0.05485581682176477 | 0.02769907856394294 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
37728 | THC2726281 | -1.224960224268181 | -0.04160685905194866 | 0.1750504555991829 | 0.299298152302968 | P97868_MOUSE (P97868) Proliferation potential-related protein, partial (4%) [THC2726281]
36430 | PLA2G4A | -1.220801416780447 | -0.1465686826413468 | -0.02438359235201737 | -0.05560070504961556 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
34482 | PLA2G4A | -1.220109297878673 | -0.1292314714824109 | 0.04992108532856787 | -0.002455359966270665 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
26333 | PLA2G4A | -1.219594416297991 | -0.1494380355710928 | 0.03009243507451553 | -0.02632242571881382 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
27807 | [NAME] | -1.21407244913876 | 0.07887760137532718 | 0.1048382614841734 | -0.05297364657906067 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
33890 | EPHA4 | -1.211930432863678 | -0.1688909912477645 | -0.2411204029448979 | -0.07711892717466418 | EPH receptor A4 (EPHA4), mRNA [NM_004438]
21744 | MYC | -1.211310512747119 | -0.5998951885896981 | -1.243605416776721 | -0.2827611531942255 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
23801 | [NAME] | -1.210898077103534 | 0.05047798165921513 | 0.06158357195969666 | -0.1692042219502135 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
32321 | PLA2G4A | -1.206630148596389 | -0.07963978721496068 | 0.0484966325956957 | 0.03248958157285142 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
37876 | MEST | -1.204084526528695 | 0.1350958209672726 | -0.7096902141887189 | -0.2445064726445356 | mesoderm specific transcript homolog ([NAME]) (MEST), transcript variant 1, mRNA [NM_002402]
37406 | ALDH1B1 | -1.20298333742869 | -0.3905194242876111 | -0.4588626960423792 | -0.3128657162295845 | aldehyde dehydrogenase 1 family, member B1 (ALDH1B1), nuclear gene encoding mitochondrial protein, mRNA [NM_000692]
36136 | LAMP3 | -1.195198131855302 | 0.04336069258217723 | 0.4730472353291755 | 0.1667359433377744 | lysosomal-associated membrane protein 3 (LAMP3), mRNA [NM_014398]
20376 | MYC | -1.194669014317866 | -0.5966602539518657 | -1.221124006095129 | -0.2906100622200137 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
44818 | C12orf24 | -1.192252160979397 | 0.02374224895507704 | -0.3908504016036102 | -0.01517918734284684 | chromosome 12 open reading frame 24 (C12orf24), mRNA [NM_013300]
38442 | RFXAP | -1.19143894600572 | -0.1206758709206815 | 0.01127865976449005 | -0.07146900943391332 | regulatory factor X-associated protein (RFXAP), mRNA [NM_000538]
32554 | PLA2G4A | -1.189174156251143 | -0.1586305683414447 | -0.07453037080412284 | -0.0282036322701773 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
39644 | GPT2 | -1.188529198430339 | -0.701108206192135 | -0.2743214275303554 | -0.05597075887017983 | glutamic pyruvate transaminase (alanine aminotransferase) 2 (GPT2), mRNA [NM_133443]
29701 | ALDH1B1 | -1.188340163946003 | -0.4692628905249734 | -0.3872119090421493 | -0.2360904575081975 | aldehyde dehydrogenase 1 family, member B1 (ALDH1B1), nuclear gene encoding mitochondrial protein, mRNA [NM_000692]
7396 | THC2693923 | -1.186742995368369 | 0.5404145442090411 | 0.2357541099632405 | -0.2020522465405516 | AY175578 antibody variable domain {Oryctolagus cuniculus} (exp=-1; wgp=0; cg=0), partial (11%) [THC2693923]
21686 | KRTAP3-2 | -1.186413775518428 | -1.926621800996141 | -2.40684140562771 | -0.4975826500931055 | keratin associated protein 3-2 (KRTAP3-2), mRNA [NM_031959]
29154 | MYC | -1.18640429174591 | -0.5468809425016978 | -1.194199201169552 | -0.2364155669039708 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
2201 | PLA2G4A | -1.185193340494372 | -0.132279957391517 | 0.001672660224072864 | -0.007176349636637047 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
17171 | PLA2G4A | -1.182965407033719 | -0.1619523927921757 | -0.0261088104614432 | -0.03343200725828599 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
41084 | PLA2G4A | -1.180780185263546 | -0.05966554017443748 | 0.0678356874535323 | 0.07769360972953177 | phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420]
35566 | [NAME] | -1.176853752957712 | -0.1265391421076836 | 0.01760709688849849 | -0.1862210972576093 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
1524 | ZNRF3 | -1.176610142516705 | -0.1625302112903499 | -0.113226099694218 | -0.08530282553192237 | zinc and ring finger 3 (ZNRF3), mRNA [NM_032173]
9734 | TNPO1 | -1.172043298116473 | 0.06827094407874335 | -0.2562541853340961 | -0.1223536984039064 | transportin 1 (TNPO1), transcript variant 1, mRNA [NM_002270]
30104 | [NAME] | -1.170260756981938 | -0.06748601299744417 | 0.1539365371141472 | -0.04858814772839626 | transcription factor 7 (T-cell specific, HMG-box) ([NAME]), transcript variant 1, mRNA [NM_003202]
8004 | ADH5 | -1.170002147537293 | 0.09480124210563691 | 0.1717193720379311 | 0.005302817636092749 | alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA [NM_000671]
40077 | AK094874 | -1.168441254414455 | -- | -- | -- | Homo sapiens cDNA FLJ37555 fis, clone BRCAN2028460. [AK094874]
19376 | MYC | -1.168133273145693 | -0.6126222657420913 | -1.259036698532395 | -0.2932083601347275 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
26676 | C10orf83 | -1.164372870473849 | 0.3655219735073254 | 0.04033185554555918 | -0.1567148609092732 | Homo sapiens chromosome 10 open reading frame 83, mRNA (cDNA clone IMAGE:4690584), complete cds. [BC022054]
16231 | ZNF711 | -1.162741184073573 | 0.2285856004091007 | 0.2471186644902874 | -0.2022560109523499 | zinc finger protein 711 (ZNF711), mRNA [NM_021998]
36424 | STXBP6 | -1.161303224547164 | -0.1784827883397164 | -0.4063532334383795 | -0.2348378102456943 | syntaxin binding protein 6 (amisyn) (STXBP6), mRNA [NM_014178]
10360 | MYC | -1.158637909589993 | -0.5811448069954982 | -1.269721600955176 | -0.2326171864220594 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
3124 | [NAME] | -1.157336280331634 | -0.4992680618703638 | -0.7341760139633959 | -0.08546390582524399 | dual specificity phosphatase 2 ([NAME]), mRNA [NM_004418]
37656 | SNAI3 | -1.156093144247555 | -0.2758931707679568 | 0.06352383641311699 | -0.05297764152978846 | snail homolog 3 (Drosophila) (SNAI3), mRNA [NM_178310]
21868 | SLC3A2 | -1.154616895347442 | 0.2626806797959944 | 0.5629485421418312 | -0.2122272076544576 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 1, mRNA [NM_001012661]
39735 | MYC | -1.153869644730427 | -0.5930363615965746 | -1.26691354135256 | -0.3278268629421104 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
42687 | BRCA2 | -1.150757151545376 | -- | -- | -- | breast cancer 2, early onset (BRCA2), mRNA [NM_000059]
23941 | BAI1 | -1.150309314147304 | 0.05792680812932849 | 0.4612328555290643 | -0.4612593176760758 | brain-specific angiogenesis inhibitor 1 (BAI1), mRNA [NM_001702]
7313 | MYC | -1.149245240617709 | -0.6295840686306627 | -1.258959197451652 | -0.2645297734345616 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
6084 | MYC | -1.148583718168557 | -0.6081755585059984 | -1.277093368692492 | -0.3057719374010327 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
43798 | MYRIP | -1.144009710196484 | 0.2133233828022929 | -0.481841660596201 | -0.2563284061769417 | [NAME] and Rab interacting protein (MYRIP), mRNA [NM_015460]
6804 | THC2552657 | -1.143115129244822 | 0.0424689140090555 | -0.02601111222397989 | -0.3570110282962045 | AY211924 sarcoma antigen NY-SAR-84 {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (22%) [THC2552657]
7098 | MYC | -1.142515552782011 | -0.6374357750188802 | -1.286700734043646 | -0.2520818499253618 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
44557 | C2orf44 | -1.140637442932018 | -0.06981970223147038 | 0.3187652760594366 | -0.04723839416279642 | chromosome 2 open reading frame 44 (C2orf44), mRNA [NM_025203]
10780 | ANXA9 | -1.139051987971135 | 0.006939871209153292 | -0.6868531746942439 | -0.09432473942462138 | annexin A9 (ANXA9), mRNA [NM_003568]
7606 | SNHG1 | -1.134305321955849 | -0.04480498353743889 | -0.1006449720506213 | -0.02246021624883854 | small nucleolar RNA host gene (non-protein coding) 1 (SNHG1) on chromosome 11 [NR_003098]
44478 | NOTCH1 | -1.13407780725304 | 0.2896437210773032 | 0.1846090177074319 | -0.3259487403691324 | Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA [NM_017617]
4555 | MMD | -1.132199950700064 | -0.168092769587262 | 0.16741171287214 | -0.1226028011547293 | monocyte to macrophage differentiation-associated (MMD), mRNA [NM_012329]
36321 | MYC | -1.125831920677768 | -0.5852553833095648 | -1.279732503567566 | -0.3090183301329081 | v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA [NM_002467]
39548 | MPHOSPH1 | -1.117312114555647 | -0.1993862600556174 | 0.3165662497180922 | -0.1426688054965106 | M-phase phosphoprotein 1 (MPHOSPH1), mRNA [NM_016195]
37105 | PDZD8 | -1.116664706812873 | 0.05984685665713485 | 0.1310643011271213 | -0.07405115344346802 | PDZ domain containing 8 (PDZD8), mRNA [NM_173791]
40112 | BRCA2 | -1.113577074524104 | -- | -- | -- | breast cancer 2, early onset (BRCA2), mRNA [NM_000059]
1390 | SNAI1 | -1.11323370138193 | -0.3950812397869969 | -0.1376755549179942 | -0.1663506445247966 | snail homolog 1 (Drosophila) (SNAI1), mRNA [NM_005985]
43572 | CDCA7 | -1.112442757942972 | -0.1895190154528056 | -0.6684480247762793 | -0.2292598674353888 | cell division cycle associated 7 (CDCA7), transcript variant 1, mRNA [NM_031942]
6883 | PATL1 | -1.10801351195684 | -0.4745152661113747 | -0.4773099414331623 | 0.5118694961282124 | protein associated with topoisomerase II homolog 1 (yeast) (PATL1), mRNA [NM_152716]
22460 | ADRA2C | -1.10667152392967 | -0.1336031637355273 | -0.06494398791349099 | -0.07259036546109376 | adrenergic, alpha-2C-, receptor (ADRA2C), mRNA [NM_000683]
29085 | NOTCH1 | -1.106445837948278 | 0.4067711907908437 | 0.1638042477834714 | -0.1045961580358464 | Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA [NM_017617]
7410 | VSNL1 | -1.10499613507386 | -0.3029645693574068 | -0.04870159854888634 | -0.09634768766490254 | visinin-like 1 (VSNL1), mRNA [NM_003385]
40603 | EDN2 | -1.104538315580836 | 1.659944363344351 | 0.03472771900003302 | -0.292270358991761 | endothelin 2 (EDN2), mRNA [NM_001956]
39834 | NELF | -1.100098748530209 | -0.2077578620099056 | -0.01369456253323564 | -0.06972229977848432 | [NAME] LHRH factor (NELF), mRNA [NM_015537]
42258 | [NAME] | -1.097843370794504 | -1.011239921219663 | -0.5217272679208693 | 0.1665087905590317 | pyruvate dehydrogenase kinase, isozyme 1 ([NAME]), nuclear gene encoding mitochondrial protein, mRNA [NM_002610]
25842 | THC2636523 | -1.094778753436473 | 0.1249658347967121 | 0.09411022080212506 | -0.004106115496143897 | Unknown
35835 | TXNL4B | -1.08673413783377 | -0.1655151556910499 | -0.2032060438531217 | -0.1635118390492325 | thioredoxin-like 4B (TXNL4B), mRNA [NM_017853]
12601 | TXNL4B | -1.081591249509351 | -0.01794483466036323 | -0.05569812125538359 | 0.09387665683503632 | thioredoxin-like 4B (TXNL4B), mRNA [NM_017853]
5728 | [NAME] | -1.079113518184422 | 0.1733326432633746 | -0.329929023853365 | 0.02660736290525884 | chromosome 14 open reading frame 172 (C14orf172), mRNA [NM_152307]
4505 | MAT1A | -1.078377729049816 | -0.2482060159327177 | -0.8406317860179889 | -0.04299543795113125 | methionine adenosyltransferase I, alpha (MAT1A), mRNA [NM_000429]
17161 | SYK | -1.073092612207919 | -0.4368496757605169 | -0.1929165326927209 | 0.002038803470884698 | [NAME] (SYK), mRNA [NM_003177]
31957 | TMPO | -1.072660006481327 | -0.2645607865898432 | 0.08939884990743507 | 0.01862489579363497 | [NAME] (TMPO), transcript variant 1, mRNA [NM_003276]
16554 | SYK | -1.06779290030884 | -0.4380393180060014 | -0.1688556746243273 | -0.03678378287710515 | [NAME] (SYK), mRNA [NM_003177]
23538 | MYBL1 | -1.064455657128857 | -0.1990381824503646 | 0.7740020504803091 | -0.4678289570093184 | [NAME] myeloblastosis viral oncogene homolog (avian)-like 1 (MYBL1), mRNA [NM_001080416]
25848 | B3GAT1 | -1.064289065092441 | -0.04303983120161292 | 0.2970163265716652 | -0.1577590731290779 | beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) (B3GAT1), transcript variant 2, mRNA [NM_054025]
3068 | C9orf21 | -1.062131746189494 | 0.3752786042162414 | 0.5695245981113823 | -0.003426020047354816 | chromosome 9 open reading frame 21 (C9orf21), mRNA [NM_153698]
42806 | SYK | -1.061171879218886 | -0.4608902966429551 | -0.2086018666063234 | -0.04356972457535413 | [NAME] (SYK), mRNA [NM_003177]
22788 | CDCA4 | -1.061035143177319 | -0.1315539018384217 | -0.03887462867010272 | -0.1991095198596238 | cell division cycle associated 4 (CDCA4), transcript variant 13, mRNA [NM_017955]
34017 | GPR161 | -1.059793338522021 | 0.4538189737493525 | 0.2676767689620687 | -0.06497750849331851 | Homo sapiens cDNA FLJ33952 fis, clone CTONG2018614. [AK091271]
35095 | THC2505349 | -1.059689682240423 | -0.08077169700769882 | 0.2477146117466541 | 0.02691865135275495 | ALU6_HUMAN (P39193) Alu subfamily SP sequence contamination warning entry, partial (13%) [THC2505349]
27477 | LOC339778 | -1.058267731251599 | -1.198480953714367 | -1.611472973349424 | 0.0959686450391053 | hypothetical protein LOC339778 (LOC339778), mRNA [NM_001105519]
39807 | 7A5 | -1.058014716598252 | 0.4579361345567544 | 0.8458401616701953 | 0.08715447356709771 | putative binding protein 7a5 (7A5), mRNA [NM_182762]
11058 | C5orf5 | -1.055333969790214 | 0.4185075971087826 | 0.4989567823920737 | -0.1099446536116735 | chromosome 5 open reading frame 5 (C5orf5), transcript variant 1, mRNA [NM_016603]
39775 | TRIM13 | -1.054428702361967 | 0.2984727316353302 | 0.2899355932537162 | -0.002366812145841002 | tripartite motif-containing 13 (TRIM13), transcript variant 3, mRNA [NM_213590]
1216 | SYK | -1.050478248363597 | -0.5429837336956043 | -0.1778290528222106 | -0.0170176430049791 | [NAME] (SYK), mRNA [NM_003177]
39258 | EIF2AK2 | -1.049040378695342 | 0.0813567739187605 | 0.5504788718296741 | 0.2111850284546464 | Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Interferon-inducible RNA-dependent protein kinase) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Protein kinase RNA-activated) (PK
24039 | PRIM1 | -1.047735260582001 | 0.02755236524422019 | -0.1343187927861303 | -0.1318833973419554 | primase, DNA, polypeptide 1 (49kDa) (PRIM1), mRNA [NM_000946]
36496 | SYNCRIP | -1.046940105270412 | -0.07402866963754362 | -0.01590941258008693 | -0.0553760756074535 | Homo sapiens synaptotagmin binding, cytoplasmic RNA interacting protein, mRNA (cDNA clone MGC:45213 IMAGE:5495201), complete cds. [BC032643]
30495 | PRIM1 | -1.046003581156334 | 0.0271006282015373 | -0.1485822881249566 | -0.1329921423999484 | primase, DNA, polypeptide 1 (49kDa) (PRIM1), mRNA [NM_000946]
10645 | C12orf29 | -1.04421809297329 | -0.2292740507395827 | -0.1830161777682011 | 0.1394401818908923 | chromosome 12 open reading frame 29 (C12orf29), mRNA [NM_001009894]
34679 | SLC7A5 | -1.04187766623792 | 0.0113433463415108 | 0.485253055190733 | -0.1992672652693307 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 (SLC7A5), mRNA [NM_003486]
2850 | PEX5 | -1.041090614936015 | -0.3206328804114877 | -0.350423325978946 | -0.1558994531308604 | peroxisomal biogenesis factor 5 (PEX5), mRNA [NM_000319]
31315 | BQ233242 | -1.038386731563181 | 0.5063739348093113 | 0.5204523325140049 | 0.2542373916299967 | BQ233242 AGENCOURT_7283259 NIH_MGC_70 Homo sapiens cDNA clone IMAGE:6017276 5', mRNA sequence [BQ233242]
24049 | PEA15 | -1.037689884395053 | -0.2811213906220236 | 0.5643783890215435 | 0.1186029808134232 | [NAME] enriched in astrocytes 15 (PEA15), mRNA [NM_003768]
29352 | C5orf26 | -1.036704250556985 | -0.196254244928951 | -0.1596709048677412 | -0.04792454508787081 | chromosome 5 open reading frame 26 (C5orf26) on chromosome 5 [NR_015370]
9839 | [NAME] | -1.033968639615014 | -0.0396373334281242 | -0.1271743492058279 | 0.05025515625654342 | [NAME] regulator of nonsense transcripts homolog B (yeast) (UPF3B), transcript variant 1, mRNA [NM_080632]
3490 | AK127132 | -1.030540026802781 | 0.3522029046512254 | 0.2146126841861763 | 0.1449739641517783 | Homo sapiens cDNA FLJ45189 fis, clone BRAWH3049068. [AK127132]
33099 | SYK | -1.027721238435434 | -0.4515753378667884 | -0.2543424280066229 | -0.0677918356773306 | [NAME] (SYK), mRNA [NM_003177]
34824 | SON | -1.027644751705435 | -0.4231999539414772 | -0.1051313276279819 | -0.2728207085106324 | SON DNA binding protein (SON), transcript variant b, mRNA [NM_032195]
4515 | CBR3 | -1.026154936715368 | 0.1490822587330947 | 0.2464742223988206 | 0.1951081461847413 | carbonyl reductase 3 (CBR3), mRNA [NM_001236]
34359 | SYK | -1.025579234451486 | -0.4437601897623242 | -0.2005744506185252 | -0.03350418279000333 | [NAME] (SYK), mRNA [NM_003177]
39403 | PEX5 | -1.022686678518383 | -0.1584145875390783 | -0.2149418152077593 | -0.07964565606532625 | peroxisomal biogenesis factor 5 (PEX5), mRNA [NM_000319]
13609 | SYK | -1.022458053959397 | -0.5104396047346631 | -0.2174380192765351 | -0.006058575644520836 | [NAME] (SYK), mRNA [NM_003177]
18715 | RAD51AP1 | -1.022287167666533 | 0.003424077184489227 | 0.3510593867129524 | 0.0717546445242318 | RAD51 associated protein 1 (RAD51AP1), mRNA [NM_006479]
38357 | GNPDA2 | -1.017197136865382 | 0.0674663164287122 | 0.2540436422334585 | 0.1068740462724908 | glucosamine-6-phosphate deaminase 2 (GNPDA2), mRNA [NM_138335]
18449 | IL15 | -1.014754442414359 | -0.1832622838076889 | -0.6510555337441084 | -0.2057967338548932 | interleukin 15 (IL15), transcript variant 1, mRNA [NM_172174]
35179 | RGS16 | -1.014678100686521 | -0.2667043987524014 | -1.079399533868042 | 0.00845074057948536 | regulator of G-protein signaling 16 (RGS16), mRNA [NM_002928]
42552 | ZNRF3 | -1.0133786409794 | -0.1712007263140869 | -0.3742528572659451 | -0.1034169343534457 | zinc and ring finger 3 (ZNRF3), mRNA [NM_032173]
35411 | [NAME] | -1.012573016943612 | -0.1763858192034424 | 0.1461572143764423 | -0.1636376051873094 | Homo sapiens cDNA [NAME] fis, clone NT2RP7004348, highly similar to ZINC FINGER PROTEIN 93. [AK096342]
10976 | SYK | -1.011179748146346 | -0.5368275431940153 | -0.199529225875037 | -0.08996787492974878 | [NAME] (SYK), mRNA [NM_003177]
28491 | MSN | -1.009347228105334 | 0.1826990748170831 | 0.7667919527117708 | 0.1208798346481657 | moesin (MSN), mRNA [NM_002444]
33203 | PRIM1 | -1.009044862722113 | 0.02557887014885724 | -0.1536228407670715 | -0.139330521523236 | primase, DNA, polypeptide 1 (49kDa) (PRIM1), mRNA [NM_000946]
11060 | SYK | -1.006960586041923 | -0.4464637243327081 | -0.1988082213136106 | -0.01285410442725166 | [NAME] (SYK), mRNA [NM_003177]
980 | RAD54B | -1.006657857405865 | -0.1266097988538767 | -0.02972121402807601 | 0.0120282098533521 | RAD54 homolog B (S. cerevisiae) (RAD54B), mRNA [NM_012415]
5988 | IMP4 | -1.006392636493829 | -0.08508478812387243 | -0.1141580782479874 | 0.0943861857929782 | full-length cDNA clone CS0DI010YB22 of [NAME]-normalized of Homo sapiens (human). [CR621399]
14345 | C11orf73 | -1.004367833454997 | -0.01875584091726976 | 0.4694422938760611 | -0.007349293398885959 | chromosome 11 open reading frame 73 (C11orf73), mRNA [NM_016401]
10796 | SYK | -1.004174053762474 | -0.5564323635939985 | -0.2438141316718694 | 0.0306992563303079 | [NAME] (SYK), mRNA [NM_003177]
1751 | THC2512148 | -1.003218510779571 | -0.1573361259084218 | 0.09427484240367301 | -0.217871897965972 | Unknown
38590 | RAD54B | -1.001961525743361 | -0.1024290285823146 | -0.124592532671945 | -0.04571625548359476 | RAD54 homolog B (S. cerevisiae) (RAD54B), mRNA [NM_012415]
17589 | AK022339 | -1.001763884475524 | 0.3721212284939202 | -0.6798905167193241 | -0.218939076003468 | Homo sapiens cDNA FLJ12277 fis, clone MAMMA1001711. [AK022339]
16825 | [NAME] | -1.001440187995427 | 0.04173070086351904 | -0.3066844754004243 | 0.03336979551769614 | Homo sapiens cDNA clone IMAGE:5260671, containing frame-shift errors. [BC038114]
4422 | BC014452 | 1.001262730762695 | 0.178695165182293 | -0.273806706265924 | 0.303358299556082 | Homo sapiens cDNA clone IMAGE:4903661, complete cds. [BC014452]
20483 | ABCA5 | 1.001451128599512 | -0.1511507957857772 | 0.6987322759516206 | 0.1339638829381455 | ATP-binding cassette, sub-family A (ABC1), member 5 (ABCA5), transcript variant 1, mRNA [NM_018672]
35372 | [NAME] | 1.001681441694547 | -0.4901686380938128 | -0.1376050001549942 | 0.3445347907979582 | jun B proto-oncogene (JUNB), mRNA [NM_002229]
24142 | OAZ3 | 1.002299963611572 | 0.1117698076093281 | -0.1085490076426616 | -0.1678415361517591 | ornithine decarboxylase antizyme 3 (OAZ3), mRNA [NM_016178]
17490 | PAQR6 | 1.002574622785711 | 0.222138325958197 | 0.8429455192340556 | 0.3064639312654331 | progestin and adipoQ receptor family member [NAME] (PAQR6), transcript variant 1, mRNA [NM_024897]
26524 | BRP44L | 1.00473737038355 | -0.117134888442677 | 0.03830170785329347 | -0.0682892449128106 | brain protein 44-like (BRP44L), mRNA [NM_016098]
42502 | N4BP2L2 | 1.005314437129397 | 0.7114868099027346 | -0.07761942642447361 | 0.02052264388594693 | NEDD4 binding protein 2-like 2 (N4BP2L2), transcript variant 1, mRNA [NM_033111]
40940 | CCDC88B | 1.006225354326851 | 0.07658295928002246 | -0.1571477775683342 | 0.07503771825188532 | coiled-coil domain containing 88B (CCDC88B), mRNA [NM_032251]
36184 | THC2717907 | 1.007832927847665 | 0.3306536472568199 | -0.4058528779848709 | 0.2408460616693123 | Q4IZP3_AZOVI (Q4IZP3) Outer membrane porin, partial (3%) [THC2717907]
31887 | CALCOCO2 | 1.007870836196216 | 0.3188303200227697 | -0.0440650485634881 | 0.1660775501249558 | calcium binding and coiled-coil domain 2 (CALCOCO2), mRNA [NM_005831]
2674 | LMF1 | 1.008087271438346 | 0.08143098512801483 | 0.1885712208671839 | -0.0004825166996387242 | [NAME] factor 1 (LMF1), mRNA [NM_022773]
15434 | [NAME] | 1.008733692900669 | -0.2228813372966736 | -0.4002447498105464 | -0.03931910763209112 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
41145 | CHP | 1.008972888665334 | -0.1093717279813899 | 0.01421771106417369 | 0.1148875896028791 | calcium binding protein P22 (CHP), mRNA [NM_007236]
37349 | SLC35A1 | 1.009371183525404 | -0.08116397828099724 | -0.5671728380535896 | 0.2404301221224114 | solute carrier family 35 (CMP-sialic acid transporter), member [NAME] (SLC35A1), mRNA [NM_006416]
2373 | RNF145 | 1.009730418822743 | -0.1438251912554521 | 0.2349971345678235 | -0.1911761224095382 | ring finger protein 145 (RNF145), mRNA [NM_144726]
9891 | PAFAH2 | 1.01133491623814 | 0.516395566020333 | 0.113374535400439 | 0.2552882742814162 | platelet-activating factor acetylhydrolase 2, 40kDa (PAFAH2), mRNA [NM_000437]
37461 | MGC50559 | 1.013089185605334 | -0.1309335703010674 | -0.3126865294349885 | 0.2028141809102286 | hypothetical protein MGC50559 (MGC50559), mRNA [NM_173802]
24900 | AATK | 1.013114248888425 | -0.6529927622874434 | -0.3457019031291568 | -0.1150257761643492 | apoptosis-associated tyrosine kinase (AATK), mRNA [NM_001080395]
4852 | FOLR1 | 1.013451919391246 | 0.353019298842967 | 0.3991916212035425 | 0.1779712645639524 | folate receptor 1 (adult) (FOLR1), transcript variant 1, mRNA [NM_016725]
32309 | [NAME] | 1.013521899626782 | 0.1458157269151239 | -0.051818605370516 | 0.2270359506508726 | [NAME] (TMEM53), mRNA [NM_024587]
45027 | [NAME] | 1.013718084195929 | -0.2131047135635189 | -- | -- | ghrelin/obestatin preprohormone ([NAME]), mRNA [NM_016362]
23978 | [NAME] | 1.015223661768026 | -0.4385532491830554 | -0.2470285774544748 | -0.0393310403300009 | ALU2_HUMAN (P39189) Alu subfamily SB sequence contamination warning entry, partial (13%) [THC2543840]
28814 | IL33 | 1.01652480203857 | -1.039004920456915 | -1.860443747024945 | 0.6843166045484157 | interleukin 33 (IL33), mRNA [NM_033439]
7853 | IL18 | 1.016868659134178 | -0.3684136996227907 | 0.4079605247614011 | 0.196078386706307 | interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA [NM_001562]
27105 | TRIM10 | 1.0172602759222 | 0.1473483660728341 | -0.07601769501250433 | 0.320654514468206 | tripartite motif-containing 10 (TRIM10), transcript variant 2, mRNA [NM_052828]
11898 | SIRT6 | 1.01728921755634 | -0.2583451045417045 | -0.3052903618368429 | 0.01314086422276506 | [NAME] (silent mating type information regulation 2 homolog) 6 (S. cerevisiae) (SIRT6), mRNA [NM_016539]
29158 | ARMET | 1.017823108870545 | -0.1759072682547827 | -0.09062808322414717 | -0.1516661583816474 | arginine-rich, mutated in early stage tumors (ARMET), mRNA [NM_006010]
19521 | PPP2R5C | 1.018071839233228 | -0.4445051533979428 | 0.1211569512186121 | 0.01200417284672772 | protein phosphatase 2, regulatory subunit B', gamma isoform (PPP2R5C), transcript variant 1, mRNA [NM_002719]
31298 | EFNB1 | 1.01867364470979 | -0.05012394325262728 | -0.2390583413166842 | 0.005114360104228777 | ephrin-B1 (EFNB1), mRNA [NM_004429]
1157 | IL18 | 1.021131972652717 | -0.5774843185196921 | 0.3055137282819427 | 0.1227274761058657 | interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA [NM_001562]
43067 | KCNK6 | 1.022619067814157 | 0.1636949336836337 | 0.03815994896011116 | 0.03323565549649674 | potassium channel, subfamily K, member 6 (KCNK6), mRNA [NM_004823]
32527 | OAZ3 | 1.023851347837221 | 0.1053534420383833 | 0.06577974881314885 | -0.1317832444321652 | ornithine decarboxylase antizyme 3 (OAZ3), mRNA [NM_016178]
44304 | LRP10 | 1.024305911674616 | 0.06806829237998015 | 0.4408158565305313 | -0.01040800041567039 | low density lipoprotein receptor-related protein 10 (LRP10), mRNA [NM_014045]
37458 | CEBPD | 1.024461908089181 | 0.4533546718790633 | -0.3439845202522118 | -0.008206335832251804 | CCAAT/enhancer binding protein (C/EBP), delta (CEBPD), mRNA [NM_005195]
15697 | THC2635964 | 1.024664382928492 | -0.4167321768825654 | -0.5184263988569469 | 0.5423424574016114 | [NAME] (Q4WTS6) Peptidyl-tRNA hydrolase, partial (6%) [THC2635964]
22255 | [NAME] | 1.024737057746003 | -0.2549992313247234 | -0.3828013183398125 | 0.01511598965399874 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
13719 | [NAME] | 1.026149500213944 | -0.1728197015226032 | -0.4915001167031643 | -0.1032804519410888 | chromosome 20 open reading frame 54 ([NAME]), mRNA [NM_033409]
32104 | THC2756581 | 1.028322334846444 | 0.4146185731913561 | 0.2021048409338949 | 0.1219254522760889 | Q4RAV2_TETNG (Q4RAV2) Chromosome undetermined SCAF22857, whole genome shotgun sequence. (Fragment), partial (19%) [THC2756581]
470 | THC2676635 | 1.02859308062319 | -0.1112066730299117 | 0.3650925990201919 | 0.161911169325482 | Unknown
29379 | TNFRSF1A | 1.028763580741914 | 0.293692501323643 | 0.07635655327071544 | 0.0531572747915191 | tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), mRNA [NM_001065]
1891 | BU956773 | 1.029463950980883 | -0.1377300607819825 | -0.8904083073475308 | 0.2224893876514571 | AGENCOURT_10624018 NIH_MGC_107 Homo sapiens cDNA clone IMAGE:6730528 5', mRNA sequence [BU956773]
26371 | NAT6 | 1.031804510759472 | -0.2137079331848707 | -0.4435374040566936 | -0.105673868246367 | N-acetyltransferase 6 (NAT6), mRNA [NM_012191]
30667 | A_32_P184304 | 1.031849446314715 | -- | -- | -- | Unknown
31145 | [NAME] | 1.032065148739508 | -0.3195759505221649 | -0.4288337732433025 | -0.05193977585360887 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
15835 | RRAS | 1.032288940059211 | -0.02167021823061643 | 0.03727506381963719 | 0.2381556928965473 | related RAS viral (r-ras) [NAME] ([NAME]), mRNA [NM_006270]
13266 | IL18 | 1.033814111492667 | -0.4949618730563863 | 0.3376178436166404 | 0.2347113766658238 | interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA [NM_001562]
43133 | NOX1 | 1.034904712777352 | -1.413218563358278 | -1.803024857382819 | -0.009154243894936798 | NADPH oxidase 1 (NOX1), transcript variant NOH-1Lv, mRNA [NM_013955]
16447 | MICALL2 | 1.035320686274358 | -0.09254355937039709 | 0.1231164161506664 | 0.1507298034865871 | MICAL-like 2 (MICALL2), transcript variant 1, mRNA [NM_182924]
21563 | NOX1 | 1.038583925699497 | -0.6984665748548791 | -0.2238601586907016 | -0.2711564660523522 | NADPH oxidase 1 (NOX1), transcript variant NOH-1L, mRNA [NM_007052]
38308 | PAOX | 1.039164369185252 | -0.3635618741534437 | 0.133743910174787 | 0.09176067633749452 | polyamine oxidase (exo-N4-amino) (PAOX), transcript variant 1, mRNA [NM_152911]
4278 | RAB11FIP1 | 1.041217241519907 | -0.07834861654891889 | 0.1293946303061406 | 0.03116936728947595 | RAB11 family interacting protein 1 (class I) (RAB11FIP1), transcript variant 2, mRNA [NM_001002233]
41356 | C17orf91 | 1.041460119807962 | 0.2273362344574765 | 0.1637858645655867 | 0.2899278775774266 | chromosome 17 open reading frame 91 (C17orf91), transcript variant 1, mRNA [NM_032895]
15547 | MMP15 | 1.042658188290156 | -0.4709322427730491 | -0.34064557411901 | -0.2556546839468603 | matrix metallopeptidase 15 (membrane-inserted) (MMP15), mRNA [NM_002428]
1040 | WWC2 | 1.043878564682182 | -0.007349826701222417 | 0.09119678402627995 | 0.270914653272734 | WW and C2 domain containing 2 (WWC2), mRNA [NM_024949]
5818 | GALNT10 | 1.044705130650969 | -0.08223759477986814 | -0.001746831237997126 | -0.01176274042787573 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) (GALNT10), transcript variant 1, mRNA [NM_198321]
12926 | [NAME] | 1.04580543246398 | -0.2405537582401946 | -0.4058718385538587 | -0.02639742422502667 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
22368 | TPMT | 1.04676293903858 | 0.285996543999224 | 0.07766581681812601 | 0.2409560251296876 | thiopurine S-methyltransferase (TPMT), mRNA [NM_000367]
44253 | PCSK4 | 1.047266064315734 | 0.238706312444059 | 0.3645281453031288 | -0.05871808010697499 | proprotein convertase subtilisin/kexin type 4 (PCSK4), mRNA [NM_017573]
4901 | [NAME] | 1.047367949677465 | -0.3058562894934014 | -0.4518101290869923 | -0.08013292910161085 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
34063 | PLD1 | 1.047493192512209 | 0.4452759739252732 | 0.04561478788754136 | 0.2475698819834159 | phospholipase D1, phosphatidylcholine-specific (PLD1), mRNA [NM_002662]
9943 | MKNK2 | 1.048256655965388 | 0.1694632346769285 | 0.5062384709001087 | 0.3427794365554866 | MAP kinase interacting serine/threonine kinase 2 (MKNK2), transcript variant 1, mRNA [NM_017572]
33978 | PVRL2 | 1.048520569034332 | 0.001204040146234098 | 0.1821531674245742 | 0.02371725343932019 | poliovirus receptor-related 2 (herpesvirus entry mediator B) (PVRL2), transcript variant delta, mRNA [NM_001042724]
25232 | [NAME] | 1.048550526846277 | -0.3038665063866424 | -0.3300701907822829 | -0.03720695233475091 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
12916 | TPMT | 1.049187371023806 | 0.294250148742232 | 0.01456950989327854 | 0.2372970801213321 | thiopurine S-methyltransferase (TPMT), mRNA [NM_000367]
11726 | APPL2 | 1.049245511409322 | -0.1361658855609668 | -0.2357053249909402 | -0.05379328101268532 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 (APPL2), mRNA [NM_018171]
1521 | CF552909 | 1.049475052654365 | -0.5141995941586521 | -0.6409055276184381 | -0.4370143822705461 | AGENCOURT_15595836 NIH_MGC_183 Homo sapiens cDNA clone IMAGE:30529642 5', mRNA sequence [CF552909]
24721 | A_24_P230486 | 1.04986018852677 | -0.2644360968893461 | -0.5476553634675744 | 0.2978252609087999 | Unknown
25506 | ABLIM2 | 1.049946434749319 | -0.853073599637721 | -0.68818732014747 | 0.08240264211972192 | [NAME] binding LIM protein family, member 2 (ABLIM2), mRNA [NM_032432]
38724 | A_32_P205792 | 1.050344369346288 | -0.1912124752652589 | 0.3577875299849631 | -0.1657896695308347 | Unknown
10336 | [NAME] | 1.050936232458158 | -0.2656987959740724 | -0.4311599224978162 | -0.02721695983129013 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
36808 | IL18 | 1.051551094108711 | -0.4749629846176404 | 0.3671601750390781 | 0.1815422352827651 | interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA [NM_001562]
4369 | FZD5 | 1.051582384179919 | 0.01207909993148615 | -0.6910378550189453 | -0.1195996562421897 | frizzled homolog 5 (Drosophila) (FZD5), mRNA [NM_003468]
8815 | RABAC1 | 1.052978546874846 | 0.02618147863509768 | -0.02790843876361637 | -0.06929217885410788 | Rab acceptor 1 (prenylated) (RABAC1), mRNA [NM_006423]
37354 | NPAS1 | 1.053018236109049 | 0.746418162430599 | 0.2184931044991869 | 0.1169282178088662 | neuronal PAS domain protein 1 (NPAS1), mRNA [NM_002517]
8296 | DOK4 | 1.054891152290562 | 0.02147919540621945 | -0.04491936482998771 | 0.01239930855317972 | docking protein 4 (DOK4), mRNA [NM_018110]
42112 | AP3S1 | 1.055063839068454 | 0.0163452923990085 | -0.005109154642904068 | 0.03431182091079532 | adaptor-related protein complex 3, sigma 1 subunit (AP3S1), mRNA [NM_001284]
31346 | AFAP1 | 1.055808590039218 | -0.1623144420948028 | -0.0982942325555779 | -0.1991175828434958 | actin filament associated protein 1 (AFAP1), transcript variant 1, mRNA [NM_021638]
23587 | [NAME] | 1.055824596645103 | -0.2602337970580296 | -0.6256577924222303 | 0.2826426167675772 | PREDICTED: Homo sapiens misc_RNA ([NAME]), miscRNA [XR_017288]
16052 | SPNS2 | 1.056144795633205 | -0.2845154068819187 | -0.3130870426786405 | -0.06482642354944224 | spinster homolog 2 (Drosophila) (SPNS2), mRNA [NM_001124758]
30279 | [NAME] | 1.056187489883563 | -0.2561579879437457 | -0.4110272839325715 | -0.01203085025467909 | Rho family GTPase 3 ([NAME]), mRNA [NM_005168]
1467 | A_32_P124773 | 1.057408653074258 | -0.3416703115353583 | -0.1377457701799433 | -- | Unknown
35444 | VPS13D | 1.060526780714428 | -0.04271298271004326 | -0.03393764125553694 | 0.02189103310274693 | vacuolar protein sorting 13 homolog D (S. cerevisiae) ([NAME]), transcript variant 1, mRNA [NM_015378]
38900 | AK125038 | 1.060886727236571 | 0.3202019841490943 | 0.4190535462147431 | 0.05603417647066833 | Homo sapiens cDNA [NAME], clone BRTHA3004502. [AK125038]
39560 | CYP4F2 | 1.062022591452513 | -0.2122003807597413 | -0.372820768117988 | 0.1220446056180037 | cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2), mRNA [NM_001082]
17353 | LMO7 | 1.062965917214365 | -0.111719634868347 | 0.3004669753939158 | 0.1373260292842851 | LIM domain 7 (LMO7), mRNA [NM_005358]
497 | PGPEP1 | 1.063832484180307 | -0.4895180394730076 | -0.335937840270514 | -0.05666173652355688 | pyroglutamyl-peptidase I (PGPEP1), mRNA [NM_017712]
37259 | C5orf30 | 1.067870899346604 | -0.2006532833605834 | -0.1372579680601707 | 0.1360988181248615 | chromosome 5 open reading frame 30 (C5orf30), mRNA [NM_033211]
6404 | AL080232 | 1.068317571279424 | 1.158186682463274 | 1.40126813631839 | 0.02916070201123322 | Homo sapiens mRNA; cDNA [NAME] (from clone [NAME]) [AL080232]
14732 | TNFRSF1A | 1.068900040476932 | 0.09231993323024601 | -0.07934180196002905 | -0.1611678480511139 | tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), mRNA [NM_001065]
40117 | PEX11G | 1.069091387687607 | -0.663559591659326 | -0.4020826115119351 | -0.191131506257681 | peroxisomal biogenesis factor 11 gamma (PEX11G), mRNA [NM_080662]
15402 | PAPSS1 | 1.069200406391632 | -0.0151039656030667 | 0.06107843259753909 | 0.03055393094536241 | 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1), mRNA [NM_005443]
3584 | ENST00000313664 | 1.069646930332556 | 0.2076928857607556 | 0.1595271693575816 | 0.1504699104821459 | Kazal-type serine protease inhibitor domain-containing protein 1 precursor. [Source:Uniprot/SWISSPROT;Acc:Q96I82] [ENST00000313664]
32846 | VASP | 1.070950130032422 | -0.2350709547861414 | -0.4379940723487712 | -0.09056572199679369 | vasodilator-stimulated phosphoprotein (VASP), mRNA [NM_003370]
44406 | CA12 | 1.071409166845997 | -0.1606768664143038 | -1.065342848949761 | -0.09372823076240677 | carbonic anhydrase XII (CA12), transcript variant 1, mRNA [NM_001218]
7173 | ZFYVE28 | 1.072381252366426 | -0.1120628843833066 | 0.3997411946758972 | 0.02649024553985402 | zinc finger, FYVE domain containing 28 (ZFYVE28), mRNA [NM_020972]
23529 | RAB24 | 1.074163785794088 | 0.1512065862393601 | 0.1487969529455084 | -0.1605237112448388 | RAB24, member RAS oncogene family (RAB24), transcript variant 1, mRNA [NM_001031677]
32782 | ZCWPW1 | 1.07473248383902 | 0.7914914311926444 | 0.728816559014591 | 0.0936002375372964 | zinc finger, CW type with PWWP domain 1 (ZCWPW1), mRNA [NM_017984]
35241 | AHNAK | 1.076492196351495 | 0.2651419202393792 | -0.0227815181170683 | 0.5432592726823986 | [NAME] (AHNAK), transcript variant 1, mRNA [NM_001620]
18555 | IL18 | 1.079457402353744 | -0.5440680993890623 | 0.3980119929103001 | 0.1905147896424801 | interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA [NM_001562]
21494 | CSTB | 1.079814032927263 | -0.1506985912813737 | -0.1839382864085302 | 0.1176800442157357 | [NAME] (stefin B) (CSTB), mRNA [NM_000100]
2800 | ZFP36 | 1.079854549985947 | -0.3402409529126373 | -0.06561702034520366 | -0.02744640577021594 | zinc finger protein 36, C3H type, homolog (mouse) (ZFP36), mRNA [NM_003407]
36933 | XR_019146 | 1.081086202496795 | -0.1164034423304238 | -0.4577297837913992 | 0.2562065383214844 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC651439), mRNA [XR_019146]
40292 | ABAT | 1.082527276330793 | -0.2853736317888098 | 0.3538867183817545 | 0.0666575443943409 | 4-aminobutyrate aminotransferase (ABAT), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_000663]
39350 | ENST00000313688 | 1.083131425095433 | 0.3008836089580338 | -0.7158682124838659 | 0.5786419878716491 | Homo sapiens mRNA for [NAME] protein. [AK090420]
2753 | CD104030 | 1.083466135760322 | 0.9846742194119065 | 1.530698311255147 | 0.7727975030756555 | AGENCOURT_14006900 NIH_MGC_186 Homo sapiens cDNA clone IMAGE:30372058 5', mRNA sequence [CD104030]
33523 | DOK7 | 1.083580951727162 | -0.3563892161754989 | -0.2182870140733371 | -0.1065830367808727 | docking protein 7 (DOK7), mRNA [NM_173660]
29843 | CYB5R4 | 1.083950441982625 | -0.297842060563561 | -0.1427311341689694 | 0.01649491901645106 | cytochrome [NAME] (CYB5R4), mRNA [NM_016230]
33557 | CANX | 1.084754484780639 | -0.05680640742222917 | -0.0159606362130208 | -0.1023480747559484 | calnexin (CANX), transcript variant 1, mRNA [NM_001746]
32721 | THC2701341 | 1.085653868409845 | 0.07313674290642891 | 0.4704749949838503 | 0.1759772576256209 | DQ071571 spermatin {Rattus norvegicus} (exp=-1; wgp=0; cg=0), partial (19%) [THC2701341]
41528 | PXMP4 | 1.086373072818437 | -0.07328682429582767 | 0.1184977786725865 | 0.03917030684597278 | peroxisomal membrane protein 4, 24kDa (PXMP4), transcript variant 1, mRNA [NM_007238]
24389 | ACSS2 | 1.087297864712966 | -0.845075738877402 | -0.5836639714672224 | 0.2538452772171476 | acyl-CoA synthetase short-chain family member 2 (ACSS2), transcript variant 1, mRNA [NM_018677]
13784 | INPP1 | 1.087958210535187 | 0.08602305475533178 | -0.03431578098127708 | 0.2179760543638456 | inositol polyphosphate-1-phosphatase (INPP1), mRNA [NM_002194]
24510 | SLC9A3R1 | 1.08919920879244 | -0.288793469927296 | -0.2498086027411712 | 0.03994426360561754 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 (SLC9A3R1), mRNA [NM_004252]
44135 | A_23_P21882 | 1.090707772246386 | -0.1684771571953632 | -0.347768749984825 | 0.1085114263379321 | Unknown
6740 | NUCB2 | 1.091571806076058 | -0.05805558190788343 | 0.8557807231527798 | 0.1722411526320992 | Homo sapiens cDNA FLJ40079 fis, clone TESTI2001498, highly similar to DNA-BINDING PROTEIN NEFA PRECURSOR. [AK097398]
35766 | RIPK3 | 1.091589507468201 | 0.5292620014446734 | 0.8640851634278621 | 0.5259065982803732 | receptor-interacting serine-threonine kinase 3 (RIPK3), mRNA [NM_006871]
32979 | PLEKHA6 | 1.094166021307925 | 0.1083600557082396 | -0.1204070558485442 | 0.006145263351314156 | pleckstrin homology domain containing, family A member 6 (PLEKHA6), mRNA [NM_014935]
3624 | MUC20 | 1.095109833400049 | 0.1360552741917354 | 0.1790496232148373 | -0.1206174886988003 | mucin 20, cell surface associated (MUC20), transcript variant L, mRNA [NM_152673]
4470 | ADAMTS13 | 1.095326371954144 | 0.2418904469615704 | 0.3937316330838381 | 0.3803884192584505 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 (ADAMTS13), transcript variant 1, mRNA [NM_139025]
37419 | IL18 | 1.095958834508515 | -0.3196798132615948 | 0.3050659626042975 | 0.2194971363377194 | interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA [NM_001562]
2778 | XR_016695 | 1.096145842118423 | -0.2298801254252551 | -0.4639287432535089 | 0.2468795627361871 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC345430), mRNA [XR_016695]
34105 | LOC339483 | 1.098219531315485 | 0.6204911563314666 | 0.8401426521372434 | 0.08636025204949582 | Homo sapiens cDNA FLJ38790 fis, clone LIVER2002842. [AK096109]
10206 | DKFZP434B0335 | 1.098476221848366 | -0.07562049273458427 | 0.468278495267795 | 0.2027979848498018 | DKFZP434B0335 protein (DKFZP434B0335), mRNA [NM_015395]
10047 | ENST00000301171 | 1.099556469015372 | -0.6314451142343218 | -0.3854057152812893 | 0.3123815774324563 | Human cytochrome P450 (CYP2A7PT) [NAME], partial cds. [U22030]
6267 | BAIAP2L2 | 1.100332272933135 | -0.07260562351865049 | -0.7658734689261595 | 0.06154268669850278 | BAI1-associated protein 2-like 2 (BAIAP2L2), mRNA [NM_025045]
44560 | DDEF2 | 1.100766558558763 | -0.2650761986160032 | -0.09437430913599593 | 0.1081056399984985 | development and differentiation enhancing factor 2 (DDEF2), mRNA [NM_003887]
41676 | RBM47 | 1.101515786719574 | 0.1948873811415317 | -0.2042646446722762 | -0.1148638155600832 | RNA binding motif protein 47 (RBM47), transcript variant 2, mRNA [NM_019027]
5619 | RNF103 | 1.101828786425108 | 0.2858479541555398 | 0.4622313855902868 | 0.1041065407149052 | ring finger protein 103 (RNF103), mRNA [NM_005667]
35690 | CYBB | 1.102224697801771 | 0.3347248697849825 | 0.1677811876806377 | 0.0500860798497631 | cytochrome [NAME], beta polypeptide (chronic granulomatous disease) (CYBB), mRNA [NM_000397]
31187 | AX721087 | 1.102750977249938 | 0.4173978045704574 | 0.5207138160908378 | 0.06889787495845101 | Sequence 47 from Patent WO0220754. [AX721087]
6660 | SPRED1 | 1.102961750597824 | -0.03627811001329628 | 0.0060060147694323 | -0.07372057841296176 | sprouty-related, EVH1 domain containing 1 (SPRED1), mRNA [NM_152594]
3007 | FA2H | 1.103186015956667 | -0.1194650633425332 | 0.4036230845766777 | -0.01725802868428783 | fatty acid 2-hydroxylase ([NAME]), mRNA [NM_024306]
26583 | PANK3 | 1.10421933873008 | -0.2077173152199654 | -0.5022243466686183 | -0.05480028481418775 | pantothenate kinase 3 (PANK3), mRNA [NM_024594]
1818 | ITPK1 | 1.105186827366412 | -0.2398521603826977 | -0.5792142092531765 | -0.0570729580024234 | Homo sapiens inositol 1,3,4-triphosphate 5/6 kinase, mRNA (cDNA clone MGC:2116 IMAGE:3010239), complete cds. [BC003622]
45121 | HHLA3 | 1.105865829469007 | 0.1040900732529535 | 0.4526240855150205 | -- | HERV-H LTR-associating 3 (HHLA3), transcript variant 3, mRNA [NM_001036645]
7649 | SERPINC1 | 1.105997199101833 | 0.3239899674611386 | 0.5821550055616885 | 0.01163398880658151 | serpin peptidase inhibitor, clade C (antithrombin), member 1 (SERPINC1), mRNA [NM_000488]
2648 | EZR | 1.106648909405875 | -0.4561005344240128 | -0.29393525753084 | -0.2279567235439144 | ezrin (EZR), transcript variant 1, mRNA [NM_003379]
15909 | TMEM16A | 1.111784489820677 | -0.02134260735654969 | 0.2489743350481923 | 0.1875344942801487 | [NAME] 16A (TMEM16A), mRNA [NM_018043]
12297 | ANXA4 | 1.112820158871904 | 0.2666375137233676 | -0.1494209627874035 | 0.1060505709060137 | annexin A4 (ANXA4), mRNA [NM_001153]
38930 | [NAME] | 1.11352597790343 | -- | -- | -- | ghrelin/obestatin preprohormone ([NAME]), mRNA [NM_016362]
31728 | FAM102A | 1.114083069729546 | 0.2148821185985877 | 0.1265226046859262 | 0.1019540966417794 | family with sequence similarity 102, member A (FAM102A), transcript variant 1, mRNA [NM_001035254]
11650 | AA334114 | 1.115378791270981 | 0.101134869410101 | -0.0766247534539628 | 0.2400628925386747 | AA334114 [NAME], 9 week Homo sapiens cDNA 5' end similar to similar to keratin 18, mRNA sequence [AA334114]
24213 | [NAME] | 1.116277445903066 | -0.6554783282136876 | -0.548853533467891 | -0.232210758086802 | ATPase, class V, type 10A ([NAME]), mRNA [NM_024490]
25412 | AK123679 | 1.116474981699686 | 0.2974851751981575 | -0.3016756931471003 | 0.06504527516206848 | Homo sapiens cDNA FLJ41685 fis, clone HCASM2006338. [AK123679]
42752 | FOSL2 | 1.116756597987834 | 0.01213215378070387 | -0.1305393521111553 | 0.1255962298926607 | FOS-like antigen 2 (FOSL2), mRNA [NM_005253]
44854 | XR_018462 | 1.117549147579026 | -0.2364872141826827 | -0.5242078480648942 | 0.2526350124420496 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC391803), mRNA [XR_018462]
36817 | MYOM3 | 1.118773042225097 | -0.4051962580372006 | -0.6831792461292165 | 0.2875206110576847 | [NAME], member 3 (MYOM3), mRNA [NM_152372]
17089 | CCL15 | 1.119661524781163 | -0.2025347582572983 | -0.4865633315940192 | -0.06866299537495912 | chemokine (C-C motif) ligand 15 (CCL15), transcript variant 2, mRNA [NM_004167]
30903 | A_24_P409420 | 1.122276973445218 | -0.1961280475381687 | -0.5571795586683754 | 0.307423206102358 | Unknown
2737 | [NAME] | 1.122847585684776 | -0.1094552266372122 | -0.07329597388237952 | 0.8399756225364587 | [NAME], axonemal, heavy chain 2 (DNAH2), mRNA [NM_020877]
2977 | GLS | 1.124599165286793 | 0.6278406497768625 | 0.646909599159593 | 0.3562583813730959 | Glutaminase kidney isoform, mitochondrial precursor (EC 3.5.1.2) (GLS) (L-glutamine amidohydrolase) (K-glutaminase). [Source:Uniprot/SWISSPROT;Acc:O94925] [ENST00000320717]
4310 | ZFYVE28 | 1.125389741984889 | -0.147166501139809 | 0.1879470777495333 | 0.0006802710791272704 | zinc finger, FYVE domain containing 28 (ZFYVE28), mRNA [NM_020972]
33773 | SLC39A11 | 1.125718070893714 | -0.04325483054032409 | -0.4611812924615181 | 0.0404944040978788 | solute carrier family 39 (metal ion transporter), member 11 (SLC39A11), mRNA [NM_139177]
43551 | THC2596442 | 1.125998219221837 | 0.13723476243249 | -0.4003508571767892 | 0.1776210280708505 | 1W7B_A Chain A, [NAME]: Does It Induce Membrane Aggregation By A New Multimeric State Of The Protein. {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (24%) [THC2596442]
11136 | UPP1 | 1.126119161820662 | 0.2806470395538346 | -0.1712016983102475 | 0.1617386486439949 | uridine phosphorylase 1 (UPP1), transcript variant 2, mRNA [NM_181597]
10122 | LRP10 | 1.126404000046869 | -0.06483606644231643 | 0.1801874749403587 | -0.008680552229476168 | low density lipoprotein receptor-related protein 10 (LRP10), mRNA [NM_014045]
40849 | LOC285813 | 1.126407317656458 | 0.5107708066130013 | 0.4844196551853728 | 0.2275313101238415 | Homo sapiens cDNA FLJ36950 fis, clone BRACE2005742. [AK094269]
10236 | A_24_P350136 | 1.126769213984296 | -0.2587472845461684 | -0.5929939202944318 | 0.1845818751464989 | Unknown
35497 | [NAME] | 1.127621700293622 | 0.3501787726086496 | 0.4550934909254691 | -0.1049709695218286 | Unknown
36930 | C12orf35 | 1.128042685417448 | -0.5210306997947014 | -1.107746619284491 | -0.2035556166582109 | chromosome 12 open reading frame 35 (C12orf35), mRNA [NM_018169]
19727 | TPCN1 | 1.128636987488925 | 0.007977307027836833 | 0.1084506975060433 | 0.002788482915626167 | Homo sapiens mRNA for KIAA1169 protein, partial cds. [AB032995]
28396 | FBLIM1 | 1.129280700583272 | 0.2500385293298734 | 0.1619065418796457 | 0.2397462888733495 | filamin binding LIM protein 1 (FBLIM1), transcript variant 1, mRNA [NM_017556]
9608 | TMPRSS4 | 1.131281452862697 | -0.7198390333894815 | -1.483184493442899 | 0.3386247306523709 | [NAME], serine 4 (TMPRSS4), transcript variant 1, mRNA [NM_019894]
6691 | C14orf24 | 1.131711239268914 | 0.007387779796145168 | 0.05937920374537204 | -0.006168836583556853 | chromosome 14 open reading frame 24 (C14orf24), transcript variant 2, mRNA [NM_001079519]
26527 | C5orf32 | 1.132061799351032 | 0.4221431185277895 | 0.2389675330570629 | 0.07636247507261446 | chromosome 5 open reading frame 32 (C5orf32), mRNA [NM_032412]
31517 | CKMT1A | 1.132121677104943 | -0.5855120670324929 | -0.5645600254059158 | 0.04676478491437086 | [NAME], mitochondrial 1A (CKMT1A), nuclear gene encoding mitochondrial protein, mRNA [NM_001015001]
6621 | CAPN12 | 1.133205867898887 | -0.1814732242197499 | -1.628297384182069 | -0.1784782652024216 | calpain 12 (CAPN12), mRNA [NM_144691]
17428 | AHNAK | 1.135105484575753 | -- | -- | -- | [NAME] (AHNAK), transcript variant 1, mRNA [NM_001620]
6423 | NXF3 | 1.135875968591767 | 0.8269666896513412 | 0.6770846016538274 | 0.3410684681888163 | nuclear RNA export factor 3 (NXF3), mRNA [NM_022052]
41172 | A_24_P6850 | 1.136081446454076 | -0.213624373272695 | -0.5200581096733939 | 0.2128591745771561 | Unknown
42844 | PIP5K1B | 1.136194469908516 | -0.1716865685959417 | -0.5806171133028828 | -0.08242289060023023 | phosphatidylinositol-4-phosphate 5-kinase, type I, beta (PIP5K1B), transcript variant 2, mRNA [NM_003558]
1959 | LIMA1 | 1.137576806240423 | 0.4935050298636253 | 0.7762271345903582 | 0.1926930802096829 | LIM domain and actin binding 1 (LIMA1), transcript variant b, mRNA [NM_016357]
35730 | KIFC2 | 1.14129774158286 | 0.4922988691645921 | 0.3757714597859087 | 0.1486072143120742 | [NAME] member C2 (KIFC2), mRNA [NM_145754]
14194 | PTRF | 1.141344156724877 | 0.1280728249188659 | 0.6199721816703021 | 0.2469600841471736 | polymerase I and transcript release factor (PTRF), mRNA [NM_012232]
18377 | BC038432 | 1.141726305851732 | -0.06784099719017994 | -0.4046794063870628 | 0.1776339195436469 | Homo sapiens cDNA clone IMAGE:5162874, partial cds. [BC038432]
33329 | FGFR3 | 1.144997252980533 | -0.2603858314089553 | 0.2464112363167917 | 0.1271960759775593 | fibroblast growth factor receptor 3 ([NAME], thanatophoric dwarfism) (FGFR3), transcript variant 1, mRNA [NM_000142]
39392 | IGF2BP3 | 1.145070285071409 | -0.1045019116138666 | 0.2591255603214742 | 0.1325283100509758 | insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3), mRNA [NM_006547]
13007 | C1orf175 | 1.146547780026751 | -- | -- | -- | chromosome 1 open reading frame 175 (C1orf175), mRNA [NM_001039464]
26417 | ENST00000342584 | 1.147524190531464 | -0.5981443224713985 | -0.3442380935209872 | 0.4411727831542818 | PP7080. [Source:Uniprot/SPTREMBL;Acc:Q71RB1] [ENST00000342584]
33707 | HKDC1 | 1.148919671566745 | -0.8775684902008223 | -2.304883661409225 | 0.3264584340947074 | hexokinase domain containing 1 (HKDC1), mRNA [NM_025130]
45179 | ANXA2 | 1.150406965877774 | 0.3187981260416394 | -0.1563065856484346 | 0.252792678125482 | annexin A2 (ANXA2), transcript variant 2, mRNA [NM_001002857]
7129 | IHPK2 | 1.152269654839261 | 0.2964290834312929 | -0.4619841259448292 | -0.09679244387500857 | inositol hexaphosphate kinase 2 (IHPK2), transcript variant 3, mRNA [NM_001005910]
24589 | A_24_P110601 | 1.152662783935048 | 0.01579248336868933 | -0.2056142081903698 | 0.10469171728381 | Unknown
36248 | XR_018618 | 1.153285096670318 | -0.06585712681645606 | -0.6047254314257744 | 0.3590258408023879 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC390634), mRNA [XR_018618]
1482 | A_24_P471242 | 1.153607341135645 | -0.2065889673314078 | -0.6092621694906564 | 0.2425751765997096 | Unknown
34416 | A_23_P21804 | 1.153874324828824 | -0.3473598531912399 | 0.1992027447887148 | -0.2349643674012891 | Unknown
1423 | NOXA1 | 1.15404031210823 | -0.05488740403944048 | 0.2558490496274999 | 0.06416214589312774 | NADPH oxidase activator 1 (NOXA1), mRNA [NM_006647]
19480 | XR_019186 | 1.155859039835985 | -0.2242459710737628 | -0.5682606274689861 | 0.2580254357333259 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC651929), mRNA [XR_019186]
28521 | S100A16 | 1.155868776739424 | 0.01344474888979996 | -0.5952249140647328 | 0.05998731010233538 | S100 calcium binding protein A16 (S100A16), mRNA [NM_080388]
26093 | C15orf52 | 1.156713170499718 | 0.161053979930017 | -0.09843408838591534 | 0.1475483450811294 | chromosome 15 open reading frame 52 (C15orf52), mRNA [NM_207380]
19987 | RBKS | 1.157056459379525 | 0.1376439208611324 | 0.2498555462358518 | 0.1885743507878352 | ribokinase (RBKS), mRNA [NM_022128]
44598 | WIPI1 | 1.157307081580259 | -0.2581629951147713 | -0.01316824222535218 | 0.09787454780050464 | WD repeat domain, phosphoinositide interacting 1 (WIPI1), mRNA [NM_017983]
3803 | SCARNA17 | 1.157876731623344 | 0.1444625808935736 | 0.2385600373198712 | -0.2207908313369207 | small [NAME] body-specific RNA 17 (SCARNA17) on chromosome 18 [NR_003003]
10053 | RGS2 | 1.159365168179348 | 1.056479424578662 | 0.1140836265311389 | -0.04773612366536484 | regulator of G-protein signaling 2, 24kDa (RGS2), mRNA [NM_002923]
29623 | A_24_P221724 | 1.159857516457377 | -- | -- | -- | Unknown
42054 | TOB1 | 1.160021941766193 | -0.1993526343035472 | -0.1643950090117925 | -0.1678464006171651 | transducer of ERBB2, 1 (TOB1), mRNA [NM_005749]
18201 | S100A4 | 1.162495452747574 | -0.1929042913876917 | -0.862709586223052 | 0.2341753513450104 | S100 calcium binding protein A4 (S100A4), transcript variant 1, mRNA [NM_002961]
13979 | CRIP1 | 1.163342567665267 | -0.01348910194495256 | -0.1335737586924171 | 0.1102780017877536 | cysteine-rich protein 1 (intestinal) (CRIP1), mRNA [NM_001311]
18120 | C17orf28 | 1.163626827875985 | -0.6820846934110627 | -0.1553103849231934 | 0.2254484668556245 | chromosome 17 open reading frame 28 (C17orf28), mRNA [NM_030630]
16241 | TMCO3 | 1.165291361002974 | 0.2298748559835952 | -0.1791412164128481 | -0.06753911966531878 | [NAME] and coiled-coil domains 3 (TMCO3), mRNA [NM_017905]
31260 | NFKBIZ | 1.166926046273838 | 0.6627086545311671 | 0.07064581671701009 | -0.08089076620517544 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta (NFKBIZ), transcript variant 1, mRNA [NM_031419]
5822 | VIPR1 | 1.167181193438925 | 0.495265957703493 | -0.1780112031088597 | 0.1641623413341227 | vasoactive intestinal peptide receptor 1 (VIPR1), mRNA [NM_004624]
39818 | S100A14 | 1.169469715213908 | -0.3408014499475849 | -0.4734816800751602 | -0.1063690212311665 | S100 calcium binding protein A14 ([NAME]), mRNA [NM_020672]
11067 | GJB5 | 1.17071201865671 | -1.194811422053367 | -0.9999851052584603 | 0.5507823253104416 | gap junction protein, beta 5, 31.1kDa (GJB5), mRNA [NM_005268]
16075 | BCL10 | 1.170808656700822 | -0.3634351891036169 | -0.1835776052087698 | 0.05691608825296224 | B-cell CLL/lymphoma 10 (BCL10), mRNA [NM_003921]
30489 | CACNA1H | 1.171453058763055 | -0.2825725948086243 | -0.3265920164970573 | 0.2889939094212639 | calcium channel, voltage-dependent, T type, alpha 1H subunit (CACNA1H), transcript variant 1, mRNA [NM_021098]
19287 | AHNAK | 1.171976485007182 | -0.06425479945058632 | -0.06466897445572173 | -0.02175368931443511 | [NAME] (AHNAK), transcript variant 1, mRNA [NM_001620]
10590 | ZC3H6 | 1.172898306599705 | 0.06234264614928398 | 0.8804063459371443 | 0.3275677587627147 | zinc finger CCCH-type containing 6 (ZC3H6), mRNA [NM_198581]
37048 | LMNA | 1.173272218673655 | -0.3948196201107706 | 0.1260173320480137 | 0.1097829742418399 | lamin A/C (LMNA), transcript variant 2, mRNA [NM_005572]
8107 | X92493 | 1.174624454350709 | -0.2961440377506768 | -0.5185477611813862 | 0.03346518800486953 | H.sapiens mRNA for STM-7 protein. [X92493]
16605 | NOX1 | 1.175597835589191 | -1.74495517578367 | -3.092691958974091 | 0.1236150168953163 | NADPH oxidase 1 (NOX1), transcript variant NOH-1L, mRNA [NM_007052]
652 | XR_018938 | 1.177019379974017 | -0.1986673756483586 | -0.4657162392431131 | 0.2789210466711191 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) ([NAME]), mRNA [XR_018938]
23879 | EME2 | 1.180419355108529 | 0.3807710940804261 | 0.3086690131827213 | 0.1278862656695918 | essential meiotic endonuclease 1 homolog 2 [Source:RefSeq_peptide;Acc:NP_001010865] [ENST00000307394]
37626 | CCNYL1 | 1.181661014761666 | -0.03004474009326163 | -0.06897424754700072 | 0.2411533924048953 | cyclin Y-like 1 (CCNYL1), mRNA [NM_152523]
44894 | A_24_P383660 | 1.18181504177116 | -0.193936852476211 | -0.472136520935431 | 0.268613756651212 | Unknown
12558 | SLC39A11 | 1.182156209599879 | 0.2321286257400061 | -0.2575783218179735 | 0.1554295474668486 | solute carrier family 39 (metal ion transporter), member 11 (SLC39A11), mRNA [NM_139177]
3648 | AK023756 | 1.182761024909391 | -1.168107979486889 | -0.2427898649727318 | -0.3599141134125983 | Homo sapiens cDNA FLJ13694 fis, clone PLACE2000115. [AK023756]
18519 | BTC | 1.183037649003998 | -0.5137103664998763 | -0.3479997392583241 | 0.08895725803315413 | betacellulin (BTC), mRNA [NM_001729]
2004 | KRT18P34 | 1.183262588382051 | -0.1715197198409221 | -0.4535402308957878 | 0.2822198297967329 | PREDICTED: Homo sapiens misc_RNA (KRT18P34), miscRNA [XR_019198]
30955 | THC2598362 | 1.183597279430954 | -0.3716950058521613 | 0.2569996117142992 | 0.06488034176435153 | Q59F29_HUMAN (Q59F29) PI-3-kinase-related kinase SMG-1 isoform 1homolog (Fragment), partial (4%) [THC2598362]
39213 | FKBP2 | 1.186952900696443 | 0.0562610070223859 | 0.05163743910540775 | 0.1066007183411046 | FK506 binding protein 2, 13kDa (FKBP2), transcript variant 1, mRNA [NM_004470]
3645 | PANK3 | 1.18812857556306 | -0.1831997624634012 | -0.3643587110250346 | -0.2028707065064985 | pantothenate kinase 3 (PANK3), mRNA [NM_024594]
37867 | PRR15 | 1.189657489978996 | 0.04824753449557262 | 0.06666187818173341 | 0.06551169512693056 | proline rich 15 (PRR15), mRNA [NM_175887]
22286 | SPAG9 | 1.190503139095918 | -0.1690306811046083 | 0.157874364563486 | 0.08578271060012432 | sperm associated antigen 9 (SPAG9), mRNA [NM_003971]
1594 | EDEM3 | 1.190695525073508 | -0.4054388418363299 | -0.04308658268884891 | -0.09067724310925196 | ER degradation enhancer, mannosidase alpha-like 3 ([NAME]), mRNA [NM_025191]
22712 | DISP2 | 1.190925406982277 | 0.6519359664379185 | 0.1518137812120632 | 0.4163183294195399 | dispatched homolog 2 (Drosophila) ([NAME]), mRNA [NM_033510]
14428 | PLCD1 | 1.19299505605039 | -0.2123174059748607 | 0.01110370776383041 | 0.05671506974692753 | phospholipase C, delta 1 (PLCD1), mRNA [NM_006225]
2461 | A_24_P247303 | 1.193135582079721 | -0.4310331819717901 | -0.8668796843198572 | 0.2162989799617197 | Unknown
10114 | COL6A2 | 1.193250318984672 | 0.2901820594566484 | 0.3204752217041045 | 0.0733601136700357 | collagen, type VI, alpha 2 (COL6A2), transcript variant 2C2a', mRNA [NM_058175]
16488 | XR_018953 | 1.193588052271934 | -0.1527674300315662 | -0.3101790690128634 | 0.6787665081325598 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC391179), mRNA [XR_018953]
6876 | KRT18 | 1.197676611776728 | -0.07719932822222969 | -0.3377339988852307 | 0.3553533688031721 | keratin 18 (KRT18), transcript variant 1, mRNA [NM_000224]
42230 | KRT18P19 | 1.197706934668571 | -0.2597427916362148 | -0.5585977130920183 | 0.2837026858789495 | PREDICTED: Homo sapiens misc_RNA (KRT18P19), miscRNA [XR_019026]
25530 | SPINK1 | 1.199089186457407 | -0.5192593969090071 | -1.847899447272786 | 0.8765881822439722 | serine peptidase inhibitor, [NAME] type 1 (SPINK1), mRNA [NM_003122]
38806 | XR_019037 | 1.200724784428015 | -0.1488828858105805 | -0.4565265152958431 | 0.2889625816461719 | PREDICTED: Homo sapiens hypothetical LOC391271 (LOC391271), mRNA [XR_019037]
26345 | A_24_P358406 | 1.201085726365911 | -0.1476903354163641 | -0.2511604943262685 | 0.3327101241824313 | Unknown
7280 | LOC257407 | 1.201299734773472 | -0.1765046894506451 | -0.4809006862279321 | 0.4292902437013275 | Homo sapiens clone 23568, 23621, 23795, 23873 and 23874 mRNA sequences. [AF007149]
10934 | [NAME] | 1.201394913992861 | -0.2591925459717097 | -0.5476928514593448 | 0.3020242481134202 | PREDICTED: Homo sapiens adenylate kinase 2 pseudogene 2 ([NAME]), mRNA [XR_017211]
13616 | GDA | 1.204166035017395 | -0.8393495362569693 | -1.03777547008542 | 0.3433446774366309 | guanine deaminase (GDA), mRNA [NM_004293]
27799 | KRT18P28 | 1.205162397686632 | -0.1780666476168498 | -0.444327539336985 | 0.257701458052016 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC343326), mRNA [XR_019568]
33509 | A_32_P21742 | 1.207439926371067 | -0.5855336462773972 | -0.1699649959704059 | 0.190952725070507 | Unknown
12738 | ATP10B | 1.207775882426798 | -- | -- | -- | ATPase, class V, type 10B (ATP10B), mRNA [NM_025153]
31931 | CCDC64B | 1.208761538023496 | -0.2004910718843074 | -0.01553967567146275 | 0.1750232872434783 | Homo sapiens mRNA; cDNA DKFZp666L166 (from clone DKFZp666L166). [AL833749]
35398 | ENST00000332750 | 1.209683318590206 | 0.4042400051582637 | -0.5836802960862668 | -0.1954868712342117 | Mucin-3B (Intestinal mucin-3B) (Fragment). [Source:Uniprot/SWISSPROT;Acc:Q9H195] [ENST00000332750]
39113 | AA639753 | 1.209900500269579 | -0.2500106042057293 | -0.7593675331117562 | 0.06150499341157611 | nq82c12.s1 NCI_CGAP_Co9 Homo sapiens cDNA clone IMAGE:1158838 3', mRNA sequence [AA639753]
13270 | XR_018953 | 1.210329955977854 | -0.1761610180903481 | -0.4615989895472277 | 0.2869590224972916 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC391179), mRNA [XR_018953]
13366 | EHD1 | 1.210654572299841 | -0.07183975454771452 | 0.3794779800864486 | 0.4221779285472257 | Homo sapiens EH-domain containing protein testilin mRNA, complete cds. [AF099011]
12478 | BTN3A2 | 1.212698714939656 | 0.5717925158598914 | 0.4216151458596527 | 0.1059898553618377 | butyrophilin, subfamily 3, member [NAME] (BTN3A2), mRNA [NM_007047]
35801 | PLEC1 | 1.213871274834298 | 0.4302233331078511 | 0.4533962696938336 | 0.1131715944946157 | plectin 1, intermediate filament binding protein 500kDa (PLEC1), transcript variant 6, mRNA [NM_201380]
17315 | BC040051 | 1.214557975505253 | 0.4959219936562043 | 0.0705213457322591 | 0.06890629571397855 | Homo sapiens, clone IMAGE:6018828, mRNA. [BC040051]
43041 | B3GNT3 | 1.216648935572576 | -0.5544711560449036 | -0.08425019355316854 | 0.02773193110403049 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3), mRNA [NM_014256]
33921 | ABCA3 | 1.216896206446151 | 0.3684087291878789 | 0.8328631217197959 | 0.09099912046830522 | ATP-binding cassette, sub-family A (ABC1), member 3 (ABCA3), mRNA [NM_001089]
12018 | PAG1 | 1.21809494645611 | -0.1721794683140333 | -0.7535103432788595 | 0.1224950172113766 | phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1), mRNA [NM_018440]
2453 | SLC25A20 | 1.218266361932119 | -0.1294267430528414 | 0.2150159207796998 | 0.01670995572685297 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (SLC25A20), nuclear gene encoding mitochondrial protein, mRNA [NM_000387]
35288 | GMPPB | 1.218702823088458 | -0.2312644922524907 | -0.09297058367312916 | -0.01086268560309867 | GDP-mannose pyrophosphorylase B (GMPPB), transcript variant 2, mRNA [NM_021971]
7458 | AHNAK | 1.220344681398656 | -0.1172514543680179 | -0.03673583217382737 | -0.03474294372868503 | [NAME] (AHNAK), transcript variant 1, mRNA [NM_001620]
14951 | KRT18P49 | 1.221698833163835 | -0.1287072712689007 | -0.4441790173337163 | 0.2843998574267121 | PREDICTED: Homo sapiens keratin 18 pseudogene 49 (KRT18P49), mRNA [XR_016590]
43705 | A_23_P66347 | 1.222173806927445 | -0.1229680531282327 | 0.03146735619852825 | 0.2883627899224213 | Unknown
27131 | FLNB | 1.222937776144176 | 0.1676984261606601 | 0.04148233823827585 | 0.2268331767051553 | filamin B, beta (actin binding protein 278) (FLNB), mRNA [NM_001457]
41867 | AMY1C | 1.225413275797811 | 0.4182860476155071 | 0.5604370239845379 | -0.07367009905801747 | amylase, alpha 1C (salivary) ([NAME]), mRNA [NM_001008219]
31356 | ANTXR2 | 1.22694222658886 | 0.2380519205135623 | -0.6169619683970324 | 0.2613091437167108 | anthrax toxin receptor 2 (ANTXR2), mRNA [NM_058172]
9612 | XR_019060 | 1.232123402459922 | -0.1916805625523386 | -0.5066941382487969 | 0.292174013011567 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC644030), mRNA [XR_019060]
14370 | ZNF226 | 1.232809937200569 | 0.9993281076075656 | 0.5350023689325993 | 0.0727099990541542 | zinc finger protein 226 (ZNF226), transcript variant 3, mRNA [NM_001032374]
36032 | EXOC7 | 1.232835054132797 | -0.2889816734977577 | 0.1957406428220945 | -0.06025674232227493 | exocyst complex component 7 (EXOC7), transcript variant 1, mRNA [NM_001013839]
1265 | ANKRD13C | 1.23438455121521 | 0.3986157702833785 | 0.3783801748684964 | 0.165260332912241 | ankyrin repeat domain 13C (ANKRD13C), mRNA [NM_030816]
7910 | A_24_P792988 | 1.235785012651188 | -0.2047179967367406 | -0.546068284416046 | 0.2870872811839879 | Unknown
34666 | RRAS | 1.236392299641299 | -0.02999488399846639 | -0.01378058020713169 | 0.169910821967035 | related RAS viral (r-ras) [NAME] ([NAME]), mRNA [NM_006270]
39755 | ENST00000328711 | 1.236707934632392 | 0.05934130736904963 | -0.3136056159180145 | -0.03412992674480297 | Uncharacterized protein C13orf29. [Source:Uniprot/SWISSPROT;Acc:Q8IVM7] [ENST00000328711]
25347 | LOC400573 | 1.237016570819278 | -1.336186754787665 | -2.379042788478139 | -0.2807516832785586 | Homo sapiens hypothetical gene supported by BC015790; BC041634, mRNA (cDNA clone IMAGE:4661388). [BC063383]
17153 | GDA | 1.239226481657341 | -0.3573367838069927 | -1.3452997895002 | 0.1125938946889322 | guanine deaminase (GDA), mRNA [NM_004293]
7680 | HRH1 | 1.239729704931373 | -0.0286150746572616 | -0.1490752144018634 | 0.1430859551553777 | histamine receptor H1 (HRH1), transcript variant 4, mRNA [NM_000861]
16188 | ANXA2P1 | 1.23992009210483 | 0.1903181526307115 | -0.439817894481808 | 0.2088819904890418 | annexin A2 pseudogene 1 (ANXA2P1) on chromosome 4 [NR_001562]
39741 | PRRG1 | 1.241212999308783 | -0.02054571467656569 | 0.1328584997378235 | 0.367795060275608 | proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1), mRNA [NM_000950]
35888 | SPRY2 | 1.241329956922666 | -0.1774494401535535 | 0.0569525334582841 | -0.015296656699753 | sprouty homolog 2 (Drosophila) (SPRY2), mRNA [NM_005842]
11881 | CA12 | 1.242936561935343 | -0.05106784409504393 | -0.8932447540432055 | 0.1194658139438132 | carbonic anhydrase XII (CA12), transcript variant 1, mRNA [NM_001218]
43233 | XR_018420 | 1.24298261764474 | -0.184438096833296 | -0.4696591277495626 | 0.3426310520069583 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) ([NAME]), mRNA [XR_018420]
8828 | LY6D | 1.24389175777676 | -- | -- | -- | [NAME] 6 complex, locus D (LY6D), mRNA [NM_003695]
30623 | XR_018749 | 1.244403874516689 | -0.1308660527437055 | -0.4135441437502415 | 0.3195935079087248 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC442405), mRNA [XR_018749]
19381 | THC2535223 | 1.244556560131617 | 0.4551540267533352 | -0.01179379580486328 | 0.2185207751636391 | BC000698 keratin 18 {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (19%) [THC2535223]
11373 | GPA33 | 1.244638897109184 | -0.6832991428189823 | -0.4094774765820759 | -0.1342716094150234 | glycoprotein A33 (transmembrane) (GPA33), mRNA [NM_005814]
8807 | THC2674900 | 1.245422565359518 | -0.2353582693436471 | -0.07967920454934907 | -0.4313515917694208 | Unknown
12799 | ANTXR2 | 1.246597338156561 | 0.2990629286009452 | -0.8636595357434276 | 0.2500279871910644 | anthrax toxin receptor 2 (ANTXR2), mRNA [NM_058172]
12765 | THC2582300 | 1.247270634183267 | 0.1406716706306848 | -0.175178580738058 | -0.1032808309730845 | Q2IIH7_ANADE (Q2IIH7) PE-PGRS family protein, partial (3%) [THC2582300]
36548 | LAMC2 | 1.250202390694951 | -0.4283196809527361 | -0.1335070464036443 | 0.06270801007176363 | laminin, gamma 2 (LAMC2), transcript variant 1, mRNA [NM_005562]
14652 | SELENBP1 | 1.250421230680829 | 0.2216638459991982 | -0.08347721410476971 | 0.2361457696041342 | selenium binding protein 1 (SELENBP1), mRNA [NM_003944]
1346 | RHOC | 1.252960743888853 | 0.2543143588436761 | 0.2477719098240827 | 0.2622956385653218 | ras homolog gene family, member C (RHOC), transcript variant 1, mRNA [NM_175744]
962 | A_24_P281443 | 1.256302689590247 | -0.1579075727425513 | -0.3792374000677025 | 0.3277336286186068 | Unknown
35620 | EPS8L1 | 1.2586302599656 | 0.3851123475064092 | 0.518577350923699 | 0.2632522490830374 | EPS8-like 1 (EPS8L1), transcript variant 1, mRNA [NM_133180]
7840 | TNFRSF14 | 1.25966555646259 | 0.4577136052441776 | 0.388699814787263 | 0.05030075646316001 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14), mRNA [NM_003820]
5630 | AA563626 | 1.260482908565517 | -- | -- | -- | AA563626 ng47f01.s1 [NAME] sapiens cDNA clone IMAGE:937945 3', mRNA sequence [AA563626]
11028 | TSPAN3 | 1.260493703669151 | 0.0840439739043159 | 0.002366507026745512 | 0.0002980975361012161 | tetraspanin 3 (TSPAN3), transcript variant 1, mRNA [NM_005724]
2528 | BTN2A2 | 1.261674933297832 | 0.5405298114598129 | 0.6903802727087065 | -0.1438726280564544 | butyrophilin, subfamily 2, member A2 (BTN2A2), transcript variant 2, mRNA [NM_181531]
38802 | LOC286144 | 1.262031340471686 | -0.06378456159376494 | 0.1531092054409341 | -0.01722366533130304 | hypothetical [NAME] (LOC286144) on chromosome 8 [NR_015339]
41868 | DHTKD1 | 1.262924134558226 | 0.1086848917757688 | 0.2501967806692288 | 0.01011079574740248 | dehydrogenase E1 and transketolase domain containing 1 (DHTKD1), mRNA [NM_018706]
39921 | THC2662587 | 1.264679245037614 | -0.1896308707512309 | -0.6592325487773467 | 0.09035792974718038 | Unknown
16532 | LAMB2 | 1.267557095293331 | 0.4610298169585557 | 0.7472436117332573 | 0.2577629303314122 | laminin, beta 2 (laminin S) (LAMB2), mRNA [NM_002292]
3383 | FUT2 | 1.269249383793938 | -1.74059774622883 | -1.40056558141341 | -0.4745699636506138 | fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 1, mRNA [NM_000511]
39045 | LOC442249 | 1.269470826344382 | -0.1600339037202606 | -0.4567030113951196 | 0.3254782899421319 | PREDICTED: Homo sapiens misc_RNA (LOC442249), miscRNA [XR_019231]
11361 | THC2689491 | 1.272544329860068 | -0.2751597498358898 | -0.03786514886949455 | -0.4766972619571748 | Unknown
1805 | TMEM61 | 1.275016477189966 | -0.2474489927015364 | -0.3823325723608986 | -0.06192361614623865 | [NAME] (TMEM61), mRNA [NM_182532]
43059 | FZD5 | 1.276148931446719 | 0.2251196697210349 | -0.6922752802103401 | -0.09666890349519375 | frizzled homolog 5 (Drosophila) (FZD5), mRNA [NM_003468]
18793 | GPT | 1.277198261761139 | 0.1338632466180563 | -0.08760605623978193 | -0.1356370782251768 | glutamic-pyruvate transaminase (alanine aminotransferase) (GPT), mRNA [NM_005309]
3127 | LMNA | 1.280208902106135 | -0.5517094270744527 | 0.1429152018650399 | 0.1178744731890705 | lamin A/C (LMNA), transcript variant 2, mRNA [NM_005572]
11068 | THC2524582 | 1.281584971454595 | -0.1813485354161734 | -0.4520103824201092 | 0.3405537878173194 | Q5U0N8_HUMAN (Q5U0N8) Keratin 18 (Cell proliferation-inducing protein 46), partial (46%) [THC2524582]
5163 | NPAL2 | 1.281732241994536 | -0.08934223445301001 | 0.3909022057766978 | 0.3151568600356313 | Homo sapiens cDNA: FLJ21362 fis, clone COL02886. [AK025015]
33505 | GALE | 1.283108523946393 | -0.1466832081055747 | -0.1972478734852687 | 0.04958355683817328 | UDP-galactose-4-epimerase (GALE), transcript variant 1, mRNA [NM_000403]
28441 | TOM1L2 | 1.283806644907849 | -0.1700620490562146 | 0.1328727467665638 | 0.167020866339586 | target of myb1-like 2 (chicken) (TOM1L2), transcript variant 3, mRNA [NM_001082968]
33573 | MARCO | 1.28450070846633 | -1.051785135569744 | -0.5878928404116346 | -0.09690849523368739 | macrophage receptor with collagenous structure (MARCO), mRNA [NM_006770]
38874 | THC2683231 | 1.287242153378422 | 0.4145362807608448 | 0.06443231631192825 | 0.05181998712650704 | Q77CB1_9ALPH (Q77CB1) UL6 protein, partial (3%) [THC2683231]
11497 | CLDN4 | 1.287253104114386 | -0.07219515401468168 | -0.308801046204588 | 0.1137625834411078 | claudin 4 (CLDN4), mRNA [NM_001305]
35021 | ANXA2 | 1.292176538228422 | 0.2889200985043451 | -0.2349250025533642 | 0.2811193227217842 | annexin A2 (ANXA2), transcript variant 2, mRNA [NM_001002857]
40963 | CYP4F11 | 1.292352974300458 | -- | -- | -- | cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11), mRNA [NM_021187]
33998 | TST | 1.294035343523774 | -0.5790056313675689 | -0.4043381830821446 | 0.06123786521452512 | [NAME] (rhodanese) (TST), nuclear gene encoding mitochondrial protein, mRNA [NM_003312]
35051 | A_24_P418687 | 1.295204782300875 | -0.177966336583282 | -0.4884176779649479 | 0.3271191812390625 | Unknown
5186 | NRBP2 | 1.297602619594158 | 0.1215168306378074 | 0.4401297086948497 | -0.08871010292877379 | nuclear receptor binding protein 2 (NRBP2), mRNA [NM_178564]
22382 | PIGR | 1.298492244063006 | -0.4860061990742857 | -0.1893570070127755 | -0.148626597496754 | [NAME] receptor (PIGR), mRNA [NM_002644]
12388 | KRT18P33 | 1.307705910773801 | -0.07845172151004275 | -0.3077448342835845 | 0.3439449282508445 | PREDICTED: Homo sapiens keratin 18 pseudogene 33 (KRT18P33), mRNA [XR_019330]
30369 | EZR | 1.307739322062194 | -0.1167185207656836 | -0.07860700541753829 | 0.005513200757084835 | ezrin (EZR), transcript variant 1, mRNA [NM_003379]
1675 | RNF145 | 1.308386748241669 | -0.1180264581993984 | 0.1461754955779151 | -0.00640164444659197 | ring finger protein 145 (RNF145), mRNA [NM_144726]
9540 | LOC284570 | 1.309226556080228 | 1.000578986607745 | 0.8517789857932092 | 0.05026668577204041 | Homo sapiens, clone IMAGE:4941949, mRNA. [BC040156]
33506 | A_24_P161733 | 1.309876509748694 | -0.1278400662203666 | -0.3808039887757808 | 0.4124399295031968 | Unknown
43485 | FER1L4 | 1.310526854408096 | 0.06880902135453981 | 0.235441846064778 | -0.0496242102620057 | Homo sapiens cDNA FLJ13459 fis, clone PLACE1003366, weakly similar to Homo sapiens otoferlin (OTOF) mRNA. [AK023521]
14372 | AGXT2L2 | 1.312598803080933 | 0.01140270946232044 | -0.2257423473036677 | -0.05382906229745837 | alanine-glyoxylate aminotransferase 2-like 2 (AGXT2L2), mRNA [NM_153373]
28552 | XR_018339 | 1.312634131620126 | -0.08859917644144338 | -0.3661042556802809 | 0.2726020116666361 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) ([NAME]), mRNA [XR_018339]
12862 | XR_018311 | 1.313303384362051 | -0.1834271273140333 | -0.4067650943219649 | 0.2894381703983303 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC139060), mRNA [XR_018311]
34778 | AGPAT4 | 1.314820955057929 | 0.186881132811747 | 0.5646362586728018 | 0.03637135786369128 | 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (AGPAT4), mRNA [NM_020133]
32453 | FLJ40504 | 1.316033757121706 | -0.111481919520937 | -0.3818142093995734 | 0.3818577206781462 | hypothetical protein FLJ40504 (FLJ40504), mRNA [NM_173624]
16214 | PLEKHM1 | 1.317316625126764 | -0.2349542837217757 | 0.4339820681717917 | 0.2405288926118258 | pleckstrin homology domain containing, family M (with RUN domain) member 1 (PLEKHM1), mRNA [NM_014798]
7065 | SELENBP1 | 1.320397975700995 | 0.05243210220691186 | -0.3341067742374286 | 0.0732811600762342 | selenium binding protein 1 (SELENBP1), mRNA [NM_003944]
31462 | BCAR3 | 1.321302669764453 | -0.4428408096208554 | -0.5671930228195183 | 0.01374483639370783 | breast cancer anti-estrogen resistance 3 (BCAR3), mRNA [NM_003567]
38819 | IQCG | 1.321818450424973 | 0.2016142121190679 | -0.5364208480082746 | -0.2104350516973404 | IQ motif containing G (IQCG), mRNA [NM_032263]
27372 | SERPINB8 | 1.322212304863759 | -0.1622946318098281 | -0.1806983028718441 | 0.3915668456228323 | serpin peptidase inhibitor, clade B (ovalbumin), member 8 (SERPINB8), transcript variant 2, mRNA [NM_198833]
1543 | KRT18 | 1.322314167802475 | -0.2139164506778252 | -0.397969446452523 | 0.3796823193579035 | keratin 18 (KRT18), transcript variant 1, mRNA [NM_000224]
8202 | [NAME] | 1.324080748567382 | 0.5131777052956457 | 1.023029146715855 | 0.2144956078465836 | retinoic acid receptor responder (tazarotene induced) 3 ([NAME]), mRNA [NM_004585]
3152 | XR_016161 | 1.324874476944759 | -0.213461057720397 | -0.4711314896283924 | 0.3234205950315843 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC642448), mRNA [XR_016161]
10092 | PTPRR | 1.324966063997202 | 0.0196287548919063 | -1.356923990577843 | -0.08721307204649875 | protein tyrosine phosphatase, receptor type, R (PTPRR), transcript variant 1, mRNA [NM_002849]
42261 | CYP2B6 | 1.328202382350963 | -0.6593472775435747 | -1.352020322434262 | -0.1112375603173388 | cytochrome P450, family 2, subfamily B, polypeptide 6 (CYP2B6), mRNA [NM_000767]
24076 | GLS | 1.332736555090093 | 0.2898653598374305 | 0.3018279814584321 | 0.3222497803450857 | glutaminase (GLS), nuclear gene encoding mitochondrial protein, mRNA [NM_014905]
1300 | XR_019191 | 1.33285193528642 | -0.05289101228892945 | -0.3306448697262145 | 0.3287388586035209 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC121054), mRNA [XR_019191]
18443 | EDEM1 | 1.333504074949669 | -0.1499710203975589 | -0.03919623645469095 | -0.07564122448919317 | ER degradation enhancer, mannosidase alpha-like 1 (EDEM1), mRNA [NM_014674]
35579 | C19orf33 | 1.336922617502978 | 0.0581636061262949 | -0.3653586452652624 | -0.09783451823476819 | chromosome 19 open reading frame 33 (C19orf33), mRNA [NM_033520]
44666 | SLC37A1 | 1.337665777996027 | 0.02050303853071633 | -0.1929147441666346 | -0.06845970134818002 | solute carrier family 37 (glycerol-3-phosphate transporter), member 1 (SLC37A1), mRNA [NM_018964]
37987 | RHOF | 1.33901241622424 | -0.545759565712467 | -0.3556424264760065 | 0.05215003230948279 | ras homolog gene family, member F (in filopodia) (RHOF), mRNA [NM_019034]
5570 | MUC13 | 1.341817068790965 | -0.8423078751362425 | -2.247779054401263 | 0.2153510544921318 | mucin 13, cell surface associated (MUC13), mRNA [NM_033049]
41133 | MGC2664 | 1.344084643650056 | -1.175905522036836 | -1.475537218875053 | -0.3112432247601791 | Homo sapiens, clone IMAGE:3543963, mRNA. [BC004968]
45087 | HEPH | 1.345264617423821 | 0.06334341552223455 | -0.694064675313017 | 0.01720738921240894 | [NAME] (HEPH), transcript variant 2, mRNA [NM_014799]
7177 | A_24_P780319 | 1.346843678005314 | -0.1229492779228328 | -0.3913602255487669 | 0.2962616992811226 | Unknown
40891 | MICAL1 | 1.347566598654865 | 0.159061939971749 | 0.3084043299247485 | 0.372800838841549 | microtubule associated monoxygenase, calponin and LIM domain containing 1 (MICAL1), mRNA [NM_022765]
2982 | [NAME] | 1.347767675128545 | -0.09864930448043474 | 0.2995710699895219 | 0.3438474939073489 | development and differentiation enhancing factor-like 1 (DDEFL1), mRNA [NM_017707]
24797 | ATP9B | 1.351819666682774 | -0.4906148298419262 | -1.012918158296622 | 0.02672372958135316 | ATPase, class II, type 9B (ATP9B), mRNA [NM_198531]
24047 | TNFRSF6B | 1.353363730087402 | 0.01658956373760967 | -0.09797079634854744 | 0.173299905828096 | tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68C, mRNA [NM_032945]
17189 | SLC22A23 | 1.353533368165785 | 0.1044730237949607 | 0.01706223689991759 | 0.03361510529101985 | solute carrier family 22, member 23 (SLC22A23), transcript variant 1, mRNA [NM_015482]
22443 | KRT18P42 | 1.356294226923952 | -0.1245671792616203 | -0.3350180694703007 | 0.3672603090803166 | PREDICTED: Homo sapiens misc_RNA (KRT18P42), miscRNA [XR_018193]
38564 | PLDN | 1.358523999403998 | 0.04148417094600609 | -0.253319945182872 | -0.08396016730575973 | [NAME] homolog ([NAME]) (PLDN), mRNA [NM_012388]
17497 | PHLDA2 | 1.358551232238328 | -0.4632220151099207 | 0.1651440830351387 | 0.0256918350709241 | pleckstrin homology-like domain, family A, member 2 (PHLDA2), mRNA [NM_003311]
32030 | DDX60 | 1.358575058435395 | 0.6602031802898498 | 0.9726588330647015 | 0.2137728413344955 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (DDX60), mRNA [NM_017631]
38164 | BE738586 | 1.359148893277399 | -- | -- | -- | 601572877T1 NIH_MGC_57 Homo sapiens cDNA clone IMAGE:3839731 3', mRNA sequence [BE738586]
43223 | SEMA4G | 1.360723846460898 | 0.28780790435485 | -0.05872336861650229 | 0.04996939313911675 | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G (SEMA4G), mRNA [NM_017893]
32316 | AF088076 | 1.360999844205963 | -0.7261348740940581 | -1.241086690301217 | 0.1253131832154946 | Homo sapiens full length insert cDNA clone ZE01A04. [AF088076]
12184 | UGT2B7 | 1.362733126129743 | 0.2634538861320834 | -0.8497300976130138 | 1.304929411547682 | UDP glucuronosyltransferase 2 family, polypeptide [NAME] (UGT2B7), mRNA [NM_001074]
6469 | BTN3A2 | 1.362861525294466 | 0.5633920616645469 | 0.4736721803602679 | 0.1755809406415381 | butyrophilin, subfamily 3, member [NAME] (BTN3A2), mRNA [NM_007047]
1569 | ITGA3 | 1.363326656185131 | 0.129410790489744 | -0.001140275736452256 | -0.05721928594526748 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant a, mRNA [NM_002204]
810 | IFIT2 | 1.36432805024666 | 0.3689738875191101 | 1.403702173492606 | 0.4991256249683357 | interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), mRNA [NM_001547]
11168 | BU943730 | 1.369182276307345 | 0.06160073436900593 | -1.144328486402784 | 1.043704739811724 | AGENCOURT_10544326 NIH_MGC_126 Homo sapiens cDNA clone IMAGE:6723988 5', mRNA sequence [BU943730]
12579 | KRT18 | 1.3701868291903 | -0.004553951166813897 | -0.2866265702515305 | 0.4627391984567846 | keratin 18 (KRT18), transcript variant 1, mRNA [NM_000224]
26063 | FUT5 | 1.372937760200259 | -0.5903804941696875 | -0.6101636077656081 | -0.1546036829231787 | fucosyltransferase 5 (alpha (1,3) fucosyltransferase) (FUT5), mRNA [NM_002034]
12550 | S100P | 1.374596015215341 | -1.184142727417417 | -1.557123938616479 | 0.1309403812502403 | S100 calcium binding protein P (S100P), mRNA [NM_005980]
41514 | ZZEF1 | 1.379066062118913 | 0.1630879447468772 | 0.3831772356956572 | 0.06357551830603148 | zinc finger, ZZ-type with EF-hand domain 1 (ZZEF1), mRNA [NM_015113]
9431 | [NAME] | 1.382498612910807 | -0.0249434550980146 | -0.2754264770097811 | 0.4410974328891033 | PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) (LOC649233), mRNA [XR_018843]
43280 | THC2702298 | 1.382552899361444 | -0.9509101087039966 | -0.3191333497783222 | 0.01780710652497053 | ALU1_HUMAN (P39188) Alu subfamily J sequence contamination warning entry, partial (6%) [THC2702298]
13984 | THC2757602 | 1.387863569138633 | 0.3916843576997335 | 0.170534302692223 | 0.1853570750546847 | Unknown
6516 | PLXNA2 | 1.388462215461576 | 0.2134127277193687 | 0.2972349396698541 | 0.2483730381588218 | plexin A2 ([NAME]), mRNA [NM_025179]
39244 | ENST00000343959 | 1.390160901165212 | 0.6072416032721357 | -0.01189481530603653 | 0.08342217042062283 | Protein FAM25. [Source:Uniprot/SWISSPROT;Acc:Q5VTM1] [ENST00000343959]
22196 | C10orf116 | 1.392984067335499 | 0.09318193038580391 | -0.4652310673927866 | 0.4519286544848393 | chromosome 10 open reading frame 116 (C10orf116), mRNA [NM_006829]
472 | SERPINB8 | 1.394684752507655 | -0.4611968418422027 | -0.5251351146961956 | 0.2819213690410138 | serpin peptidase inhibitor, clade B (ovalbumin), member 8 (SERPINB8), transcript variant 3, mRNA [NM_001031848]
38543 | KLF2 | 1.395512322197016 | -0.2990526010586909 | 0.06561755401295177 | 0.2549002910183452 | Kruppel-like factor 2 (lung) (KLF2), mRNA [NM_016270]
36921 | [NAME] | 1.398592639817706 | -0.5640148880363389 | -0.1393704215669955 | -0.3114615953576165 | ATPase, class V, type 10A ([NAME]), mRNA [NM_024490]
34977 | TOB1 | 1.400980800334449 | 0.1499837170724918 | 0.200662784008496 | -0.05915916771257135 | Homo sapiens, clone IMAGE:4133978, mRNA. [BC015064]
44995 | CAMK2N1 | 1.403187046919727 | 0.07163789426510081 | -0.0896831601131709 | 0.2298555502662791 | calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1), mRNA [NM_018584]
12714 | FGFBP1 | 1.407150371728501 | -0.6396964049222191 | -0.6692292658598493 | -0.1293948860946035 | fibroblast growth factor binding protein 1 (FGFBP1), mRNA [NM_005130]
28149 | TSPAN8 | 1.408493284414355 | -0.8427208539150697 | -1.377152984657215 | 0.2242382319778793 | [NAME] (TSPAN8), mRNA [NM_004616]
13619 | GALNT10 | 1.414721013800143 | 2.227899563034297 | 2.026316545813197 | -0.05473145612502606 | Homo sapiens cDNA FLJ11715 fis, clone HEMBA1005223. [AK021777]
36373 | MAGT1 | 1.423451034006945 | -0.2808789089057443 | -0.262205033009753 | 0.1690919441025341 | magnesium transporter 1 (MAGT1), mRNA [NM_032121]
36288 | [NAME] | 1.424745976506413 | 0.1501924952703633 | 0.3313784374875034 | 0.02484582502651544 | KIAA1324-like ([NAME]), mRNA [NM_152748]
29949 | RILP | 1.425338988739649 | 0.02310559744937812 | -0.005093861814726264 | 0.03568399745781647 | Rab interacting lysosomal protein (RILP), mRNA [NM_031430]
44392 | NDRG1 | 1.42560686769245 | -1.20214034884398 | -0.2909045283239793 | 0.2280433159113711 | N-myc downstream regulated gene 1 (NDRG1), mRNA [NM_006096]
36711 | TP53INP1 | 1.426925251427349 | 1.043990951821295 | 0.9053760788815992 | 0.2788611723387948 | tumor protein p53 inducible nuclear protein 1 (TP53INP1), mRNA [NM_033285]
7526 | PLSCR4 | 1.429720628174254 | 0.3576220411608672 | 0.1953497350664055 | 0.2176782773938046 | phospholipid scramblase 4 (PLSCR4), mRNA [NM_020353]
11543 | [NAME] | 1.429833388033699 | 0.8158978957171995 | 0.1599757401377199 | 0.5447361790253008 | hypothetical LOC388610 (LOC388610), mRNA [NM_001013642]
32408 | FUT6 | 1.431841711153349 | -0.5683485209592729 | -0.298767532124578 | 0.1083578144033535 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (FUT6), transcript variant 1, mRNA [NM_000150]
37130 | [NAME] | 1.432017334183484 | 0.1085524568006031 | -0.5200541040924974 | 0.1261657381226355 | MOB1, [NAME] kinase activator-like 2B (yeast) (MOBKL2B), mRNA [NM_024761]
31504 | HEPH | 1.440900142171113 | -0.1166823894825664 | -0.6897988426103071 | -0.0149695603923472 | [NAME] (HEPH), transcript variant 2, mRNA [NM_014799]
28953 | [NAME] | 1.442715905576332 | -0.1684795220759741 | -- | 0.1998934723009063 | [NAME] ([NAME]), mRNA [NM_002273]
39919 | PDZK1IP1 | 1.442980741809094 | -0.6353648511940797 | -0.4878613500826363 | -0.1462094264158611 | PDZK1 interacting protein 1 (PDZK1IP1), mRNA [NM_005764]
41571 | DKFZP564O0823 | 1.443945693821133 | -0.4922909182957937 | -0.2852900316813045 | 0.05415119169119542 | DKFZP564O0823 protein (DKFZP564O0823), mRNA [NM_015393]
11999 | [NAME] | 1.444661259555787 | -0.1395515541676849 | -0.1182176136550969 | 0.08084103878194263 | acyl-CoA synthetase family member 2 (ACSF2), mRNA [NM_025149]
32303 | CALML4 | 1.447285863121479 | 0.1646271677700772 | -0.8396166526279562 | -0.2183079365730567 | calmodulin-like 4 (CALML4), transcript variant 1, mRNA [NM_033429]
40689 | SOD3 | 1.450427184131414 | 0.05532552848517591 | 0.03255380274774544 | -0.1048098091700409 | superoxide dismutase 3, extracellular (SOD3), mRNA [NM_003102]
7237 | ENST00000375606 | 1.450832209716094 | 0.1285894935972043 | -0.1085977629169252 | 0.07231957284516177 | [NAME] protein 16M (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5TEV4] [ENST00000375606]
13788 | SLC22A18 | 1.450876413118385 | -1.066498270685169 | -1.089822761271275 | 0.1727579229614382 | solute carrier family 22, member 18 (SLC22A18), transcript variant 2, mRNA [NM_183233]
37415 | FUT3 | 1.453691344228924 | -0.6084728420368402 | -0.5000062690364304 | -0.315785258509953 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, [NAME] blood group) (FUT3), transcript variant 1, mRNA [NM_000149]
31292 | THC2533833 | 1.463607015235118 | -0.1031277153345637 | 0.1399805597679911 | -0.099085864962423 | AA873311 oh76g08.s1 NCI_CGAP_Kid3 Homo sapiens cDNA clone IMAGE:1472990 3' similar to gb:J05021 EZRIN (HUMAN);, mRNA sequence [AA873311]
32475 | [NAME] | 1.471713889915886 | -0.2625857380944649 | -0.3418818243444376 | 0.2997417726462012 | lysine-rich coiled-coil 1 ([NAME]), mRNA [NM_016618]
29644 | C8orf73 | 1.472980505719932 | -0.08583699489150898 | -0.4300835563394028 | -0.0814936469898615 | chromosome 8 open reading frame 73 (C8orf73), mRNA [NM_001100878]
44521 | ST3GAL4 | 1.477118339218061 | -0.07466388474153396 | 0.097694378711772 | 0.162636414660315 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (ST3GAL4), mRNA [NM_006278]
39023 | C15orf52 | 1.477269594742945 | 0.2603953268082219 | -0.1054465839192719 | 0.1765574333639716 | chromosome 15 open reading frame 52 (C15orf52), mRNA [NM_207380]
10971 | SQRDL | 1.479259119071506 | 0.08813695771904317 | -0.2719970387648551 | 0.03868885216674633 | sulfide quinone reductase-like (yeast) (SQRDL), mRNA [NM_021199]
40219 | C19orf33 | 1.488536085122149 | 0.2851114046315923 | -0.277373968052018 | -0.06634501806355964 | chromosome 19 open reading frame 33 (C19orf33), mRNA [NM_033520]
38404 | C7orf53 | 1.490919358418279 | 0.254662099804736 | 0.610189728086218 | 0.7095421272849484 | chromosome 7 open reading frame 53 (C7orf53), mRNA [NM_182597]
7298 | F2RL1 | 1.491258450706324 | -0.2425344020583795 | -0.4570230408320128 | -0.148010037676559 | coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA [NM_005242]
11310 | GPR120 | 1.500109574143784 | -2.243986862870708 | -2.057856016752159 | 0.605193152589871 | G protein-coupled receptor 120 (GPR120), mRNA [NM_181745]
26916 | OPTN | 1.50322508709435 | 0.1020276970481149 | 0.7303409579336682 | 0.2675675144011489 | [NAME] (OPTN), transcript variant 1, mRNA [NM_001008211]
43888 | PLCE1 | 1.515165209181094 | 0.4046972283651956 | 0.2280395488449119 | 0.3055195602589063 | phospholipase C, epsilon 1 (PLCE1), mRNA [NM_016341]
36981 | PDE9A | 1.516177731037356 | -0.7242632878464579 | -0.7082531540743415 | 0.1871771122864949 | phosphodiesterase 9A (PDE9A), transcript variant 1, mRNA [NM_002606]
28646 | C12orf35 | 1.516410568797744 | -0.419184819511654 | -0.9612509217154505 | 0.1806254967385164 | chromosome 12 open reading frame 35 (C12orf35), mRNA [NM_018169]
42646 | ANKRD42 | 1.516941628998729 | 0.6045270923869412 | 0.2180919095958895 | -0.2454639161025018 | ankyrin repeat domain 42 (ANKRD42), mRNA [NM_182603]
17260 | IGSF9 | 1.520087890380127 | -0.04576166062659304 | -0.01402792399702779 | 0.04637643690359494 | immunoglobulin superfamily, member 9 (IGSF9), mRNA [NM_020789]
38832 | C4orf34 | 1.524395097863355 | 0.3319910212919619 | -0.1411509268578981 | 0.05235562378173264 | chromosome 4 open reading frame 34 (C4orf34), mRNA [NM_174921]
14617 | GBP3 | 1.525672154155211 | 0.1458803409379126 | 0.4211032319898731 | 0.387599592335113 | guanylate binding protein 3 (GBP3), mRNA [NM_018284]
18730 | A_24_P844100 | 1.526302354974839 | -0.218582468683446 | -0.4522551515164167 | 0.3961425665803463 | Unknown
43902 | THC2559002 | 1.527360651173187 | 0.4406579617004989 | 0.621744078981809 | 0.03438759907353184 | Unknown
22051 | TMSL3 | 1.529660463683475 | 0.1811790694801045 | -0.4505570699054045 | 0.2862681368676347 | thymosin-like 3 (TMSL3), mRNA [NM_183049]
38676 | CDA | 1.533395178549747 | -0.7201337147876069 | -0.5814487008974936 | 0.2401647079738188 | cytidine deaminase (CDA), mRNA [NM_001785]
28936 | MICAL2 | 1.534169197263351 | -0.2739009343176414 | -0.7769140373009796 | 0.2057335842343443 | microtubule associated monoxygenase, calponin and LIM domain containing 2 (MICAL2), mRNA [NM_014632]
12211 | XR_018991 | 1.534817119074497 | -0.1689258829102276 | -0.2930414319856265 | 0.7271780880744705 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC344320), mRNA [XR_018991]
33581 | ENST00000211092 | 1.548992241027338 | -0.5997371759308763 | -0.8812329635619132 | 0.2888988687262763 | Homo sapiens HSPC323 mRNA, partial cds. [AF161441]
19048 | AK057652 | 1.549433944352306 | 0.06450615978374236 | 0.6978481633919633 | -0.172776373215831 | Homo sapiens cDNA FLJ33090 fis, clone TRACH2000559. [AK057652]
29316 | C1orf54 | 1.552164028270313 | 0.1953268439920968 | 0.01613781274282911 | 0.2134351882717969 | chromosome 1 open reading frame 54 (C1orf54), mRNA [NM_024579]
35152 | ENST00000343505 | 1.553451424229461 | -0.5399106254262452 | -0.6370656565569168 | -0.08939140281235342 | NHS-like protein 1. [Source:Uniprot/SPTREMBL;Acc:Q5SYE7] [ENST00000343505]
39934 | PLCXD1 | 1.558829350925534 | -0.1147792429249077 | 0.2696637945363161 | -0.1258494570165287 | phosphatidylinositol-specific phospholipase C, X domain containing 1 (PLCXD1), mRNA [NM_018390]
18285 | LOC644186 | 1.560330295537394 | 0.9503713687367645 | 1.035948329076476 | 0.6916187885223138 | hypothetical protein LOC644186 (LOC644186), mRNA [NM_001123225]
2056 | LOC339240 | 1.560499779312216 | -- | -- | -- | keratin pseudogene (LOC339240) on chromosome 17 [NR_001443]
24564 | AGPAT4 | 1.56142069352008 | 0.4429336070178003 | 0.8319891987759387 | 0.4071935384034777 | 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (AGPAT4), mRNA [NM_020133]
28514 | [NAME] | 1.565598374043996 | -0.2516846828930994 | -0.2896738273794353 | 0.1501542492478203 | trefoil factor 3 (intestinal) ([NAME]), mRNA [NM_003226]
13956 | PSORS1C1 | 1.565678364411557 | -0.6292901004172795 | -1.268467088994775 | 0.1254320261896673 | psoriasis susceptibility 1 candidate 1 (PSORS1C1), mRNA [NM_014068]
37624 | TncRNA | 1.567217202091098 | 0.7401988958227301 | 0.2876564636324748 | 0.2154235456070173 | trophoblast-derived noncoding RNA (TncRNA) on chromosome 11 [NR_002802]
21438 | TMSB4X | 1.569549183488672 | 0.1569886535584687 | -0.3781902170542466 | 0.2029868952601237 | thymosin beta 4, X-linked (TMSB4X), mRNA [NM_021109]
41636 | GSN | 1.572106835752865 | 0.9874243563149538 | 1.005658222305262 | 0.3525272711309997 | [NAME] (amyloidosis, Finnish type) (GSN), transcript variant 2, mRNA [NM_198252]
24321 | GBP3 | 1.574353932586215 | -0.2470600636855362 | 0.1573034095673875 | 0.2102040371771876 | guanylate binding protein 3 (GBP3), mRNA [NM_018284]
3245 | POLD4 | 1.57438651405697 | -0.006658170012523612 | 0.0629209692483357 | 0.1917801058085978 | polymerase (DNA-directed), delta 4 (POLD4), mRNA [NM_021173]
19976 | CRIP2 | 1.57679162454572 | -0.01462523723022735 | -0.2117679258486853 | 0.2389836792221297 | cysteine-rich protein 2 (CRIP2), mRNA [NM_001312]
42936 | PLCD3 | 1.578721247368585 | -0.482947653038136 | 0.01701909834167692 | 0.273849076130003 | phospholipase C, delta 3 (PLCD3), mRNA [NM_133373]
7547 | CK570316 | 1.587698533648775 | -1.137295086640311 | -1.356388299775189 | -0.09940161921073365 | b21 cDNA subtractive library of human rectum adencarcinoma Homo sapiens cDNA, mRNA sequence [CK570316]
15620 | KRT80 | 1.589158929975827 | 1.007638219344046 | -0.5811791579576915 | 0.5826269279682466 | keratin 80 (KRT80), transcript variant 1, mRNA [NM_182507]
540 | MUC5AC | 1.592734224516246 | -- | -- | -- | Homo sapiens mucin (MUC 5AC) mRNA, partial cds. [AF015521]
23659 | BCAS4 | 1.595101926938817 | 0.1576935235151382 | -0.140276212763646 | 0.3097081644782927 | Homo sapiens breast carcinoma amplified sequence 4, mRNA (cDNA clone IMAGE:5764497), partial cds. [BC056883]
38945 | NR3C2 | 1.595804065606207 | -0.6105333376981825 | 0.05115542710630461 | -0.02089691422984252 | nuclear receptor subfamily 3, group C, member 2 (NR3C2), mRNA [NM_000901]
35139 | [NAME] | 1.596429898588679 | -0.04518328916026826 | -0.5207301850244024 | 0.2737285329265925 | laminin, beta 3 (LAMB3), transcript variant 2, mRNA [NM_001017402]
35355 | ALOX5 | 1.597069580523283 | 0.04151937773653369 | -0.3762581046123717 | 0.1365028292591395 | arachidonate 5-lipoxygenase (ALOX5), mRNA [NM_000698]
8208 | [NAME] | 1.597679122936474 | 0.2478364609328756 | 0.3521257013481172 | 0.0566110877502799 | multiple EGF-like-domains 6 ([NAME]), mRNA [NM_001409]
40055 | MLPH | 1.598634696647212 | -0.0444633608238179 | -0.2829200026799537 | 0.1097666718464949 | [NAME] (MLPH), transcript variant 2, mRNA [NM_001042467]
21923 | A_24_P530977 | 1.599259198200904 | 0.1801158834036001 | -0.4626711929247951 | 0.2888590510995523 | Unknown
32279 | LOC541469 | 1.603273678875278 | 0.605625649025028 | -0.114077841393362 | 0.02186170678933241 | Homo sapiens cDNA: FLJ23477 fis, clone HSI15732. [AK027130]
25689 | MUPCDH | 1.603470877994485 | -0.07809184246954715 | -0.2376381524446192 | -0.01744730450670007 | mucin-like protocadherin (MUPCDH), transcript variant 1, mRNA [NM_021924]
12943 | NOSTRIN | 1.604546370818003 | 0.1291228656940476 | -0.4810647133538376 | 0.5175034835195985 | nitric oxide synthase trafficker (NOSTRIN), transcript variant 1, mRNA [NM_052946]
32219 | SLC16A5 | 1.606462207473177 | -0.09183979669208747 | 0.2672345329659301 | 0.4556541250896088 | solute carrier family 16, member 5 (monocarboxylic acid transporter 6) (SLC16A5), mRNA [NM_004695]
19735 | LAMC2 | 1.609198926444264 | 0.02654944395946846 | 0.05134341501719408 | 0.1220105854201909 | laminin, gamma 2 (LAMC2), transcript variant 2, mRNA [NM_018891]
13401 | S100A6 | 1.609352598173548 | 0.08684474898369088 | -0.2146876550539469 | 0.2752031620877857 | S100 calcium binding protein A6 (S100A6), mRNA [NM_014624]
5881 | APOL6 | 1.613027558197249 | -0.6293584730721529 | -0.1207244829534055 | 0.05204345944145582 | apolipoprotein L, 6 (APOL6), mRNA [NM_030641]
38510 | FLJ46111 | 1.614862145141922 | -0.01785941526571677 | -0.2933440287411394 | 0.3404327557921899 | Homo sapiens cDNA FLJ46111 fis, clone TESTI2034913, moderately similar to Keratin, type II cytoskeletal 8. [AK127993]
32784 | TNFAIP2 | 1.6172873785423 | -0.3694561957345417 | 0.1783971679684198 | 0.126256438718567 | tumor necrosis factor, alpha-induced protein 2 (TNFAIP2), mRNA [NM_006291]
25869 | XR_017139 | 1.622854254515253 | -0.1352446454719572 | -0.398952428129639 | 0.4145184207466356 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) ([NAME] endo A) (LOC342419), mRNA [XR_017139]
7450 | TMSL3 | 1.624179180123149 | 0.1593735062653108 | -0.4408995595513696 | 0.3120246767861836 | thymosin-like 3 (TMSL3), mRNA [NM_183049]
31718 | ITPK1 | 1.624318834644644 | -0.1834531820597827 | -0.05260617622197561 | 0.1844256153860846 | inositol 1,3,4-triphosphate 5/6 kinase ([NAME]), mRNA [NM_014216]
40043 | DHRS3 | 1.624868321746868 | 0.6483472544638271 | 0.622756796333539 | 0.6571819205712157 | dehydrogenase/reductase (SDR family) member 3 (DHRS3), mRNA [NM_004753]
41235 | A_24_P76319 | 1.626130477364158 | -- | -- | -- | Unknown
32421 | WBSCR27 | 1.63003655040318 | 0.04633007707168058 | -0.3940359748481795 | 0.03414911652682839 | [NAME] syndrome chromosome region 27 (WBSCR27), mRNA [NM_152559]
4559 | XR_019369 | 1.630807362459594 | -0.09591292368162718 | -0.5238128262009176 | 0.4367807803006005 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC652524), mRNA [XR_019369]
3870 | ABAT | 1.634924103707477 | 0.4642665993856714 | 1.169559720862482 | 0.3687379081781037 | 4-aminobutyrate aminotransferase (ABAT), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_000663]
42299 | KCNK5 | 1.636773038723977 | 0.03600031875925325 | -0.4964247754459929 | 0.1827794970352965 | potassium channel, subfamily K, member 5 (KCNK5), mRNA [NM_003740]
43362 | SPINK4 | 1.639678137593181 | -0.3389788408790428 | -1.19191337364435 | -0.2434350764227444 | serine peptidase inhibitor, [NAME] type 4 (SPINK4), mRNA [NM_014471]
39793 | ETHE1 | 1.640957824519895 | -0.4107151446064132 | -0.5860198559644989 | -0.174350326399316 | ethylmalonic encephalopathy 1 (ETHE1), mRNA [NM_014297]
26876 | PLAUR | 1.641167035232804 | -0.1538307117795996 | -0.2154232549383091 | 0.4277961656809365 | plasminogen activator, urokinase receptor (PLAUR), transcript variant 3, mRNA [NM_001005377]
34376 | [NAME] | 1.649554573638839 | -0.2396950936429008 | -0.4178304049819643 | 0.1512778050557859 | trefoil factor 3 (intestinal) ([NAME]), mRNA [NM_003226]
42320 | A_24_P93111 | 1.649604836736264 | -0.074414859723829 | -0.3000929541946274 | 0.2896610153007196 | Unknown
5389 | CALB2 | 1.657549901462205 | -1.07147594474285 | -2.39877838621117 | 0.2213401320789785 | calbindin 2, 29kDa (calretinin) (CALB2), transcript variant CALB2, mRNA [NM_001740]
19017 | KLF4 | 1.658126083412504 | -0.8014999095615674 | -0.6098223557260116 | -0.05732138640184203 | Kruppel-like factor 4 (gut) (KLF4), mRNA [NM_004235]
33235 | UGT2B10 | 1.661154966457826 | -- | -- | -- | UDP glucuronosyltransferase 2 family, polypeptide B10 (UGT2B10), mRNA [NM_001075]
18463 | BCL3 | 1.663990418114785 | 0.3515569721434995 | 0.1073898580395456 | 0.2985763222756288 | B-cell CLL/lymphoma 3 (BCL3), mRNA [NM_005178]
6271 | MUC2 | 1.665440301702091 | -0.6813807386455826 | -0.8937089099928205 | -0.140342598772641 | mucin 2, oligomeric mucus/gel-forming (MUC2), mRNA [NM_002457]
40344 | AK091178 | 1.666886613884503 | -0.05336946826366484 | -0.3614846163751256 | 0.3520934379519773 | Homo sapiens cDNA FLJ33859 fis, clone CTONG2006223, moderately similar to KERATIN, TYPE II CYTOSKELETAL 8. [AK091178]
19240 | C14orf129 | 1.670047814640929 | -0.1537888159546599 | -0.08494602221814307 | 0.2327173365082107 | chromosome 14 open reading frame 129 (C14orf129), mRNA [NM_016472]
39908 | THC2764011 | 1.670783977492445 | -0.3445184625912316 | -- | -- | Unknown
6472 | AK126071 | 1.673268533552549 | 0.08777685772382204 | 0.4106858747657766 | 0.1589262817297525 | Homo sapiens cDNA FLJ44083 fis, clone TESTI4040939. [AK126071]
18290 | LAMA3 | 1.674793053555905 | 0.7463877530357486 | 0.1288134194549959 | 0.6423989626231738 | laminin, alpha 3 (LAMA3), transcript variant 1, mRNA [NM_198129]
1856 | ALS2CL | 1.676014774830521 | -0.7968263075276678 | -0.6974589935361768 | -0.004517653122906751 | [NAME] like (ALS2CL), transcript variant 1, mRNA [NM_147129]
27204 | ISG20 | 1.67707208740596 | -0.391424243554539 | -0.2949265773803514 | 0.1596455838030303 | interferon stimulated exonuclease gene 20kDa (ISG20), mRNA [NM_002201]
18900 | PRSS3 | 1.684841349053263 | 0.6699757904362609 | -0.4170708704063619 | 0.438730679840363 | protease, serine, 3 (PRSS3), transcript variant 2, mRNA [NM_002771]
1468 | hCG_1988300 | 1.685712477026479 | -0.03300437312928139 | -0.2780609564019452 | 0.3548123217236583 | full-length cDNA clone CS0DI072YA21 of [NAME]-normalized of Homo sapiens (human). [CR613736]
12709 | BG216229 | 1.685782604091237 | -0.7377763474703922 | -1.213320751622701 | 0.002573495037566875 | BG216229 RST35803 Athersys RAGE [NAME] sapiens cDNA, mRNA sequence [BG216229]
33324 | RELL1 | 1.689711308761984 | 0.09742648879660865 | 0.4674996170716779 | 0.1593960003692126 | RELT-like 1 (RELL1), transcript variant 1, mRNA [NM_001085400]
39259 | DENND2A | 1.689776147483311 | 0.5114027209495792 | -1.060019616304903 | -0.1792196594263025 | DENN/MADD domain containing 2A (DENND2A), mRNA [NM_015689]
13804 | BDKRB2 | 1.693969933545114 | -0.3383785604996703 | -0.9687017805544602 | 0.3127789899884252 | bradykinin receptor B2 (BDKRB2), mRNA [NM_000623]
44767 | ADH1C | 1.694905368565065 | -- | -- | -- | alcohol dehydrogenase 1C (class I), gamma polypeptide (ADH1C), mRNA [NM_000669]
3445 | CORO2A | 1.700460930715313 | -0.6609345794632588 | 0.1431231176978524 | 0.1083725581168169 | Homo sapiens mRNA; cDNA DKFZp686G19226 (from clone DKFZp686G19226). [BX648086]
24317 | AGR3 | 1.700604231883374 | 0.3037775654160225 | -1.1998833206083 | 0.5279497445078567 | anterior gradient homolog 3 ([NAME] laevis) (AGR3), mRNA [NM_176813]
22803 | XR_016392 | 1.703441671880394 | -0.1558952203300823 | -0.3808744083695266 | 0.5719785057306899 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC643447), mRNA [XR_016392]
35685 | DKFZP564O0823 | 1.706405887781976 | -0.4649598479090944 | -0.4076400517142305 | -0.05130900980791564 | DKFZP564O0823 protein (DKFZP564O0823), mRNA [NM_015393]
34158 | MSTP9 | 1.716868102662102 | 0.3098820427985727 | 0.1205112796815571 | 0.2597071103414774 | macrophage stimulating, pseudogene 9 (MSTP9) on chromosome 1 [NR_002729]
17656 | PAG1 | 1.723002049533167 | -0.2366560939645392 | -0.8944059692992763 | 0.05983316313801866 | phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1), mRNA [NM_018440]
20849 | CTH | 1.724443477484701 | -0.2607129917299156 | -0.3226490358071031 | 0.02636125839385756 | cystathionase (cystathionine gamma-lyase) (CTH), transcript variant 1, mRNA [NM_001902]
26195 | PACSIN1 | 1.725410300904932 | -0.03991479843560874 | 0.5290636474571633 | 0.4575988100327439 | protein kinase C and casein kinase substrate in neurons 1 (PACSIN1), mRNA [NM_020804]
12713 | ATAD4 | 1.727170573328387 | 0.1537078021010529 | 0.1385267534818944 | 0.06542710123141582 | ATPase family, AAA domain containing 4 (ATAD4), mRNA [NM_024320]
22357 | XR_017341 | 1.729323693480318 | -0.09954424924966196 | -0.4448789373119073 | 0.3719565357034532 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC390610), mRNA [XR_017341]
16840 | MLPH | 1.731561391914702 | 0.01092065856343916 | -0.05296374225044631 | 0.1672302950706364 | [NAME] (MLPH), transcript variant 1, mRNA [NM_024101]
33317 | AA593970 | 1.732747744953084 | -0.3998804479084783 | -0.2321404787116419 | 0.1416135481979836 | AA593970 nn01c05.s1 [NAME] sapiens cDNA clone IMAGE:1076456 3', mRNA sequence [AA593970]
41458 | KRT15 | 1.734792113816202 | 0.3750189496930176 | 0.212926163914732 | 0.05859720776692878 | keratin 15 (KRT15), mRNA [NM_002275]
13970 | XR_015430 | 1.737212066015295 | -0.1516790012878548 | -0.5463537486928214 | 0.2404571602253158 | PREDICTED: Homo sapiens similar to tau tubulin kinase 2 (LOC731274), mRNA [XR_015430]
27820 | AK000038 | 1.738331960892403 | 0.3400887110076438 | 0.2066504384813479 | -0.1829658023896061 | Homo sapiens cDNA FLJ20031 fis, clone ADSU02180. [AK000038]
25398 | [NAME] | 1.742809274015393 | 0.813838616180512 | 0.03616650751359873 | 0.2731875264410398 | hypothetical LOC388610 (LOC388610), mRNA [NM_001013642]
12806 | FLJ41603 | 1.744549120899571 | 0.03607806649315737 | 0.4523594201954587 | 0.07473912674507599 | FLJ41603 protein (FLJ41603), mRNA [NM_001001669]
31336 | OAS1 | 1.744719391971352 | -0.307714172123225 | -0.0997636688455541 | 0.3166199009164194 | 2',5'-oligoadenylate synthetase 1, 40/46kDa (OAS1), transcript variant 2, mRNA [NM_002534]
28986 | ENST00000334647 | 1.748118685114027 | 0.3116763497041308 | -0.3098453600753923 | 0.3202153309917939 | Thymosin-like 4. [Source:Uniprot/SPTREMBL;Acc:Q5T4B6] [ENST00000334647]
34147 | LOC730091 | 1.749294199199324 | 0.4191215878727005 | 1.050130077844015 | 0.6155785514704852 | Homo sapiens cDNA FLJ31839 fis, clone NT2RP7000086. [AK056401]
4833 | [NAME] | 1.756816839908285 | -0.1277414830876973 | -0.2259655349293785 | 0.1840967295560139 | FXYD domain containing ion transport regulator 3 ([NAME]), transcript variant 1, mRNA [NM_005971]
2015 | A_24_P890995 | 1.756881762010007 | -0.2639039233441596 | -0.3617539071473664 | 0.4419156978246515 | Unknown
3191 | PIGR | 1.764964350572762 | -0.8540420712325769 | -0.569627978839045 | -0.09992098605872979 | [NAME] receptor (PIGR), mRNA [NM_002644]
11582 | UGT2B11 | 1.765624563351764 | 1.815322756772659 | 0.341710294594101 | 0.9264861491786913 | UDP glucuronosyltransferase 2 family, polypeptide B11 (UGT2B11), mRNA [NM_001073]
21231 | SHD | 1.766650780022692 | 0.08296268199092349 | -0.2032346629280446 | 0.0634923564937182 | Src homology 2 domain containing transforming protein D (SHD), mRNA [NM_020209]
38060 | XR_018299 | 1.774904659323058 | -0.08564311653772128 | -0.5647575072212048 | 0.4566340261102672 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC347333), mRNA [XR_018299]
15542 | PRSS2 | 1.775890150982603 | 0.898196819900337 | -0.3121324324931467 | 0.3929686187553378 | protease, serine, 2 (trypsin 2) (PRSS2), transcript variant 1, mRNA [NM_002770]
13929 | MXD1 | 1.77613248082033 | -0.3851606019667928 | -0.6432480164590757 | 0.02430268048160278 | MAX dimerization protein 1 (MXD1), mRNA [NM_002357]
30773 | RILP | 1.777383854123409 | 0.219122547088727 | 0.08087494220069558 | 0.2221263879452025 | Rab interacting lysosomal protein (RILP), mRNA [NM_031430]
33550 | STYK1 | 1.780031192134501 | -0.3042009461482942 | 0.720979293512872 | 0.329672687537677 | serine/threonine/tyrosine kinase 1 (STYK1), mRNA [NM_018423]
22708 | A_23_P111766 | 1.781275045422856 | 0.8187917312237865 | -0.4719698171161344 | 0.5101879504108711 | Unknown
300 | THC2659414 | 1.787190764705487 | -- | -0.06175300723436905 | -0.1688828463351792 | Unknown
33056 | AI359640 | 1.790298104384169 | -- | -- | -- | AI359640 qy33b12.x1 [NAME] sapiens cDNA clone IMAGE:2013791 3', mRNA sequence [AI359640]
42654 | EPB41L1 | 1.794202231271616 | 0.04999225730580825 | 0.1021454673717062 | 0.2602313909855105 | erythrocyte membrane protein band 4.1-like 1 (EPB41L1), transcript variant 1, mRNA [NM_012156]
13153 | THC2656077 | 1.795479249029106 | -0.05700498404536036 | -0.2220260408022763 | 0.06883036906105566 | Unknown
44192 | EPAS1 | 1.797467501889689 | 0.284386221416816 | 1.036472309052797 | 0.5261409118073179 | endothelial PAS domain protein 1 (EPAS1), mRNA [NM_001430]
42774 | AKR1C3 | 1.797597685760281 | 0.6856418811844538 | 0.21384814280055 | 0.6302295950991177 | aldo-keto reductase family 1, member [NAME] (3-alpha hydroxysteroid dehydrogenase, type II) (AKR1C3), mRNA [NM_003739]
15839 | XR_019203 | 1.799916927231418 | -0.1942502875204228 | -0.5093432204382347 | 0.4304308805978023 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC390472), mRNA [XR_019203]
39563 | A_24_P281605 | 1.801782897759574 | -0.2489911855284538 | -0.5819405279317843 | 0.4219720364404836 | Unknown
6602 | TMEM105 | 1.80281127019574 | -0.1454399302416048 | -0.2079686212395971 | -0.06312843362364562 | [NAME] 105 (TMEM105), mRNA [NM_178520]
41331 | A_24_P15973 | 1.804310622109175 | -0.1520966397352217 | -0.3886961727581766 | 0.4048570174250663 | Unknown
16395 | BM807051 | 1.805400637737937 | -0.0315482454798317 | -0.37255277585422 | -0.1010967094254966 | AGENCOURT_6552906 NIH_MGC_85 Homo sapiens cDNA clone IMAGE:5552012 5', mRNA sequence [BM807051]
25060 | ATP8A1 | 1.805745017538931 | -0.8812076883398108 | -0.734834977199144 | -0.01453372110094886 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 (ATP8A1), transcript variant 1, mRNA [NM_006095]
10001 | CA313037 | 1.806617469964878 | 0.1038396719604383 | -0.03313026290952215 | -0.1387737600960889 | CA313037 UI-CF-FN0-aex-g-14-0-UI.s1 UI-CF-FN0 Homo sapiens cDNA clone UI-CF-FN0-aex-g-14-0-UI 3', mRNA sequence [CA313037]
2726 | A_24_P798431 | 1.806752983204714 | 0.1827238152087629 | -0.1832737946207306 | -0.09595533374103615 | Unknown
32286 | ENST00000327506 | 1.806984538202568 | -0.139474977925012 | -0.2948203410900794 | 0.2494107865709392 | Homo sapiens hypothetical protein LOC339766, mRNA (cDNA clone IMAGE:5478533), partial cds. [BC042133]
8149 | AATK | 1.810366939839169 | -0.4627824124061829 | 0.08727476490192032 | 0.2152192330770843 | apoptosis-associated tyrosine kinase (AATK), mRNA [NM_001080395]
28657 | PI3 | 1.811399299253435 | -- | -- | -- | peptidase inhibitor 3, skin-derived (SKALP) (PI3), mRNA [NM_002638]
2479 | FOS | 1.813834592780855 | -1.066539357288426 | -0.789448329146806 | 0.3241015423888332 | v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), mRNA [NM_005252]
9339 | FCGBP | 1.815832009180088 | -0.6965175039700795 | -1.156287682668455 | 0.367287205901619 | Fc fragment of IgG binding protein (FCGBP), mRNA [NM_003890]
25389 | [NAME] | 1.828280713143074 | 0.1832871494360577 | -0.01474658394160544 | 0.1517140459682917 | macrophage stimulating 1 (hepatocyte growth factor-like) ([NAME]), mRNA [NM_020998]
45105 | SLCO2B1 | 1.828413924785029 | 0.5713759790967579 | -1.412463967127763 | 0.4096243589547188 | solute carrier organic anion transporter family, member 2B1 (SLCO2B1), mRNA [NM_007256]
38939 | A_24_P315594 | 1.83070015609059 | 0.05687439307247932 | -0.2052013303981558 | 0.6862212556073094 | Unknown
19730 | CAPN9 | 1.831188149154789 | -0.7817558146686632 | -0.8236145914733024 | 0.145745226827739 | calpain 9 (CAPN9), transcript variant 1, mRNA [NM_006615]
27571 | C1orf116 | 1.83312076769241 | -0.8222983076952493 | -1.199465914363707 | -0.2380882504479791 | chromosome 1 open reading frame 116 (C1orf116), transcript variant 1, mRNA [NM_023938]
4426 | A_23_P62857 | 1.833799076176419 | -0.5555841570907336 | -2.38252520560301 | -0.08051164518187548 | Unknown
13192 | PRSS2 | 1.839583874784807 | 0.9941801814130944 | -0.247149403951914 | 0.4767431354588161 | protease, serine, 2 (trypsin 2) (PRSS2), transcript variant 1, mRNA [NM_002770]
40725 | EPB41L1 | 1.843922438113419 | -0.1258642444133466 | -0.2495348438095466 | 0.2126294154136304 | erythrocyte membrane protein band 4.1-like 1 (EPB41L1), transcript variant 1, mRNA [NM_012156]
3478 | FAM83E | 1.843963218601001 | -1.072715829157612 | -1.003458829854222 | -- | family with sequence similarity 83, member E (FAM83E), mRNA [NM_017708]
23628 | COPA | 1.845055481181927 | 0.3305018946053961 | 0.4914215470910311 | 0.1660403581701294 | coatomer protein complex, subunit alpha (COPA), transcript variant 1, mRNA [NM_001098398]
43398 | GPRC5A | 1.850826879630669 | -0.1155083370456313 | -1.777891351390129 | 1.08744774346475 | G protein-coupled receptor, family C, group 5, member A (GPRC5A), mRNA [NM_003979]
14940 | A_24_P298894 | 1.858122664209065 | -0.05493836384484548 | -0.3995839208803223 | 0.301459236412095 | Unknown
19969 | A_32_P57002 | 1.862095170328804 | -0.03255854313913709 | -0.4672049009261843 | 0.09796635426629918 | Unknown
33790 | PLA2G2A | 1.86316530920081 | -0.8175708326246633 | -3.030572411854695 | -0.1370062667975338 | phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), mRNA [NM_000300]
35391 | UGT2B17 | 1.876922470313162 | 0.1681209803972221 | -0.2671594321443322 | 0.068335465888131 | UDP glucuronosyltransferase 2 family, polypeptide B17 (UGT2B17), mRNA [NM_001077]
15553 | CDH12 | 1.87936784223823 | 0.2014884791338334 | 0.1922327470136693 | 0.1593135457953907 | cadherin 12, type 2 (N-cadherin 2) (CDH12), mRNA [NM_004061]
4225 | XR_018641 | 1.891456540050464 | -0.2289551570699062 | -0.4576509862617786 | 0.4616478659991161 | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) ([NAME]), mRNA [XR_018641]
39837 | ALDH1L1 | 1.89431949677376 | -0.2152484574073061 | 0.1725647292570309 | 0.0505179092417587 | aldehyde dehydrogenase 1 family, member L1 (ALDH1L1), mRNA [NM_012190]
23210 | TPO | 1.895059987765391 | -- | -- | -- | thyroid peroxidase (TPO), transcript variant 1, mRNA [NM_000547]
29259 | LOC100128116 | 1.895824231871672 | -0.1014431463304633 | -0.3501348981768977 | 0.3759859088140118 | PREDICTED: Homo sapiens misc_RNA (LOC100128116), miscRNA [XR_038299]
22124 | BC018589 | 1.898510339108981 | 0.04991341502981575 | -0.398375482135879 | 0.3761524028203299 | Homo sapiens cDNA clone IMAGE:3863301. [BC018589]
13845 | AKR1C1 | 1.901319741866785 | 0.2283400328541567 | 0.1810373879180864 | 0.4703322862816651 | aldo-keto reductase family 1, member [NAME] (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1), mRNA [NM_001353]
20049 | [NAME] | 1.901417487275627 | -0.1063170989303157 | -0.5749172662620073 | -0.07459870183523691 | Kruppel-like factor 6 (KLF6), transcript variant 2, mRNA [NM_001300]
13320 | PTRF | 1.901825093167955 | 0.6610206456705245 | 1.156422089540139 | 0.568740426090653 | polymerase I and transcript release factor (PTRF), mRNA [NM_012232]
30261 | [NAME] | 1.907337165133873 | -0.05013687146594836 | -0.2397774571958928 | 0.4363939041963001 | [NAME] ([NAME]), mRNA [NM_002273]
30306 | POLD4 | 1.909021679160064 | 0.08808738166278643 | 0.229027623602525 | 0.2071779320610153 | polymerase (DNA-directed), delta 4 (POLD4), mRNA [NM_021173]
34880 | ST3GAL4 | 1.909118235318648 | -0.2589134045199926 | 0.01644231728164725 | 0.09080047700798144 | Homo sapiens cDNA FLJ11867 fis, clone HEMBA1006976, weakly similar to H.sapiens mRNA for Gal-beta(1-3/1-4)GlcNAc alpha-2.3-sialyltransferase. [AK021929]
26786 | COL17A1 | 1.919975100903725 | -- | -- | -- | collagen, type XVII, alpha 1 (COL17A1), mRNA [NM_000494]
16738 | SLC7A7 | 1.920668451742533 | -0.1331005912272085 | -1.78088021058343 | 0.795202018895163 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (SLC7A7), mRNA [NM_003982]
12085 | CDH15 | 1.927041746190377 | 0.06072499658939212 | -0.143263773083063 | -0.08590373780845836 | cadherin 15, M-cadherin (myotubule) (CDH15), mRNA [NM_004933]
7970 | C17orf91 | 1.927149300422402 | 0.4782032715792393 | 0.4347068148852172 | -0.065452121329441 | chromosome 17 open reading frame 91 (C17orf91), transcript variant 1, mRNA [NM_032895]
3808 | EGR1 | 1.927203708953897 | -0.4219643438515939 | 0.8354063522650157 | 0.1996610310126368 | early growth response 1 (EGR1), mRNA [NM_001964]
9166 | HLA-DMA | 1.93000106723091 | -0.1806900876440077 | -0.003115539027701453 | 0.2150113421662067 | major histocompatibility complex, class II, DM alpha (HLA-DMA), mRNA [NM_006120]
4023 | SGK2 | 1.93373692102023 | -- | -- | -- | serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 1, mRNA [NM_170693]
9355 | [NAME] | 1.941405792671734 | -0.03391970450478854 | -0.5366193376965471 | -0.00624417708226721 | Kruppel-like factor 6 (KLF6), transcript variant 2, mRNA [NM_001300]
36827 | SLC22A18AS | 1.942550037115681 | -0.1073965733171891 | -0.5818919859253049 | 0.03308740040350688 | Homo sapiens ORCTL2S hypothetical protein (ORCTL2S) mRNA, complete cds. [AF037066]
39657 | CLDN23 | 1.944074635184348 | 0.7150472437978216 | 0.8213175698809038 | 0.404673471596425 | claudin 23 (CLDN23), mRNA [NM_194284]
34060 | UGT2B15 | 1.947597989385847 | 1.215850397873801 | -0.01812240998763937 | 0.3402452861020828 | UDP glucuronosyltransferase 2 family, polypeptide B15 (UGT2B15), mRNA [NM_001076]
43850 | STAT4 | 1.955122639363016 | -- | -- | -- | signal transducer and activator of transcription 4 (STAT4), mRNA [NM_003151]
4004 | BC031250 | 1.959252874448917 | 0.344960663906441 | -0.1939651132479699 | 0.1602391124299898 | Homo sapiens cDNA clone IMAGE:5268928. [BC031250]
5798 | LTBP1 | 1.959836154030783 | -0.227490941057054 | -0.2312840042615414 | 0.08021355063550972 | latent transforming growth factor beta binding protein 1 (LTBP1), transcript variant 1, mRNA [NM_206943]
6292 | MMEL1 | 1.968258859032015 | -0.5373986407672682 | -0.3386724308822714 | 0.2845543953553902 | membrane metallo-endopeptidase-like 1 (MMEL1), mRNA [NM_033467]
2452 | LOC149501 | 1.970897607699728 | -0.09619009140976675 | -0.3739811919795021 | 0.4403975243649202 | PREDICTED: Homo sapiens misc_RNA (LOC149501), miscRNA [XR_018597]
4673 | DEFB1 | 1.978324443836335 | -0.8393286361470444 | -1.484824605315841 | 0.7541846914266319 | [NAME], beta 1 (DEFB1), mRNA [NM_005218]
42973 | FOXQ1 | 1.980783249638619 | 0.2679886857190447 | -0.2881678140368105 | 1.191836430813624 | forkhead box Q1 (FOXQ1), mRNA [NM_033260]
30607 | XR_015516 | 1.984555497973857 | -- | -- | -- | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) ([NAME] endo A) (LOC729344), mRNA [XR_015516]
36876 | SLC22A18 | 1.986017102153963 | -0.1810001464466001 | -0.04634728798114052 | 0.2373253859384358 | solute carrier family 22, member 18 (SLC22A18), transcript variant 2, mRNA [NM_183233]
36061 | MGC3771 | 1.987540942490831 | 0.3733247866283871 | 0.0771286467608916 | 0.1047814634897999 | Homo sapiens cDNA clone IMAGE:2959625. [BC001809]
19235 | GJB1 | 1.988303046444937 | -0.2402721085666693 | -1.404685446934667 | 0.4669661459813772 | gap junction protein, beta 1, 32kDa (GJB1), transcript variant 2, mRNA [NM_000166]
23803 | KLK10 | 1.995256231609702 | -0.6345029812683682 | -0.3789677385749308 | -0.4725039226947012 | kallikrein-related peptidase 10 (KLK10), transcript variant 1, mRNA [NM_002776]
7318 | TncRNA | 1.999983167033069 | 0.6106085640886629 | 0.0123926813066304 | -0.1687132778511904 | Human clone 137308 mRNA, partial cds. [U60873]
36193 | OASL | 2.005686956106356 | 0.1946480541607065 | 0.4285146322892983 | 0.4934189341244182 | 2'-5'-oligoadenylate synthetase-like (OASL), transcript variant 1, mRNA [NM_003733]
44914 | SFTPG | 2.006326414973488 | -- | -- | -- | surfactant associated protein G (SFTPG), mRNA [NM_205854]
13553 | SPIB | 2.016182991204224 | -1.387393824920326 | -- | 0.1785674420299364 | Spi-B transcription factor (Spi-1/PU.1 related) (SPIB), mRNA [NM_003121]
26535 | [NAME] | 2.018430014290771 | -0.4268196394070296 | -0.2631738804807728 | -0.07614916563194507 | trefoil factor 3 (intestinal) ([NAME]), mRNA [NM_003226]
31792 | PKIB | 2.034841680307982 | 0.01498941157025657 | -0.04629809952745412 | 0.3570584943301741 | [NAME] (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 1, mRNA [NM_181795]
2324 | TMEM45B | 2.039058251308491 | 0.3437635942948061 | -0.823494070593249 | 0.2021847266939405 | [NAME] (TMEM45B), mRNA [NM_138788]
4624 | THC2656519 | 2.039638473055545 | -0.05659432496892025 | -1.030235819244334 | 0.007644782689923524 | Unknown
2676 | LOC654346 | 2.041076334585076 | -0.3860754857457085 | 0.03878809576515918 | 0.3466343068897215 | similar to galectin 9 short isoform (LOC654346), mRNA [NM_001040078]
36012 | XR_016847 | 2.04248567005367 | -- | -- | -- | PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (LOC644998), mRNA [XR_016847]
35416 | UGT1A6 | 2.053180896929313 | -0.0390262268518704 | -1.406051815754799 | 0.143488569319234 | UDP glucuronosyltransferase 1 family, polypeptide [NAME] (UGT1A6), transcript variant 1, mRNA [NM_001072]
23967 | TMSB4X | 2.057853566497996 | 0.05746655934350763 | -0.5701285401524371 | 0.01490563181287946 | Thymosin beta-4 (T beta 4) (Fx) [Contains: Hematopoietic system regulatory peptide (Seraspenide)]. [Source:Uniprot/SWISSPROT;Acc:P62328] [ENST00000380635]
41114 | CDH17 | 2.081858297767587 | 0.05816164917845512 | -1.67524888969176 | 1.151105670501997 | cadherin 17, LI cadherin (liver-intestine) (CDH17), mRNA [NM_004063]
2339 | CU450678 | 2.08294961758532 | -0.8295158110380898 | -0.6751935817946784 | -0.04878268016982545 | CU450678 Homo sapiens ORESTES from keratinocytes Homo sapiens cDNA, mRNA sequence [CU450678]
12172 | C1orf34 | 2.086790628171157 | -0.3329556999093186 | -0.07627495907627035 | 0.2208846166752814 | chromosome 1 open reading frame 34 (C1orf34), mRNA [NM_001080494]
30014 | SEMA3B | 2.107446253655538 | -0.005539087546150068 | -0.1946717531279289 | 0.2234968998740547 | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B (SEMA3B), transcript variant 1, mRNA [NM_004636]
3542 | MLPH | 2.108237935226919 | 0.1113113326998905 | -0.06303052610471216 | 0.4134210732903754 | [NAME] (MLPH), transcript variant 1, mRNA [NM_024101]
11760 | GALNT5 | 2.108571104517171 | -0.4822267305283335 | -1.140533751271886 | 0.2878808155939827 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) (GALNT5), mRNA [NM_014568]
41777 | CFB | 2.109996010859325 | -0.03462789140666089 | 0.4193997502525506 | 0.4558580472929914 | complement factor B (CFB), mRNA [NM_001710]
10564 | RAB37 | 2.129548113423116 | -0.4747369751468905 | -0.7459419879892986 | 0.2309366515009987 | RAB37, member RAS oncogene family (RAB37), transcript variant 3, mRNA [NM_175738]
43913 | GUCY2C | 2.134551075824515 | -0.3200936364745441 | -- | 0.035372744089881 | guanylate cyclase 2C (heat stable enterotoxin receptor) (GUCY2C), mRNA [NM_004963]
7407 | MEI1 | 2.141725579465709 | -0.2862458829391341 | -0.2045487266615524 | 0.3093830433561133 | meiosis inhibitor 1 (MEI1), mRNA [NM_152513]
20510 | SLPI | 2.156848495339786 | -0.2886161341110354 | -1.2318732971512 | 0.7138241012362716 | secretory leukocyte peptidase inhibitor (SLPI), mRNA [NM_003064]
33122 | LCN2 | 2.160599702416374 | -0.1268818807101031 | -0.4852690300107492 | 0.3055071432238803 | lipocalin 2 (LCN2), mRNA [NM_005564]
4737 | A_32_P119949 | 2.164820588767574 | 0.1959791025803705 | -0.2381300054231679 | 0.5172601625846254 | Unknown
6092 | UGT1A6 | 2.166125463383586 | -0.2997192213386981 | -1.723302490357347 | 0.05990513025196753 | UDP glucuronosyltransferase 1 family, polypeptide [NAME] (UGT1A6), transcript variant 1, mRNA [NM_001072]
11279 | SFTPG | 2.168321823910854 | -- | -- | -- | surfactant associated protein G (SFTPG), mRNA [NM_205854]
18128 | LDHD | 2.180067428172652 | -0.1557062647415388 | 0.01030503884889455 | 0.07616854110975058 | lactate dehydrogenase D (LDHD), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_153486]
1226 | ELF3 | 2.195901585793677 | 0.003145374326938746 | -0.869307619869562 | 0.2057925075318743 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) (ELF3), transcript variant 1, mRNA [NM_004433]
30673 | SGK2 | 2.197255556845967 | 0.2591329615772691 | -0.2865335868266117 | 0.7060887707591075 | serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 1, mRNA [NM_170693]
41326 | CD177 | 2.203822372208136 | -- | -- | -- | CD177 molecule (CD177), mRNA [NM_020406]
42253 | [NAME] | 2.205733769272508 | -0.09504708172649212 | -1.087161964966797 | 0.5421593709956256 | KIAA1217 (KIAA1217), transcript variant 1, mRNA [NM_019590]
8599 | LGALS3 | 2.206410895316212 | -0.04316378878237709 | -1.243061647177819 | 0.2824834244588694 | lectin, galactoside-binding, soluble, 3 (LGALS3), transcript variant 1, mRNA [NM_002306]
6721 | SPDEF | 2.206840671756645 | -0.5885963324325306 | -0.7048681108405186 | 0.416389550893509 | SAM pointed domain containing ets transcription factor (SPDEF), mRNA [NM_012391]
15279 | DQX1 | 2.214035247151774 | -0.4029425040267293 | -0.86841268732503 | 0.4246877515246124 | DEAQ box polypeptide 1 (RNA-dependent ATPase) (DQX1), mRNA [NM_133637]
10012 | BG542103 | 2.218900589878732 | -0.3486963910970808 | -1.059161146704789 | 0.311345842108764 | 602571323F1 NIH_MGC_77 Homo sapiens cDNA clone IMAGE:4695748 5', mRNA sequence [BG542103]
30249 | SMPD3 | 2.219632716421517 | -0.3669915247360135 | 0.9231277199704322 | 0.5763742133314602 | sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (SMPD3), mRNA [NM_018667]
44080 | B3GALT4 | 2.241467180742929 | 0.248069107649179 | 0.6507244607565807 | 0.3590824836627196 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (B3GALT4), mRNA [NM_003782]
12680 | HMGCS2 | 2.243922780884601 | -0.6220298103083843 | -0.3594245382801429 | -0.3483227711867056 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) (HMGCS2), nuclear gene encoding mitochondrial protein, mRNA [NM_005518]
2664 | UGT2B17 | 2.245175341610878 | -0.0323408668246703 | -0.4553460152622293 | 0.09431541510465191 | UDP glucuronosyltransferase 2 family, polypeptide B17 (UGT2B17), mRNA [NM_001077]
21517 | THC2660636 | 2.251968651677835 | -0.02427322261983544 | -0.286544710302838 | 0.4220617115572121 | Unknown
33255 | AQP3 | 2.257236697297349 | 0.5768295628380682 | 0.1378366029886129 | 0.4573116529346302 | aquaporin 3 ([NAME] blood group) (AQP3), mRNA [NM_004925]
30761 | MVP | 2.27031796297426 | 0.5749455489252723 | 0.4431993895017801 | 0.5622498499748394 | major vault protein (MVP), transcript variant 1, mRNA [NM_017458]
13940 | HYAL1 | 2.284590145686563 | -1.45539835401998 | -1.48209460195459 | 0.2451914439197247 | hyaluronoglucosaminidase 1 (HYAL1), transcript variant 1, mRNA [NM_007312]
37039 | SLPI | 2.312342820238388 | -0.2022696139157061 | -1.007238967436492 | 0.792797290760336 | secretory leukocyte peptidase inhibitor (SLPI), mRNA [NM_003064]
41709 | SLC44A4 | 2.315624423115939 | -- | -- | 0.3850055990080443 | solute carrier family 44, member 4 (SLC44A4), mRNA [NM_025257]
43195 | UGT1A8 | 2.325083335320749 | -- | -- | -- | UDP glucuronosyltransferase 1 family, polypeptide A8 (UGT1A8), mRNA [NM_019076]
28131 | MGLL | 2.333884615552495 | -0.389842587749941 | -0.7320675413555411 | 0.7829183795460549 | monoglyceride lipase (MGLL), transcript variant 1, mRNA [NM_007283]
32948 | THC2604598 | 2.338584037438609 | -0.3996990052921716 | -1.185608496963162 | 0.06040626170787855 | AF154107 UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5 {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (25%) [THC2604598]
38991 | MTMR11 | 2.343465279577815 | 0.1226166775127668 | -0.3967663598989681 | 0.5195011870995149 | myotubularin related protein 11 (MTMR11), mRNA [NM_181873]
32342 | LOC124220 | 2.358538538440247 | -0.106962689977053 | -0.5059054140571217 | 0.4533327826650484 | similar to common salivary protein 1 (LOC124220), mRNA [NM_145252]
30718 | AHNAK | 2.365021028318691 | -0.1876806182566084 | -1.035327799186795 | 0.003069921646716933 | [NAME] (AHNAK), transcript variant 2, mRNA [NM_024060]
14586 | CYP4F8 | 2.387146061026178 | -0.4541066301996975 | -0.6337553518186732 | 0.3198616263393217 | cytochrome P450, family 4, subfamily F, polypeptide 8 (CYP4F8), mRNA [NM_007253]
15726 | RPESP | 2.390137163118891 | 0.09164567749851282 | -0.2614956733011664 | 0.6197519210286551 | RPE-spondin (RPESP), mRNA [NM_153225]
20923 | PCK1 | 2.394443374688076 | -1.96160200945269 | -3.617619424595774 | -0.07932796413635701 | phosphoenolpyruvate carboxykinase 1 (soluble) (PCK1), mRNA [NM_002591]
36677 | CLIC3 | 2.396457361529031 | -0.2851744183520631 | -0.2707906629377584 | 0.372323787710205 | chloride intracellular channel 3 (CLIC3), mRNA [NM_004669]
12566 | DIO3OS | 2.397432927931815 | -- | -- | -- | deiodinase, iodothyronine, type III opposite strand (DIO3OS) on chromosome 14 [NR_002770]
33489 | FER1L3 | 2.402674402278981 | 1.3013341851065 | -0.2403466074548963 | 0.5770838677282881 | fer-1-like 3, myoferlin (C. elegans) (FER1L3), transcript variant 1, mRNA [NM_013451]
6020 | KLK10 | 2.43607520766325 | -0.5130430349950643 | -0.4501652807093151 | -0.167545046096663 | kallikrein-related peptidase 10 (KLK10), transcript variant 1, mRNA [NM_002776]
5656 | WDR78 | 2.436904806552388 | 0.4670330555926785 | 0.1661916314673288 | 0.5322503438456219 | WD repeat domain 78 (WDR78), transcript variant 2, mRNA [NM_207014]
10059 | [NAME] | 2.438798343934742 | -0.4224176707690628 | -0.6241658519296909 | 0.08009707254194787 | [NAME] protein tyrosine kinase 6 ([NAME]), mRNA [NM_005975]
1922 | RAB3B | 2.442603367575239 | 0.2565280407677326 | 0.2752162747677733 | 0.4813125306015351 | Homo sapiens cDNA FLJ11245 fis, clone PLACE1008629. [AK002107]
44934 | ELA3B | 2.442793035551263 | 2.157094962472858 | -0.5402153039311155 | -0.1796287797856484 | elastase 3B, pancreatic (ELA3B), mRNA [NM_007352]
20594 | B3GALT4 | 2.451880012893725 | 0.2669401473522819 | 0.7902904143331697 | 0.2516478287584283 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (B3GALT4), mRNA [NM_003782]
22029 | THC2736540 | 2.465693907887238 | -0.5959337361192576 | -0.4383415104828652 | 0.3293681308445882 | 1PE3_1 Chain 1, Solution Structure Of The Disulphide-Linked Dimer Of Human Intestinal Trefoil Factor (Tff3). {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (36%) [THC2736540]
39977 | C1orf116 | 2.488044189908669 | -0.5708037135003678 | -1.138676173595062 | -0.216060333311769 | chromosome 1 open reading frame 116 (C1orf116), transcript variant 1, mRNA [NM_023938]
12958 | AGR2 | 2.491268591675871 | -0.2897756089309125 | -0.7256404346622953 | 0.2180579365694557 | anterior gradient homolog 2 ([NAME] laevis) (AGR2), mRNA [NM_006408]
42172 | RSPH1 | 2.503020748939126 | 0.4955322138944191 | 0.3332819607518083 | 0.3742768455731038 | radial spoke head 1 homolog ([NAME]) (RSPH1), mRNA [NM_080860]
3143 | ST6GALNAC1 | 2.505847428048373 | -1.192807834342216 | -1.837561365205132 | -0.1328161109387551 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GALNAC1), mRNA [NM_018414]
9892 | [NAME] | 2.512182204241668 | -0.6216490990781058 | -1.466610245355113 | 0.4146125293085997 | acyl-Coenzyme A oxidase 2, branched chain ([NAME]), mRNA [NM_003500]
40678 | MUC5AC | 2.521578793587394 | -- | -- | -- | mucin 5AC, oligomeric mucus/gel-forming (MUC5AC), mRNA [NM_017511]
23355 | TSPAN1 | 2.573266734736515 | -0.8578124058050385 | -1.104061949597161 | -0.1345734520928583 | tetraspanin 1 (TSPAN1), mRNA [NM_005727]
32239 | BHLHB3 | 2.59574703652529 | 0.3429931783783173 | 0.8572120702816584 | 0.5648870426514327 | basic helix-loop-helix domain containing, class B, 3 (BHLHB3), mRNA [NM_030762]
5995 | EFNB2 | 2.600916597108672 | -0.4185141816918097 | -0.6785147405310195 | 0.2749989818038094 | ephrin-B2 (EFNB2), mRNA [NM_004093]
40045 | SLC44A4 | 2.608546941370324 | -- | -- | -- | solute carrier family 44, member 4 (SLC44A4), mRNA [NM_025257]
43317 | BC015783 | 2.617943785341838 | 0.8776689416522903 | 0.2738372567098413 | 0.4968062643396385 | Homo sapiens, clone IMAGE:4857346, mRNA. [BC015783]
22181 | MYO1A | 2.627679329115594 | 0.3385695874764779 | -0.1965196691762049 | 0.6863468315982222 | [NAME] IA (MYO1A), mRNA [NM_005379]
9456 | BDKRB1 | 2.650373003993181 | 0.03804501400180671 | -1.473480944055546 | 0.1677965695364885 | bradykinin receptor B1 (BDKRB1), mRNA [NM_000710]
7435 | AKR1C1 | 2.656919984787081 | 0.01949968004700864 | -0.5784590290277025 | 0.2707454724577532 | aldo-keto reductase family 1, member [NAME] (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1), mRNA [NM_001353]
32887 | ENST00000311208 | 2.657136730131199 | -0.1924827888735642 | -0.3526980840092535 | 0.2862187451119484 | DA072538 BRACE2 Homo sapiens cDNA clone BRACE2023553 5', mRNA sequence [DA072538]
37724 | CEACAM7 | 2.684497677939184 | -0.7169079284739934 | -0.9602875532798218 | 0.382540791146079 | carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7), mRNA [NM_006890]
45156 | CCL28 | 2.687760378381489 | -0.6121511671737001 | 0.09112526723290326 | 0.1191414524020846 | chemokine (C-C motif) ligand 28 (CCL28), mRNA [NM_148672]
8836 | CD68 | 2.689738867597111 | -0.5976950841830289 | -0.9340808140391061 | 0.4948662653082729 | CD68 molecule (CD68), transcript variant 1, mRNA [NM_001251]
25016 | ENST00000358378 | 2.700032926809267 | -0.4052711133683127 | -0.5736361395452185 | 0.1646080457553853 | Mucin-5AC (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM) (Major airway glycoprotein) (Fragment). [Source:Uniprot/SWISSPROT;Acc:P98088] [ENST00000358378]
30720 | AK024898 | 2.712634862179969 | 0.1649505265761841 | -0.2260991242745574 | 0.4105542593102713 | Homo sapiens cDNA: FLJ21245 fis, clone COL01184. [AK024898]
37213 | LOC643100 | 2.723366816957014 | 0.7938460294393628 | 0.2829547145696341 | 1.494874690169767 | PREDICTED: Homo sapiens hypothetical LOC643100 (LOC643100), mRNA [XM_931316]
12968 | AKR1C1 | 2.740811128738692 | 0.08673379721648766 | -0.4905008003415636 | 0.2985396143057946 | aldo-keto reductase family 1, member [NAME] (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1), mRNA [NM_001353]
33229 | C15orf48 | 2.751098357900589 | 0.833939658226682 | -0.5129598349805786 | 0.6734468857591542 | chromosome 15 open reading frame 48 (C15orf48), transcript variant 2, mRNA [NM_032413]
2459 | ENST00000358378 | 2.757328061342147 | -0.3978524473477585 | -0.4340922498828429 | -0.16507085146248 | Mucin-5AC (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM) (Major airway glycoprotein) (Fragment). [Source:Uniprot/SWISSPROT;Acc:P98088] [ENST00000358378]
12140 | TAX1BP3 | 2.765728447803377 | 0.2574816942379348 | 0.3262341880030482 | -0.04544169384126517 | Tax1 (human T-cell leukemia virus type I) binding protein 3 (TAX1BP3), mRNA [NM_014604]
21014 | PCP4 | 2.769756949505758 | 0.02867267157534181 | 0.06770783707132955 | -0.255872288507681 | Purkinje cell protein 4 (PCP4), mRNA [NM_006198]
35031 | KRT33A | 2.809866369742662 | -0.06669263740883122 | -0.4934221310483595 | 0.1861967351006631 | keratin 33A (KRT33A), mRNA [NM_004138]
40922 | [NAME] | 2.823066646815501 | 0.5320346208248752 | 0.1315371633071373 | 0.02973243374055867 | zinc finger protein 575 (ZNF575), mRNA [NM_174945]
26935 | CEACAM1 | 2.869234834538273 | 1.313931667598686 | 1.162986801457438 | 0.1913237801201992 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 2, mRNA [NM_001024912]
42836 | ZG16 | 2.876398619978469 | -0.09246045710032202 | -2.300621998058466 | -0.1066333005426827 | [NAME] protein 16 (ZG16), mRNA [NM_152338]
31845 | EFNB2 | 2.903738307446647 | -0.2810373920160231 | -0.4486302625826969 | 0.3362142496024694 | ephrin-B2 (EFNB2), mRNA [NM_004093]
27811 | LRRC19 | 2.923129275403593 | -1.38849959147115 | -2.382954254833519 | 0.6362704838683211 | leucine rich repeat containing 19 (LRRC19), mRNA [NM_022901]
43994 | PLA2G10 | 2.930657017597528 | -0.3871790195290022 | -0.3529544228163871 | -- | phospholipase A2, group X (PLA2G10), mRNA [NM_003561]
42478 | REG4 | 2.933912276256516 | -0.5272037181874412 | -0.03383843187298297 | -0.1020505446051665 | regenerating islet-derived family, member 4 (REG4), mRNA [NM_032044]
18798 | NCF2 | 2.961115660032068 | 0.4857608268487135 | -0.06854013054244168 | 0.5348343235526416 | neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) (NCF2), mRNA [NM_000433]
21045 | TFF1 | 2.972064489044041 | 0.04609196491996048 | -0.1964015641351384 | 0.7707038977569898 | trefoil factor 1 (TFF1), mRNA [NM_003225]
13920 | KRT19 | 2.973976493689061 | -0.185839968527408 | -0.1683069277141215 | 0.4469119979995975 | keratin 19 (KRT19), mRNA [NM_002276]
38150 | BDKRB1 | 2.986038769549614 | -0.06430353778301601 | -1.543281268284545 | 0.2994937149075187 | bradykinin receptor B1 (BDKRB1), mRNA [NM_000710]
14176 | S100A10 | 2.993788399764552 | 0.7575970264922263 | -1.722033305208016 | 0.8850546989921728 | S100 calcium binding protein A10 (S100A10), mRNA [NM_002966]
21584 | SLC37A2 | 2.994164527398445 | 0.1063431078666772 | 0.1173751563264158 | -0.2994173205271204 | solute carrier family 37 (glycerol-3-phosphate transporter), member 2 (SLC37A2), mRNA [NM_198277]
40000 | THC2621222 | 2.99419914853305 | -- | -- | -- | HSU44975 DNA-binding protein CPBP {Homo sapiens} (exp=-1; wgp=0; cg=0), complete [[NAME]]
36760 | ISX | 3.026205091923337 | 2.291599737356475 | 1.003658414616091 | -0.1706597656047038 | intestine-specific homeobox (ISX), mRNA [NM_001008494]
6668 | [NAME] | 3.070783380942014 | -0.4643952878903321 | 0.4801018532429686 | 0.7124542995356455 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) ([NAME]), transcript variant alpha, mRNA [NM_033292]
2377 | P2RX5 | 3.092217075400828 | -0.613063721749513 | -0.2900982133271484 | -0.5350219184794378 | purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), transcript variant 1, mRNA [NM_002561]
28032 | CLIC5 | 3.093473404688433 | 0.1645771338856914 | 0.1883402844123419 | 0.3658257345986362 | chloride intracellular channel 5 (CLIC5), transcript variant 2, mRNA [NM_016929]
14360 | BCAS1 | 3.128185484217092 | -0.5608986138659504 | -1.13667305626893 | 0.6642720871019379 | breast carcinoma amplified sequence 1 (BCAS1), mRNA [NM_003657]
19725 | ARL14 | 3.169008943430497 | 0.478694204483364 | -- | 0.8345675876779741 | ADP-ribosylation factor-like 14 (ARL14), mRNA [NM_025047]
34929 | CDKN2B | 3.184686707666549 | 0.3859844758782711 | 0.9470045557128177 | 1.044452227448309 | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 2, mRNA [NM_078487]
37029 | HSD17B2 | 3.210866583305245 | 0.4900586756300158 | 0.2585248916087068 | 0.1916024277673056 | hydroxysteroid (17-beta) dehydrogenase 2 (HSD17B2), mRNA [NM_002153]
31835 | CA1 | 3.282260128332531 | -- | -- | -- | carbonic anhydrase I (CA1), mRNA [NM_001738]
29963 | LGALS4 | 3.285342069545577 | -0.8210299590074142 | -0.8867567346941971 | -0.2780759299928333 | lectin, galactoside-binding, soluble, 4 (galectin 4) ([NAME]), mRNA [NM_006149]
6879 | SDCBP2 | 3.29872146232375 | -0.3785524879294779 | -0.5892786365316525 | 0.1819870906192054 | syndecan binding protein (syntenin) 2 (SDCBP2), transcript variant 1, mRNA [NM_080489]
42691 | CEACAM5 | 3.32494101141749 | -0.7677321234724142 | -0.5401507940806696 | 0.09775066380044795 | carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), mRNA [NM_004363]
6011 | TFF1 | 3.353249799155414 | -0.2810479095725644 | -0.1736346900736914 | 0.4305764195162851 | trefoil factor 1 (TFF1), mRNA [NM_003225]
5235 | GCNT3 | 3.353739926890607 | -- | -- | -- | glucosaminyl (N-acetyl) transferase 3, mucin type (GCNT3), mRNA [NM_004751]
21191 | ABCC3 | 3.407985631920705 | 0.167201261086894 | -0.3650389804431984 | 0.6599916163230775 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 (ABCC3), mRNA [NM_003786]
3300 | BTNL3 | 3.410390719488152 | -1.589558786474295 | -- | -0.2335691891597538 | butyrophilin-like 3 (BTNL3), mRNA [NM_197975]
30757 | A_32_P121234 | 3.535174186388672 | 1.254574975716244 | 0.1727478754577223 | 1.238149104636209 | Unknown
8206 | DPCR1 | 3.56074113025094 | -- | -- | -- | diffuse panbronchiolitis critical region 1 (DPCR1), mRNA [NM_080870]
18849 | MUC5AC | 3.57664104610299 | -- | -- | -- | H.sapiens (MAR11) MUC5AC mRNA for mucin (partial). [Z34282]
4068 | CEACAM6 | 3.599714135164031 | -1.174513666387779 | -1.072667257585972 | 0.491856024757324 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6), mRNA [NM_002483]
44074 | CEACAM6 | 3.606942951332998 | -1.049735387674559 | -0.8823537601764029 | 0.5213028112160871 | Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen), mRNA (cDNA clone [NAME]), complete cds. [BC005008]
41278 | PDZD3 | 3.610760206478838 | -- | -- | -- | PDZ domain containing 3 (PDZD3), mRNA [NM_024791]
8119 | CEACAM1 | 3.626189073259224 | 0.5327315128390331 | 0.04376235654172245 | 0.6766975415545735 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 1, mRNA [NM_001712]
37310 | BTNL3 | 3.697928030542755 | -- | -- | -- | butyrophilin-like 3 (BTNL3), mRNA [NM_197975]
12676 | MUC17 | 3.79794134460999 | -- | -- | -- | mucin 17, cell surface associated (MUC17), mRNA [NM_001040105]
5733 | LBH | 3.833296936588538 | 0.5778654144292443 | 0.4869747613577777 | -0.03143073825294529 | [NAME] and heart development homolog (mouse) (LBH), mRNA [NM_030915]
37592 | MALL | 4.207950565544142 | -1.280859920120362 | -1.408952567881091 | 0.2791752304106208 | mal, T-cell differentiation protein-like (MALL), mRNA [NM_005434]
18578 | GCNT3 | 4.239116589312991 | -1.190576422158462 | -2.44535112282194 | 1.381372434938899 | Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N- acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.150) (Core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase) (C2/4GnT) (C2GnT- mucin type) (C2GnT-M) (hC2GnT-M). [Source:Uniprot/SWISSPRO
38972 | VILL | 4.246956309719572 | -0.04817014552990284 | -0.896868541636511 | 1.004585020326544 | villin-like (VILL), mRNA [NM_015873]
8064 | SEMG1 | 4.260686112594809 | -- | -- | -- | semenogelin I (SEMG1), transcript variant 1, mRNA [NM_003007]
5832 | CAPN8 | 4.271911724821744 | -- | -- | -- | Calpain 8 (NCL-2). [Source:Uniprot/SPTREMBL;Acc:A2CEN9] [ENST00000366872]
31529 | THC2719076 | 4.275093318064263 | 0.9454996984011708 | 0.660119351434375 | 0.6285544185809512 | Unknown
38468 | TFF2 | 4.353135313341783 | -0.7966177492414364 | -1.286438669827002 | 0.3320102618994878 | trefoil factor 2 (spasmolytic protein 1) (TFF2), mRNA [NM_005423]
15226 | DPCR1 | 4.44484924516809 | -- | -- | -- | diffuse panbronchiolitis critical region 1 (DPCR1), mRNA [NM_080870]
2471 | IL1R2 | 4.472177628114959 | -- | -- | -- | interleukin 1 receptor, type II (IL1R2), transcript variant 1, mRNA [NM_004633]
549 | PLAC8 | 4.52744752892103 | 0.9944433688068459 | -0.4750330467387052 | 0.519001213335545 | placenta-specific 8 (PLAC8), mRNA [NM_016619]
19820 | DHRS9 | 4.535466003939362 | -0.5581951111860768 | -0.287580218738841 | -0.4681895097833393 | dehydrogenase/reductase (SDR family) member 9 (DHRS9), transcript variant 1, mRNA [NM_005771]
32732 | PLAC8 | 4.549978230504573 | 0.8345745660523223 | -0.3045416513985266 | 0.243740142367411 | placenta-specific 8 (PLAC8), mRNA [NM_016619]
8748 | TM4SF4 | 4.638330993960372 | -- | -- | -- | transmembrane 4 L six family member 4 (TM4SF4), mRNA [NM_004617]
2423 | CYP3A7 | 4.650227330045089 | 1.090237848145672 | 0.5161787706811973 | 1.50808170926177 | cytochrome P450, family 3, subfamily A, polypeptide 7 (CYP3A7), mRNA [NM_000765]
1419 | BTNL8 | 4.670899283304346 | -- | -- | -- | butyrophilin-like 8 (BTNL8), transcript variant 2, mRNA [NM_001040462]
29733 | BTBD16 | 4.682431521121188 | 0.6179757030181521 | 0.4316330703636488 | 0.7925060500160157 | BTB (POZ) domain containing 16 (BTBD16), mRNA [NM_144587]
38078 | KRT20 | 4.781848570687923 | -2.211118543625059 | -- | 0.4170954018155451 | keratin 20 (KRT20), mRNA [NM_019010]
18444 | FAM101A | 4.834246016879985 | -0.1500929643251699 | -0.1991965875949909 | 1.113197099680575 | family with sequence similarity 101, member A (FAM101A), mRNA [NM_181709]
27090 | EMP1 | 4.8745269911173 | 0.1423397688509054 | -0.5425942276606941 | 1.191393466318655 | epithelial membrane protein 1 (EMP1), mRNA [NM_001423]
3131 | PTPRH | 4.87753553017668 | 0.6756908777524115 | 0.7272662663304001 | 0.612134523649559 | protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA [NM_002842]
27988 | A_32_P218707 | 4.935972309744773 | -1.528533493763911 | -1.647991738516836 | 0.2716752993986953 | Unknown
35807 | PSCA | 4.978345477481314 | 0.1452479674112146 | -0.02291951997933594 | 0.3598798510462267 | prostate stem cell antigen (PSCA), mRNA [NM_005672]
1602 | FABP1 | 5.065272961044145 | -1.027670406457823 | -1.88463920928755 | 0.6704274713715783 | fatty acid binding protein 1, liver (FABP1), mRNA [NM_001443]
12733 | A_24_P334208 | 5.097454695886322 | -1.130658099865645 | -2.053725900425188 | 0.6375112409535948 | Unknown
28237 | AKR1B10 | 5.136011672490593 | -1.325533071612585 | -1.686431827766004 | 1.004102382997731 | aldo-keto reductase family 1, member B10 (aldose reductase) (AKR1B10), mRNA [NM_020299]
14611 | AKR1B10 | 5.230711237021103 | -1.252617079797267 | -2.030989123696665 | 1.03306770547587 | aldo-keto reductase family 1, member B10 (aldose reductase) (AKR1B10), mRNA [NM_020299]
31671 | IL1R2 | 5.270006326116489 | -0.6073031300311524 | -2.238939516021938 | 0.4194641484862118 | interleukin 1 receptor, type II (IL1R2), transcript variant 1, mRNA [NM_004633]
31816 | [NAME] | 5.570644730274127 | -0.6724311716960909 | -1.882312299311502 | 1.067548593259512 | PREDICTED: Homo sapiens misc_RNA ([NAME]), miscRNA [XR_018726]